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TABLE 2. Taken from Reference 1./
Table 1. Stable changes in enzyme and carrier activityJollowing short term exposure of tissues to insulin
Enzyme or carrier

Tissue

Change in activity

Possible mechanism

References

Glucose uptake
Glucose transport

W,(SM,H)

increase (V*)

? translocation

26-30

Cyclic AMP metabolism
Phosphodiesterase (low Km)
Protein kinase (Cyclic AMP dep.)

W,L
W,SM

increase (V*)
? (W); phosphorylation (l)
decrease
association of Rand C subunits
(V+ in W; Ka* in SM)

Glycogen metabolism
. Glycogen synthase
PhosphoryJase kinase
Phosphorylase
Glycolysis and pyruvate oxidation
Pyruvate kinase
Pyruvate dehydrogenase

34-44

45-48

-,1
1
j

H,SM. W,L

L
W,L

L,W
W,B,L

increase (Ka*)
decrease (V+)
decrease (Ka +)

dephosphorylation
dephosphorylation
dephosphorylation

49-54,86
J
51, 55
,,~
52,53,55-57,86:

increase
(Ks + in L; Ks* in W)
increase (V*)

dephosphorylation (l); ? (W)

58~2

dephosphorylation

63-71

(MG)

Lipid metabolism
Acetyl CoA carboxylase

W,B,L

increase (V*)

71-82

Column 2 and elsewhere: W. white fat; B. brown fat; H. heart muscle; SM. skeletal muscle; L.liver; MG. mammary gland. Column 3: ":1
change in Vmax; Ks. change in Km for substrate; Ka change in sensitivity to appropriate activator; * change in activity most marked in absence:
of other hormones; + change in activity most marked under conditions of increased cell cyclic AMP concentrations
.:;.~
9
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CHARLES F. BURANT.

The Role of the Insulin Receptor in Skeletal Muscle

Insulin Resistance: Evaluation of Two Animal Models.

(Under the

direction of MARIA G. BUSE.)

The role of the insulin receptor in muscle insulin resistance was
studied.

Denervation of skeletal muscle resulted in the rapid appear-

ance of a decrease in basal and insulin stimulated glucose transport,
glycogen synthesis and a defect in the activation of glycogen synthase
which was independent of levels of glycogen in the muscle.

The effect

was seen in both predominantly red and predominantly white muscle.
There was no change in the denervated muscles' sensitivity to epinephrinemediated decrease in glycogen synthesis or glycogen content, nor was
there a major change in the insulin binding capacity of denervated
muscles.
A technique was developed to investigate the properties of the
insulin receptor solubilized from skeletal muscle.

Freezing hindlimb

muscles with subsequent powdering and homogenization with buffered
Triton X-100 produced a fraction with specific insulin binding.

Further

purification on agarose-bound wheat germ agglutinin yielded insulin
receptors with intact insulin binding, as well as insulin stimulatable
autophosphorylation and exogenous substrate kinase activity.
phorylation of the insulin receptor

~-subunit

The autophos-

in intact tissues was also

demonstrated.
The binding and kinase domains of insulin receptors solubilized
from denervated skeletal muscle were identical to that from contralateral controls.

No significant changes were seen in the autophos-

phorylation of the

~-subunit

in intact, denervated solei.

Injection of

vi

insulin in the rat and subsequent partial purification of insulin receptors in the presence of phosphatase inhibitors allowed the demonstration of an increased kinase activity towards histone H2 b as compared to
saline treated rats.

The increase was due to an increase in tyrosine

phosphorylation attributed to the activation of the insulin receptor
kinase.

Again, no change in the insulin receptors from denervated

muscles was observed.
Streptozotocin diabetes resulted in an increase in specific insulin
binding but a decrease in insulin-stimulatable autophosphorylation and
tyrosine kinase activity.
a-subunit but the

Structural analysis showed no change in the

~-subunit

on electrophoresis.

The

attained a component with a slower migration

~-subunit

change was shown to be, in part, due

to increased sialic acid content of the receptor subunit.

The kinetic

and structural changes were reversible with insulin treatment of the
rat.
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CHAPTER I: INTRODUCTION & LITERATURE REVIEW
Insulin has varied and profound effects upon its target tissue.
Even with the immense amount of effort to elucidate the mode of action
of insulin, the exact pathway leading from insulin binding to the
changes in intracellular metabolism remain a mystery.

Many theories on

the mechanism by which insulin acts upon the cell, including searches
for tsecond messengers' analogous to cAMP have been proposed (Table 1).
Most, however, have not withstood the test of time (1).

INSULIN MEDIATORS:

Two areas of investigation into the mode of

action of insulin have recently received much attention: the generation
of small peptide mediators and the recently discovered kinase activity
of the insulin receptor.
below.

This latter aspect is discussed in detail

By taking extracts of cells treated with insulin, several investi-

gators have been able to demonstrate insulin-like effects on certain
enzyme systems in broken cell preparations (2,3,4,5).

Two commonly used

end point assays are the activation of pyruvate dehydrogenase and the
inhibition of cAMP dependent protein kinase (6).

Since the insulin-like

activity of the substance is eliminated by protease treatment, the
mediator is thought to be a protein.

Gel filtration has shown that the

molecular weight of the substance to be small - "" 1000-2000 daltons (5).
Further data revealed that some of the 'mediator' effects could be
abolished by treatment with glycosidases (6), suggesting a glycoprotein
nature of the substance.
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Because cells treated with low concentrations of trypsin show
insulin-like responses, and this same treatment can reproduce the generation of the small peptide 'mediators', Larner has proposed that insulin
acts to produce these mediators by the initiation of a proteolytic event
(6).

However, due to complications such as mUltiple peaks of activity

when the mediator extract is separated by chromatography, the nonspecificity of the end point assays and the fact that the exact chemical
nature of the peptide has not been determined, it is difficult to assess
at this time the merits of the mediator theory in insulin action.
GLUCOSE TRANSPORT:

Upon exposure of a cell to insulin, one wit-

nesses an increase in the influx of glucose.

Glucose enters the cell by

facilitated diffusion and the effect of insulin is to increase the Vmax
of the transport reaction.

In independent observations Suzuki and Kono

(7) and Cushman and Wardzala (8) have provided a mechanism for the
increase in glucose transport.

By isolating plasma membranes from

insulin treated cells they showed there is an increase in the ability of
the membranes to transport glucose and bind [3H]cytochalsain B, which
tightly binds hexose transporters.

In parallel to the observed increase

in glucose transporters on the surface membranes there was a concommittant decrease in glucose transporters in the low density microsome
fraction of these cells.

These results suggested that insulin causes

the translocation of the glucose transporters from the interior of the
cell to the cell surface.
This redistribution theory has been elegantly confirmed by Oka and
Czech (9).

Cytochalasin B binds to the "inside tt hexose binding site of

the glucose transporter while the non-transportable glucose analogue
ethylidene glucose binds to the "outside tt hexose binding site and
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changes the transporters conformation such that the "inside" site now
loses its ability to bind the cytochalasin.

•

Incubation of control cells

with ethylidene glucose along with Cytochalasin B (which can be photocrosslinked to the glucose transporter) allowed the demonstration of
labeling of only the low density microsomal fraction of the glucose
transporters.

Furthe"rmore, upon stimulation of the cells with insulin

there was an increase in the number of photo-crosslinked transporters
isolated from the plasma membrane.
In addition to increasing glucose transport insulin also causes the
stimulation of intracellular glucose metabolism such as increases in
glucose oxidation and glycogen synthesis as well as an increase in
pentose shunt activity.

The immediate effects of insulin on the intra-

cellular metabolism of glucose occur primarily through the increase in
activity of certain sets of enzymes and inhibition of others.

For

example, the increase in glycogen accumulation seen in cells after
insulin treatment is due to the activation of the enzyme glycogen synthase which incorporates glucose into glycogen.

Dephosphorylation of

certain sites on the enzyme increases its affinity for glucose-6-phosphate which is an allosteric activator of the enzyme (10).

The Concen-

tration of glucose-6-phosphate also increases in the cell as a result of
the insulin stimulation of glucose transport.

The enzyme phosphorylase,

which breaks down glycogen into glucose monomers is inactivated in cells
treated with insulin also by the dephosphorylation of sites on the
enzyme (11).

This cycle of phospborylationderhospporylation is repeated

on numerous other metabolic pathways that are modulateq by insulin
(Table 2).
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In addition to the effects on glucose metabolism, insulin also has
effects on transport of amino acids, ion fluxes across cell membranes,
the synthesis and degradation of protein and triglycerides and influences RNA synthesis (1).

These effects of insulin are also seen rela-

tively rapidly after insulin exposure and occurs at relatively low
concentrations of insulin.

This is in contrast to the growth promoting

effects of insulin which require higher concentrations of insulin and
occurs in a time frame of hours to days.

This growth promoting effect

of insulin may be mediated through a pathway distinct from that associated with the well-characterized changes in intermediary metabolism
(see below).
INSULIN BINDING:

Although the results of insulin exposure to cells

are well-characterized, the mechanism by which insulin causes changes in
the metabolic state of the target tissues are unknown.

The initial

event in insulin action is binding to specific cell surface receptors.
The binding of insulin to this receptor is specific and saturable with a
dissociation constant of approximately lO-1 2 M.

The number of these high

affinity receptors is low on most cells and in the most abundant case
represents only 0.01% of the protein in plasma membrane preparations
(12)..

Even with this small number of receptors it has been observed in

a number of cell types that the maximal biological response can be
elicited when only a fraction of the high affinity receptors are occupied (13).

Binding isotherms of insulin to receptors on intact cells,

on membranes and to receptors solubilized by the use of non-ionic detergents are non-linear when plotted by the method of Scatchard.

Debate

exists for the reason behind this curvilinearity, which may be due on
one hand to the existence of two different classes of receptor molecules
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that differ in their affinity for insulin or to a negative cooperativity
in insulin binding where the bivalent receptor, after binding one insulin molecule, has a reduced affinity for the second.

The negative

cooperativity model was given strong experimental support by the experiments of DeMeyts (14) who showed that the dissociation of previously
bound [ 125 1]insulin was increased in the presence of unlabeled insulin.
EVidence also exists for the first model however.

Pollet et al. (15)

have demonstrated that the increase in the dissociation of labeled
insulin from its receptor induced by added insulin to the media occurs
at the same rate regardless of the degree of receptor occupancy_

He

also points out that univalent receptors such as the prolactin receptor
also show curvilinear Scatchard binding profiles.
BINDING INDUCED CONFORMATIONAL CHANGES:

The binding of insulin to

its receptor appears to result in change in the conformation of the
receptor.

By the use of radiation inactivation it was shown that the

occupied receptor was altered in rat liver membranes (16).

The occupied

receptor is more susceptible to the digestive actions of trypsin (17)
suggesting a conformational change upon insulin binding that exposes
trypsin sensitive sites.

In a series of reports, Donner and co-workers

have demonstrated a time and temperature dependent increase in insulin
receptor affinity.

They suggest that the receptor exists in two affi-

nity states and that binding of insulin shifts the equilibrium towards
the higher affinity conformation (18,19,20,21).

In a recent report,

this group used affinity cross-linking techniques to show that a biphasic pattern of trypsin sensitivity of the receptor occurred upon insulin binding.

After an initial increase in trypsin sensitivity, com-

ponents of the receptor became less trypsin labile.

This shift in
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protease sensitivity was correlated to an increase in the amount of
insulin receptor in the higher affinity state (22).
LIGAND INDUCED AGGREGATION AND INTERNALIZATION:

In an analogous

fashion to that seen with surface immunoglobulin molecules which are
exposed to antigen, the insulin receptor, upon binding insulin, aggregates to form patches and caps on the cell surface.

This has been

directly observed using fluorescent microscope techniques (23).

The

importance of microaggregation in the signalling of the receptor was
demonstrated by the use of fragments of antibodies directed towards the
insulin receptor.

It was shown that bivalent Fab fragments of these

antibodies were insulinomimetic in that they could stimulate the uptake
of glucose into the target cells (in this case lymphocytes) but the
monovalent Fab did not change glucose flux.

The addition of bivalent

antibodies towards the monovalent antibodies resulted in aggregation and
an increase in glucose transport.

Bivalent antibodies directed towards

insulin were synergistic with insulin in eliciting a metabolic response
(23,25).
Several morphological and biochemical studies have shown that the
aggregated insulin receptor and associated insulin are internalized and
the insulin subsequently degraded in a time and temperature dependent
fashion.

This is known as receptor mediated endocytosis and is common

to many cell surface receptors.

For low density lipoproteins, trans-

ferrin and certain toxins (i.e . tetanus toxin) this endocytotic event is
required for these substances to alter cellular metabolism (26).

The

receptors for these substances are seemingly the shuttle for transfer of
the ligands to the interior of the cell.

In most cells the endosomes

fuse with lysosome like vesicles (receptosomes) and the bound insulin is
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rapidly degraded.

The unoccupied receptor is then either degraded or

recycled back to the surface of the cell (27,28).

The exact role of the

endocytotic event in peptide hormone action remains unclear.

It has

been suggested that some of insulin's effects may be mediated through
binding of intracellular insulin receptors which reside on various
organelles (29).

This is unlikely in that substances which interfere

with the internalization of insulin have little effect on insulin's
biological effects (30).

Furthermore, microinjected insulin had no

insulin-like effects on the cells treated.
STRUCTURE OF THE INSULIN RECEPTOR:

Various methodologies that have

evolved over the last IS years have allowed the determination of the
structure

of

the insulin receptor.

By using affinity chromatography

after solubilizing membrane components in non-ionic detergents, Jacobs
and Cuatrecasas were able to isolate receptor-rich fractions that were
analyzed by gel electrophoresis (31).

They identified a component of

135,000 daltons, but the affinity of the fractions isolated had a much
lower affinity for insulin than the crude receptor preparation making
interpretation of the data difficult.

A major step in elucidating the

structure of the insulin receptor was the development of ways to label
the insulin receptor with [12 5 I]insulin either by the use of photoactivable insulin analogues (32) or by cross-linkage with chemical
reagents such as disuccinimidyl suberate as used by Pilch and Czech
(33).

Combining these techniques with affinity chromatography allowed

the identification of the molecular weight and subunit composition of
the insulin receptor (33,34,35).

As shown in Figure 1 the insulin

receptor is considered to be a heterotetramer composed of 2 a and 2
subunits of molecular weight of -

125,000 daltons and

~

~

95,000 daltons
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respectively.

The subunits are held together by disulfide bonds.

Using

various concentration of reducing agents Massague and Czech (36) have
shown that the disulfide bonds that link the

~-subunits

units are much stronger than thea-S-S-a bond.

to the a-sub-

This proposed structure

of the insulin receptor was confirmed in a report by Fujita-Yamaguchi
(37) who used affinity chromatography to obtain an apparently homogeneously pure preparation of the insulin receptor.

She identified subunits

of 135,000 and 95,000 daltons and determined by peptide mapping that an
often identified subunit of approximately 50,000 daltons was a proteolytic degradation product of the

~-subunit.

On the basis of their relative labeling after cross-linkage of
insulin, it has been suggested that the a-subunit of the insulin receptor is the primary binding subunit with perhaps only a small domain of
the

~-subunit

involved in insulin binding (38).

This is consistent with

the orientation of the subunits in the membrane of intact cells.

The

a-subunit is sensitive to digestion when cells are treated with trypsin
added to the media while the

~-subunit

remains intact (38).

Likewise,

the a-subunit is preferentially labeled when membrane proteins are
surface iodinated with much weaker labeling of the
indicating that the

~-subunit

outer face of the cell.

~-subunit

(39,40),

has less of its protein sequence on the

It has been shown that the

~-subunit

of the

insulin receptor is very susceptible to proteolytic cleavage by elastase
type enzymes (41).
that the

~-subunit

a-subunit intact.
insulin nearly as

Using this property, Roth et al. (42) demonstrated
could be preferentially degraded while leaving the
The a-subunit in these preparations could bind
w~ll

as the insulin receptor before degradation.
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Since most, if not all surface proteins and receptors are glycoproteins (43) , it is not surprising that the insulin receptor too is a
glycoprotein.

This was first assumed based on studies that showed that

insulin binding to isolated adipocytes was severely impaired after
treatment with neuraminidase and other glycosidases (44).

Subsequently

it was shown that concanavalin A and wheat germ agglutinin could modulate insulin binding (45) as well as specifically adsorb insulin binding
activity when the lectins were immobilized on an insoluble matrix (46).
Direct demonstration of the glycoprotein nature of the insulin receptor
was carried out by Hedo et ala (39) by metabolically labeling IM9lymphocytes with [3H]monosaccharides and specifically immunoprecipitating the insulin receptor with anti-insulin receptor antibodies.
results presented suggest that both the

Q-

and

~-subunits

The

contain com-

plex carbohydrate side chains since all the major [3H]monosaccharides
known in complex carbohydrate sugar side chains were incorporated into
both subunits.

It appears that the a-subunit has a relatively greater

abundance of galactose and N-acetylglucosamine residues whereas the
f3-subunit has a higher sialic acid content.
Tunicamycin, a potent inhibitor of core oligosaccharide addition to
asparagyl residues (n-linked core glycosylation) effectively reduces
cell surface insulin binding capacity (47) but has no effect on recycling of previously synthesized receptors (48).

Furthermore, tunica-

mycin causes the accumulation of intracellular aglycoreceptor precursors
which will appear on the cell surface after removal of tunicamycin from
the media (49).

Using pulse chase labeling techniques in 3T3-LI adipo-

cytes Ronnett et a1. (50) have proposed a model for the synthesis and
~~~t-t~anslational

processing of the insulin receptor.

They proposed
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that in these cells both the a- and

~-subunits

are synthesized as a

180-190kDa pro-receptor peptide that is rapidly converted to a 210kDa
core glycosylated peptide.
immature a(12SkDa) and

Specific proteolytic cleavage forms an

~(83kDa)

subunit which through further side chain

modifications (conversion from a 'high mannose' to a 'low mannose' state
and subsequent addition of monosaccharides) are converted to the mature
135kDa a and 9SkDa

~

subunits.

This latter glycosylation event appears

to occur immediately prior to the mature receptors' appearance on the
cell surface.

Some refinements of the results presented in this paper

were provided in a report by Salzman et al. (51).

Using different

concentrations of the ionophore monensin, the investigators were able to
block processing of the core glycosylated pro-receptor (210 kDa above)
or with a lower concentration block the maturation of the immature forms
of the insulin receptor subunits.

They were able to show that the

uncleaved, pro-receptor and the immature subunits could accumulate on
the cell surface, suggesting that the signal for transit to the cell
surface resides in the core peptide or the core glycosylated peptide.
The 210 kDa peptide and the immature a-subunit were able to bind insulin
and the former peptide and the immature
phorylate.

~-subunit

were able to autophos-

The invesgigators in this report were also able to show that

the mature a- and P-subunits were sensitive to the enzyme endoglycosidase H, suggesting that not all the carbohydrate side chains on the
receptor subunits are processed to a 'low mannose t state.
Indirect evidence for the existence of possible O-link carbohydrate
side chains on the insulin receptor
et al. (52).

~-subunit

was provided by Herzberg

Using both enzymatic and chemical deglycosylation methods,

they were able to show that both the a- and f3-subunits of the insulin
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receptor were sensitive to digestion with endoglycosidase Hand endoglycosidase F.

The former endoglycosidase removes 'high mannose' carbohy-

dr.ate side chains at the chitobiose core (the cleavage takes place
between the two N-acetylglucosamine residues that are attached to the
asparigyl group in N-linked glycoproteins) while endoglycosidase F
removes both high and low mannose sugar side chains of most
glycoproteins, also at the chitobiose core.

N-link~d

The a-subunit was appar-

ently completely deglycosylated by treatment with endoglycosidase F as
judged by its mobility shift when compared to insulin receptors deglycosylated by chemical means (treatment in this case was performed with
trifluoromethanesulfonic acid, TFMS) and resolved at a molecular weight
of - 98 kDa.

The

~-subunit

on the other hand did not achieve the same

decrease in molecular weight after digestion with Endoglycosidase F as
was observed after treatment with TFMS.

This suggested to the authors
~-subunit

that there may be Q-linked oligosaccharide side chains on the
of the insulin receptor.

Data relevant to this point are presented in

Chapter 5 of this dissertation.
The role of the carbohydrate moiety of the insulin receptor in
insulin binding and signal transmission has been studied by several
groups (53,54,55).

In general it was shown that removal of sialic acid

residues with neuraminidase did not affect insulin binding.

Cuatrecasas

and Illiano (56) showed however that the treatment affected the ability
of insulin to promote glucose transport and inhibit lypolysis.

A recent

report by Fujita-Yamaguchi (57) using highly purified insulin receptor
preparations showed that the removal of the sialic acids from the receptor resulted in an increase in the binding activity and the tyrosine
kinase activity of the insulin receptor (the tyrosine kinase activity of
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the insulin receptor will be discussed in detail below).
Two groups have recently produced a cDNA clone of the insulin
receptor which allowed the peptide sequence of the receptor to be deduced (58,59).

The data suggest that the insulin receptor is synthe-

sized as a single polypeptide and is post-translationally cleaved to
form the a and

~-subunits.

This is exactly the results that are ob-

tained in the pulse-chase studies of Ronnett et ale (50) and Salzman et
al. (51).

The predicted molecular weight of the unglycosylated a-and

~-subunits

are -84,000 and -70,000 kDa respectively.

The a-subunit

occupies the N-terminus of the precursor and is rich in cysteine residues that may compose a cross-linking domain on the external face of the
membrane.

This region is probably distinct from the insulin binding

domain that also is predicted to lie in the C-terminus region of the
a-subunit.

At the end of the a-subunit coding sequences a run of basic

amino acids are predicted which may code for the cleavage site of the
polypeptide precursor which would then form a- and
~-subunit

~-subunits.

The

coding region predicts a transmembrane region and a concenSllS

sequence for an ATP binding site and an area that may code for phosphotyrosyl transferase activity.

It is of considerable interest that even

though the two reported cloned insulin receptor cDNAs came from placental mRNA, the sequence that were obtained were different in 22 nucleotide residues and a block of additional nucleotides that were found in
the Ebina paper that was not found in the Ulrich paper.
these differences are not apparent.

The basis for

It is also of interest to note that

while the Ulrich et al. found 15 possible glycosylation sites on the asubunit, Ebina et al. found only 13, while on the

~subunit

7 or 4 poten-
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tial glycosylation sites were quoted by the groups respectively.

Part

of these differences are due to differences in the predicted amino acid
sequence and to the assessment of the groups of asparagine residues that
are potentially glycosylated.

Because of the absence of a hydrophobic

domain in the a-subunit that is long enough to span the membrane, Ulrich
et al. (58) have suggested that the a-subunit is entirely extracellular
and anchored to the cell via disulfide linkages with the f3-subunit.

The

schematic representations of the insulin receptor as derived from sequence data is presented in Figure 2.

By comparing predicted sequences, it was noted that there is a
great deal of homology between the insulin receptor and the EGF receptor
and, in the region that codes for the phosphotransferase activity, there
is a great deal of homology with the src family of oncogene products.
The consequences of these homologies will be discussed below.

Jacobs et

al. have recently published data on the structure and synthesis of the
IGF I receptor (60).

It shows that there is remarkable structural

similarities between the receptors for IGF I and insulin.

The hormones

themselves are also homologous (61) and they can cross react, with lower
affinity, with each others' receptors.

These observations have lead to

the suggestion that the growth promoting effects of insulin may be
mediated through the IGF I receptor.

INSULIN RECEPTOR KINASE ACTIVITY:

Perhaps the most important

recent discovery in the field of insulin research is the identification
of the insulin stimulated protein kinase activity that appears to be an
intrinsic part of the insulin receptor.

The distinguishing feature of

the insulin receptor associated protein kinase is that the phosphoryltransferase reaction uses tyrosine as the acceptor amino acid (62,63).

14

This tyrosine kinase activity was first recognized as a unique feature
of the transforming gene product of the Rous sarcoma virus (64,65) and
has been identified as a feature of many of the transforming peptides
associated with retroviruses (64).

In most cases the protein carrying

out the phosphotransferase activity are themselves substrates for their
own kinase activity (i.e. undergo autophosphorylation).

Evidence sug-

gest$ that this tyrosine kinase activity is related to the transformation of cells infected with these viruses.

The tyrosine content of

cells that are transformed with the retroviruses increases substantially
(65).

Rous sarcoma virus that is temperature sensitive for the induc-

tion of the transformed phenotype also show a temperature lability of
the tyrosine kinase activity associated with the transformation associated peptide, pp60src (66).

Mutation of the gene that codes for the

tyrosine kinase containing peptide such that the tyrosine kinase activity is abolished (as assessed by in vivo tyrosine content of the cells
thus infected and by in vitro assays) show a marked decrease or an
elimination of the transforming activities of the alt.ered viruses
(65,66,61).

A recent report (68) demonstrated that the addition of

vanadate ion, a potent inhibitor of phosphotyrosyl phosphatases, to the
culture medium of several different cell types resulted in the morphological transformation of these cells.

The transformation was dose-

dependent and correlated with an increase in the phosphotyrosine content
of the cells.

Thus, it seems that there ia evidence that the phosphory-

lation of tyrosine is correlated with cell multiplication and gr9wth.
The fact that the transforming proteins of the retroviruses originated in the genome of eukaryotic cells strongly suggests that the
tyrosine kinase activity is important for normal cellular growth and

15

differentiation.

It is then perhaps not surprising in retrospect that

many of the surface receptors for polypeptide hormones contain tyrosine
kinase activity.

Tyrosine kinase activity as an integral aspect of a

normal cellular component was first identified in the epidermal growth
factor (EGF) receptor (69) and has since been identified in the receptors for the platelet derived growth factor receptor (70), the insulin
like growth factor I receptor (71) and as mentioned above, the insulin
receptor.
The tyrosine kinase activity of the insulin receptor has been
well-characterized and has been identified in numerous tissues (Table
3).

The initial characterization of the skeletal muscle insulin re-

ceptor was carried out as part of this dissertation (Ref. 72) and the
data is presented in Chapter 3.

The autophosphorylation event is seen

in both the intact tissues as well as in the detergent solubilized
system (62,63) and occurs on the

~-subunit

binding site of the receptor (80,81).

which also contains the ATP

Eviden·ce that the

~-subunit

is

the actual moiety that carries out the phosphotransferase reaction comes
from the experiments of Roth et al.
~-subunit

(42) who preferentially digested the

of the insulin receptor and showed while binding remained

intact the ability of the solubilized receptor to act as a kinase was
eliminated.

In the solubilized receptor the autophosphorylation is

stimulated by insulin binding, is ATP dependent, requires Mn++ of Co++
cations and occurs almost exclusively on tyrosine residues (76).

Avruch

et a1. (76) have shown that the autophosphorylation event parallels
insulin receptor occupancy and is saturated when insulin binding is
saturated.

In an elegant series of experiments White et al. (82) showed

that insulin's effect on the reaction is to increase the Vmax while the
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required cation reduces the Km.

Using High Performance Liquid Chroma-

tography (HPLC) to separate peptides generated by trypsin digestion of
the autophosphorylated receptor, this group showed that the solubilized
receptor contained approximately 5 sites that were phosphorylated in
response to insulin.

Using a similar system

Yu and Czech (78) identi-

fied 3 sites on the ~-subunit that was labeled by y[ 32 p]ATP in response
to insulin.
In addition to its ability to autophosphorylate, the insulin receptor, in the solubilized system, has an insulin stimulatable exogenous
substrate kinase activity.

First identified by Rosen et ale (83) a wide

variety of substrates have been identified for the tyrosine kinase of
the solubilized insulin receptor system (Table 4).

While many of these

substrates are obviously not possible intracellular targets of the
insulin receptor, they serve as useful tools in examining the exogenous
substrate kinase activity of the insulin receptor.

The identification

of physiologically relevant intracellular targets for the insulin receptor has been elusive.

The activation of the exogenous substrate

kinase activity of the insulin receptor is dependent on the autophosphorylation of the insulin receptor

~-subunit

(78,84) and is thought to be

due to the phosphorylation of a specific tyrosine residue on the insulin
receptor

~-subunit

(78).

The cation requirement of the exogenous sub-

strate kinase activity is complex and seemingly depends upon the substrate, thephosphoacceptor, as well as on the concentration of ATP used
in the kinase reactions (90,91).

As expected from their similarity in

structure and function, the properties of the EGF receptor and the IGF I
receptor associated kinases are very similar to those of the insulin
receptor (Table 5).
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In the intact cell, the observed insulin stimulated autophosphorylation of the insulin receptor p-subunit is different than that seen in
the solubilized system.

The formation of phospho-tyrosine, serine and

threonine is observ.ed in the immunoprecipitated insulin receptor p-subunit after insulin stimulation.

Recently it has been shown that the

labeling of the serine and threonine residues are likely due to other
kinases, distinct from the insulin receptor, and the initial autophosphorylation events occur almost exclusively on tyrosine residues (92).
In this same report it was demonstrated that insulin receptors that were
phosphorylated on serine residues prior to insulin binding were poorly
labeled on tyrosine subsequent to insulin binding.

This was done by

first preCipitating the solubilized proteins from the labeled cells with
anti-phosphotyrosine antibodies and then preCipitating with anti-insulin
receptor antibodies.

Within seconds after tbe exposure of the cells to

insulin, the proteins that were precipitated with the anti-phosphotyrosine sera were almost exclusively labeled on tyrosine with the
content of phospho serine and phoshhothreonine increasing with longer
incubations.

On the other hand the receptors precipitated with anti-

insulin receptor serum after the first immunoprecipitation were labeled
almost exclusively on serine residues.
The modulation of insulin receptors by serine phosphorylation was
directly demonstrated by White et a1. (93) wherein treatment of hepatoma
cells with the phorbolester 12-0-tetradeconoyl phorbol acetate (TPA)
resulted in decreased phosphorylation of the insulin receptor on tyro'"
sine residues upon exposure to insulin.

It had previously been shown

(94) that the treatment of lymphocytes with TPA resulted in a decrease
in insulin receptor affinity.

It is interesting to note that Pessin and
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Czech (95) have recently reported that the treatment of fat cells with
isoproterenol (a

~-adrenergic

agonist) greatly reduces the affinity of

insulin receptors for insulin and in a preliminary report Czech has
stated that this treatment decreases the ability of the insulin receptor
to autophosphorylate (62) possibly due to the cAMP mediated phosphorylation of the insulin receptor.

It has been previously demonstrated

that cAMP mediated hormones have the ability to phosphorylate the EGF
receptor (96).
White et a1. (97) compared the sites of autophosphorylation on the
insulin receptor
bilized receptor.

~-subunit

in the intact cell as compared to the solu-

In the hepatoma cell line employed insulin was able

to induce the autophosphorylation 3-4 fold.

The increase in labeling

occurred on all the phospho-accepting amino acids.

Time course analysis

showed that the stimulation of tyrosine phosphorylation was at steady
state after 20 sec and that no change in the amount of phosphoserine or
phosphothreonine occurred during this initial stage of autophosphorylation.

The phosphotyrosine content of the receptor remained constant

for one hour.
~-subunit

Two in vivo sites of tyrosine phosphorylation on the

were autophosphorylated, one minor site corresponded to the

major site seen in vivo, while a major site seen in the in vitro system
was a minor site observed in vivo.

One of the sites autophosphorylated

in the solubilized system did not occur in the whole cell labeling
experiments.

This report points out that while there are similarities

in the tyrosine autophosphorylation event in the intact cell and in the
solubilized system, there are also differences that could make interpretation of experiments performed in vitro difficult.
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INSULIN RESISTANCE:

This dissertation is concerned with the role

of the insulin receptor in insulin resistance.

As seen in the above

discussion, the insulin receptor is a complex molecule that has two
domains, a binding domain which presumably lies in the a-subunit, and a
kinase domain which lies in the

~-subunit.

It is not then surprising

that pathologies exist that show alterations in one or another of these
functional domains of the insulin receptor.
Flier (98) has defined insulin resistance as "a state in which a
given concentration of insulin produces less than the expected
response".

Two experimentally defineable endpoints of insulin action

can be used to quantitate insulin resistance,
that produces half-maximal response and
achievable with the hormone.

(a) the dose of insulin

(b) the maximal effect

Kahn (99) has proposed that an alteration

in the dose to give half maximal effect is defined as a change in
sensitivity whereas a change in maximal achievable effect is a change in
responsiveness.
A wide variety of physiological and pathological states exist which
manifest themselves, at least in part, with alterations in the insulin
receptor (Table 6).

The most common alteration of the insulin receptor

is down-regulation that occurs in the hyperinsulinemic state.

With

chronic exposure to insulin in the plasma, the number of insulin receptors decreases on the cell surface without an apparent change in the
affinity of the insulin receptors which remain.

Using lymphocytes this

decrease in insulin receptor number was shown to be due to an increase
in the rate of degradation with no alteration in the rate of synthesis
(100).

This is a common occurence and is a major part of the insulin

resistance which is seen in obesity.
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Experimental studies with obese animals have shown that all tissues
respond to hyperinsulinemia with a decrease in receptor numbers and that
the decrease is proportional to the degree of hyperinsulinemia (101).
This decrease in insulin receptors, by mass action should only result in
a shift in the dose response curve i.e. a decrease in sensitivity.
However, in adipocytes there also develops a decrease in responsiveness.
The nature of this defect is unclear but experiments directed towards
understanding this phenomenon have recently been carried out by Garvey
et al. (102).

They showed that concommittant with a decrease in surface

insulin receptors in adipocytes chronically exposed to insulin there
occurred a decrease in the number of surface glucose transporters.
These "co-down-regulated" transporters could not be recruited to the
cell surface upon further stimulation of the adipocytes with insulin.
This suggests that in the case of glucose transport the mechanism of
down-regulation of the receptors is related to the insulin resistance
seen in these cells.

The relationship of down-regulation and defects in

intracellular glucose metabolism is still to be determined.
In many patients obesity is associated with the development of
non-insulin dependent (type II) diabetes.

These patients have fasting

hyperglycemia and normal or high fasting insulin levels that are subnormal after the administration of an oral glucose load (103).

These

subjects have approximately the same degree of impairment of insulin
binding as compared to obese individuals but a greater defect in insulin
action thus the appearance of overt diabetes (104).

That fibroblasts

from obese type II diabetics bind and respond to insulin normally after
culturing (105) suggests that the defect is due to an alteration in the
metabolic milieu of the subject rather than a genetically defined defect
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expressed constitutively in all cells.
A rare subset of patients with severe insulin resistance have a
defect in the action of insulin at the cellular level.

Characterized as

a syndrome with virilization, polycystic ovaries and acanthosis nigricans, most of these patients have a genetic defect in the structure of
the insulin receptor which results in defective insulin binding (106) or
decreased or eliminated insulin receptor kinase activity (73,107).
has been deSignated the Type A syndrome of insulin resistance.

This

Patients

with Type B syndrome exhibit the acanthosis nigricans and rheumatic type
symptoms but not the virilization of the Type A patients and are characterized by a high titer of anti-insulin receptor antibodies (106).
There has also been described a defect in the action of insulin in
insulinopenic diabetes mellitus (Type I diabetes).

A discussion of this

problem and our experiments in trying to understand this is contained in
Chapter 5 of this dissertation.

DENERVATION INDUCED INSULIN RESISTANCE:

Patients with peripheral

neuropathies or paralysis often have glucose intolerance (108,109).

In

early work from this laboratory, it was shown that the glucose intolerance could come from an alteration in the ability of skeletal muscle to
respond to insulin.

Buse and Buse (110) showed that in the absence of

insulin there was no change in xylose uptake of denervated diaphragms
but the response of the denervated diaphragms to insulin was significantly less than controls.
after denervation.

This effect was seen within twelve hours

Using relatively unrefined techniques there was no

demonstrable change in insulin binding to the denervated muscle.

In a

later report it was shown that in addition to decreased hexose transport, the denervated diaphragm was also resistant to insulin stimulated
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accumulation of glycogen (111).

Recently, numerous reports have ap-

peared in the literature investigating the effects of denervation on
glucose and protein metabolism in the denervated skeletal muscle (112118).

Our own efforts in this regard have been published (118) and are

contained in Chapter 2 of this dissertation.
Our observations and those of others on ,the insulin resistance of
skeletal muscle following denervation can be summarized as follows: 1)
The ability of skeletal muscle to transport glucose, both basal and
insulin stimulated, is decreased and a change in both sensitivity and
responsiveness is observed.

2) There is a decrease in basal and insulin

stimulated glycogen synthesis.

3) As expected, due to decreased glucose

transport, there is a decrease in glucose-6-phosphate levels.

4) There

is a decrease in the active form of glycogen synthase and a decrease in
the activation by insulin which is independent of the decrease in glucose6-phosphate concentration.
genase activity.

5) There is an impairment of pyruvate dehydro-

7) Both fast twitch, white and slow twitch, red skele-

tal muscle are affected.

The effect of denervation has been seen in the

soleus, diaphragm, extensor digitorum longus, the levator ani, and the
epitrochlearis muscles.

8) Even with the severe insulin resistance

there is no apparent effect of denervation on the muscles' ability to
respond to epinephrine as assessed by a decrease in glycogen synthesis
and increase in glycogenolysis in response to epinephrine.
Identical results have been observed in the immobilized muscle
(119,120).

In this latter case it should be noted that the electromyo-

genic activity of immobilized muscles drops to 15-20% of control levels
and thus, is v.ery similar to the denervated state.

Using the immo-

bilized muscle system, Butler and Booth (121) saw a decrease in the
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basal rate of protein synthesis in the extensor digitorum longus and the
soleus muscle after 24 hrs but did not observe any impairment of insulin
stimulated increase in the rate of synthesis, although in absolute terms
the immobilized leg still synthesized significantly less protein than
the contralateral control muscle.

This raises the interesting possi-

bility that the pathway leading to an alteration in glucose transport
and intracellular metabolism, thus the differences in the two system's
respon.se to denervation.
In contradistinction to the decrease in action of insulin on denervated skeletal muscle the exact opposite is true of exercised muscle.
There is an apparent insulin-like effect of exercise on glucose transport (122).

In addition to increasing the basal state of these activi-

ties (which apparently can occur in the absence of insulin (125), exercise also increases the sensitivity of muscle to insulin (122-124).
Changes which occur in the membrane of denervated skeletal muscles

may have some bearing on the insulin resistance.

There is a rapid

appearance of extra-junctional acetylcholine receptors (126,127) which
is due to an increase in the transcription of a subclass of these receptors (128).

There is an increase in phospholipid turnover but no

change in the total content of phospholipids (129).

The membrane

content of glycoproteins are increased as assessed by concanavalin A,
ricin, and wheat germ agglutinin binding (130).

The activities of

sialyl-galactosyl- and N-acetylglucosaminyltransferases in the sarcolemmal fraction was increased while there was a decrease in fucosylglucoprotein transferase.

The changes

wer~

observed to be due to an

increase in the Vmax of the enzyme with no change in affinities.

There

is no change in the membrane associated Na/K ATP ase activity seen after
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denervation (130), however, a decrease in the resting membrane potential
of denervated muscles has been described (131).
Even with these alterations in the membrane of skeletal muscle
after denervation, there has been no observable change in insulin binding to its receptor after denervation that could account for the severe
insulin resistance (114,118,132).

Thus, two groups have suggested that

the insulin resistance be classified as a 'post receptor' defect
(114,132).

This may have been premature considering the above mentioned

cases of normal insulin binding associated with severe insulin resistance and defects in the insulin receptor kinase activity.

Studies

investigating the possible alteration in activation of the insulin
receptor kinase in denervated skeletal muscle are contained in Chapter 4
of this dissertation.
In summary, the mode of insulin action is unknown but the effects
of insulin on many systems affected by insulin treatment are beginning
to be well characterized.

These include the glucose transport system,

the various phosphorylation-dephosphorylation cascades and the insulin
receptor associated tyrosine kinase activity.

Inroads are also being

made in elucidating the mechanism of various insulin resistant states
(i.e. obesity, Type A and Type B syndromes of insulin resistance) and
into the structural characteristics of the glycoprotein insulin receptor.

In this dissertation I present data on the role of the insulin

receptor and associated kinase activity in two models of insulin resistance.

In Chapter 2 I present the characterization of the insulin

resistance seen shortly after denervation.

In Chapter 3 I present a

method that was developed for the purification of functionally active
insulin receptors from skeletal muscle.

In Chapters 4 and 5 this method
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was used to investigate what, if any, role the insulin receptor plays in

the insulin resistance seen in denervated skeletal muscle and in
diabetic skeletal muscle from rats with insulinopenic diabetes.
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TABLE 1. Taken from Reference 63.'
froposed second messengers for insulin
action
Cyclic nucleotides (cA~'lP. cGMP)
~1onovalent cations; altered membrane pOlt!ntial
Calcium:! •
H~02
~1embrane

phospholipids
Dt!gradation fra~menls of insulin
Peplidcs of membrane or,~in that modify protein
kinases and alter phosphorylatIon
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TABLE 3

Tissues and Cells where Insulin Receptor and
Associated Kinase Have Been Identified

---------~-------~-~-----------~-~-~~-~--~-~-----~---~-------~-----~----

Tissue or Cell

Species

Fibroblasts

Human

73

Erythrocytes

Human

73

Lymphocytes

Human

74

Monocytes

Human

75

Placenta

Human

76

Skeletal Muscle

Rat

73

Liver

Rat

77

Adipocyte

Rat

78

Brain

Rat

79

Reference
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TABLE 4

Identified Substrates for the Insulin Receptor Kinase

--------------~---------------------------------------------------------

Substrate

Reference

Angiotensin II

84

Casein

85

Histone H2b

86

Src related peptide

86

Tyrosine containing

86

synthetic peptides
Fodrin

87

Tubulin

88

Microtubule-associate proteins

88

Actin

89
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TABLE 6. Taken from Reference

63.l

Alterations in insulin receptors in disease states
Receptor number

Type II diabetes mellitus
Obesity

Uremia
Insulin resistance and acanthosis nigricans

!
1
!
!

Acidosis
Glucocorticoid excess
Anlireceptor antirody
Lipoatrophic diabetes (some)
Lcprechaunism (some)
Growth hormone excess
Insulinoma

Obese-72 he fast
Lipoatrophic diabetes (some)
Leprechaunism (some)
Variants, Type A syndrome

Receptor affinity

!
!
!

1
!
!
!
!
i

t

t

FIGURE 1. Taken from

~ference

62 1

Proposed structural features of the heterotetrameric insulin receptor complex.
See text for detailed description of supporting data.
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FIGURE 2. TAKEN from Reference

58.1

Schematic comparison of insulin and EGF receptor~.
Regions of high Cys-residue concentration are shown as hatch~d
boxes, transmembrane domains as black boxes and ~ingle cysteine
residues, possibly involved in formation of the Q2-i32 insulin receptor complex, as black circles.
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CHAPTER II: INSULIN RESISTANCE OF DENERVATED. RAT MUSCLE:
A MODEL FOR IMPAIRED RECEPTOR-FUNCTION COUPLING
Glucose metabolism and insulin response of skeletal muscle is
profoundly affected by antecedent activity.

In animals and hwnans,

depleted glycogen stores are rapidly replenished after exercise to
levels that exceed resting values.

This phenomenon, termed supercompen-

sation, involves activation of glycogen synthase (1).

Richter et ale

(2) observed that prior exercise lowered the insulin-dose required for
half-maximal stimulation of glucose transport and glutose utilization by
skeletal muscle, suggesting that at least one of the mechanisms is
enhanced insulin sensitivity.

On the other hand, when muscles were

denervated (3,48) or immobilized (5) for 24 hrs before experiments,
their subsequent response to insulin was markedly impaired.

Others

reported that the impaired insulin response required 3 days of denervation (6).

Early studies from this laboratory (3,4) using hemidiaphragms

1-7 days after cutting the phrenic nerve suggested that denervation
impaired the response to insulin without affecting insulin binding.
However, at that time methods for assessing insulin-receptor interactions were relatively unsophisticated.

Since short-term denervation and

immobilization affected the insulin responsiveness of muscles similarly
(3-5), we felt that muscles studied early after denervation may serve as
useful models to elucidate how work and/or nervous stimuli modify the
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insulin receptor or its coupling to the glucose transport and glycogen
synthase system.

We addressed the following questions:

a) Does short-

term denervation affect primarily insulin binding or coupling of the
receptor to intracellular events;

b) is there decreased insulin sensi-

tivity and/or impaired maximal response,

c) are glucose transport and

glycogen synthesis affected in parallel,

d) are red and white muscles

similarly affected by denervation?

Our results indicate that 24 hours

after denervation, specific insulin binding to muscles is minimally
decreased, while insulin sensitivity and response of glucose transport
and glycogen synthesis are markedly impaired, suggesting that in red and
white muscles, contractile activity and/or nervous stimuli are needed
for efficient coupling of the insulin receptor to intracellular responses.

MATERIALS AND METHODS
Denervation and muscle preparation.

Male Wistar rats (50-100 g)

were purchased from Charles River Breeding Laboratories (Wilmington,
Mass.).

One hind limb was denervated under methoxyflurane (Metofane,

Pitman-Moore, Inc., Washington Crossing, N.J.) anesthesia via a small
incision in the posterior aspect of the upper thigh 6 or 24 hrs before
experiments.

A small section (approx. 3mm) of the sciatic nerve was

removed and the incision closed with a stainless steel clip.

Rats were

either allowed food and water ad libitum or food was withheld for 24 hrs
before experiments.
Rats were killed by decapitation and the soleus and/or extensor
digitorum longus (EDL)

1

were dissected free, split in half longitu-

dinally, rapidly weighed and placed either directly into 30% KOH for
measurement of tissue glycogen or attached to stainless steel clips,
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care being taken to attach muscles at in vivo resting length.

Muscles

were removed within 2 min. after decapitation and the time required
between killing the animal and start of incubation was 4-5 min.
Following decapitation, spontaneous muscle contractions were observed in
non-denervated legs; the rapid removal of the muscles was aimed at
minimizing their metabolic effects.
Muscle incubation.

Gey and Gey's balanced salt solution (7)

(bicarbonate buffer), pH 7.4 containing 5 roM glucose or 2 ruM pyruvate as
indicated, gas phase 95% 02 + 5% CO

2

was used in all experiments.

Bovine serum albumin, 1mg/ml, was included in all media except where
indicated in Methods.

In insulin binding studies higher concentrations

of albumin (10 mglml) were used.

Muscles were incubated with shaking

(80 cycles/min.) at 37°C, except for insulin binding studies which were
carried out at 25°C to minimize insulin degradation (8).
Glycogen synthesis.

Muscles were pre-incubated for 30 min. in 2 rol

medium containing 5 roM glucose, with or without insulin at the doses
indicated, then transferred to identical media supplemented with
[U I4 C]glucose (SmM, 0.2J,JCi/ml) and incubated for 1 hr.

In experiments

testing epinephrine responsiveness all media contained 5 roM glucose and
1 mg/ml ascorbic acid; after 30 min. preincubation in this medium the
muscles were transferred to media supplemented with [U

14
C]glucose with

or without epinephrine (10- 9 - lO-6 M) and incubated for 60 min.
[14C]glucose incorporation into glycogen was assessed by two
methods which yielded identical results.

The first method was used in

initial experiments, the second was adopted to allow the simultaneous
measurement of tissue glycogen.

In the first method (2) muscles were

digested in O.Sml 1 N NaOH containing 20 mg/ml oyster glycogen to which
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1 ml absolute ethanol was added and glycogen was allowed to precipitate
at -80°C overnight.

The precipitate was centrifuged and washed twice

with 1 ml 66% ethanol, dissolved in 0.5 ml H 0 and an aliquot counted in
2
Scintiverse scintillation cocktail (Fisher Scientific) in a Beckman
LS-7000 J3-scintillation counter.

In the second method (10), muscles

were digested in 0.5 mI 30% KOH and glycogen preCipitated by the
sequential addition of SO

10% Na S0 and 1 ml absolute ethanol and
2 4
The precipitate was washed twice by

~l

cooled at -20°C for 1 hr.

sequential addition of O.Sml 30% KOH and 1 mi absolute ethanol,
dissolved in 0.75 ml 4 N H S0 and an aliquot counted in Scintiverse.
2 4
Dpm in muscle glycogen was related to the specific activity of the
medium, and expressed as nmol of glucose incorporated/mg tissue.

No

change in muscle weight was observed within 24 hrs after denervation, in
either fed or fasted animals.
Glycogen content.

Glycogen extracted by the second method (37) was

hydrolysed in 4 N H S0 at lOQoC for 2 hrs.
2 4

The solution was neutral-

ized with 4N NaOH and glucose assayed by the glucose oxidase method.
Glycogen recovery was greater than 95%.

Values were expressed as

glucose equivalents, nmol/mg wet weight.
2-deo?cyglucose uptake.

Muscles were preincubated for 30 min. in

buffer containing 2 roM pyruvate with or without insulin at varying
concentrations, then transferred to identical media supplemented with
3
0.1 or 5 roM [ H]2-deoxyglucose (0.5

(0.2

~Ci/ml).

~Ci/ml)

and 0.1 mM [

14

C]sucrose

After 15 or 30 min. incubations (with 5 and 0.1 mM

2-deoxyglucose respectively) the muscles were extracted for 10 min. in 1
ml of boiling water (11).

Aliquots of the incubation media and of the

tissue extracts were courited as described above.

In preliminary

57

Glycogen synthase assay.

Half-solei or EDL were preincubated for

15 min. in buffer containing 2 ruM pyruvate without albumin then

transferred to identical media, except for the presence of 10 mU/ml
insulin in alternate vials.

After 30 min. incubation the individual

muscles were frozen in liquid nitrogen, placed in a precooled PotterElvejhem homogenizer and crushed in 1.2 ml of Tricene buffer (25 roM)
containing 50 roM KF; 20 roM EDTA; 1 mg/ml glycogen and 10% w/v glycerol
pH 7.1 at 4°C.

The frozen slurry waS homogenized as it thawed and the

mixture placed in 1.5 ml microfuge vials and centrifuged at 15,OOOXg for

5 minutes in a Fisher Model 235 microcentrifuge at 4°C.
(30

~l)

The supernate

was assayed for glycogen synthase activity by the method of

Thomas et ale (13) as modified by Kochan et ale (14) using 0.075 roM
[3H]UDP-glucose (6.75 Ci/mole) as the final substrate concentration.
The reaction was run for 10 min at 30°C in 90
absence or presence of 100 or 1000

~M

~l

final volume in the

G-6-P; the latter concentration of

G-6-P resulted in complete activation of the enzyme.
pressed as activity ratio (-G-6-P/+I000
velocity (+100

~M

G-6-P/IOOO

~M

~M

Results are ex-

G-6-P) and as fractional

G-6-P) (14).

In some experiments the

assay was also performed using 4.4 rnM UDP-glucose at pH 7.8, without or
with increasing concentrations of G-6-P up to 10 mM (13).
The low (0.075 roM) 3[H]UDP-glucose concentration in the assay was
selected based on considerations discussed (1,15), indicating that the
assay becomes more sensitive to changes in the phosphorylation state of
the enzyme when subsaturating concentrations of UDP-glucose are used.
With respect to muscle pretreatments (e.g. denervation and insulin) we
obtained qualitatively identical results in solei with low or high
substrate assays although baseline activity ratios were higher in the
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latter system.

Studies in EDL were done only with the low UDP-glucose

concentration.

The data presented are those obtained with 0.075 IBM

UDP-glucose, except for assays of total enzyme activity, where both
measurements are shown; the total activity measured with 4.4 mM UDPglucose represents Vmax (IS).

Total enzyme activity was measured as UDP-glucose incorporation

into glycogen during incubation with 1 or 10 mM G-6-P and related to the
protein concentration..

Maximal enzymatic activity was observed with

1 mM G-6-Pin the low s.ubstrate assay and with 10 mM in the high
substrate assay.

The assay was linear with time for 15 min, UDP-glucose

was depleted less than 10% during either assay..

Protein was measured by

the method of Lowry et ale (16) against bovine serum albumin standards.
Insulin Binding.

Monocomponent porcine insulin was labeled with

125 1 by the lactoperoxidase method to a specific activity of 100-

200mCi/mg and was purified before each experiment as previously
described (17) by adsorption to and elution from a Whatman CF11
cellulose column. Before use 1251-insulin was 99% precipitable with
. hI oroace t-1C aC1"d
t rlC

(TCA)
. .

,
125 1 -lDSU
1"1D b"Ind"lng was measure d b y th e

method of LeMarchand-Brustel et al .. (23).

Briefly,muscles were

preincubated for 30 min. at 25°C in 3 ml buffer containing 2 roM pyruvate
and 10 mg/ml bovine serum albumin; the muscles were then transferred to
vials containing the same buffer supplemented with 0.135 ~Ci/ml 1251_
insulin and increasing concentrations of non-labeled insulin and incubated for an additional 2 brs.

The muscles were then washed with 5 ml

0.9% NaCl containing 5 mg/ml albumin at 4°C for 15 min three times,
digested in 1 N KOHand counted in a Beckman Gamma 4000 SCintillation
counter.

Non-specific binding was estimated in the presence of 50 IJg/ml
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unlabelled insulin and was subtracted from all measurements to calculate
specific binding.

Non-specific binding was typically 30-40% of total

. t h e presence
· d"1ng 1n
b 1n

0

f

"
tracer on1 y .Th
e d egra datlon

0

f

125 I"
.
-1nsu 1 1n

in the medium during 2 hrs. incubation was 5-7% as assessed by TCA
precipitation.
Although this insulin binding assay was originally developed for

mouse soleus muscles (8) it has been adapted with various modifications
(6,18) to rat solei.

We found the hemisected soleus of young rats

(muscle weight 17.2 ± 0.5 mg, n = 128) to be suitable for the assay.
Experiments varying the time of incubation with 125I-insulin between 1
and 3 hrs at 25°C indicated that most of the specific insulin binding

occurred during the first hour of incubation; with gradual smaller
increases thereafter.

After 2 hrs incubation, specific binding was 80%

of that observed at 3 hrs . , although the difference between binding at 2
and 3 hrs was not statistically significant.

Concommitantly the

% of

degraded insulin in the medium increased significantly (p < 0.001),
reaching 15% of total in some experiments.

The 2 hrs. incubation time

was selected as a compromise between the achievement of binding equilibrium and minimizing insulin degradation.

When muscles were homogenized

. 6°1* TCA a f ter 1ncu
.
b
·
.. h 12 5 1 -1nsu
.
1 In
.
( 1 ng or 50
1D
at10n
w1t
or 3

hrs~

~g /

m1) f o r1, 2

followed by 45 min. washing at 4°C as described above, it was

found that 85 ± 1% (n = 12) of the muscle associated radioactivity was
TCA precipitable at 2 hrs.

The respective values after 1 and 3 hrs.

incubation were 86 ± 1 and 83 ± 1.5.

Because the fraction of TCA solu-

ble radioactivity associated with the muscles appeared constant and
relatively small and the additional manipulations involved in homogenizing, precipitating and washing with TeA may introduce errors of similar
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magnitude in the measurements the TCA

prec~pitation

step was not

routinely applied.
Time course experiments as described above were run in parallel
using control and denervated solei of rats 24 hrs. after unilateral
denervation.

There was no significant difference in the time course of

specific or non-specific insulin binding or in the rate of insulin
degradation (assessed by muscle associated TCA precipitable
radioactivity) between control and denervated solei.
Materials.

Monocomponent porcine insulin was a gift from Dr.

Ronald Chance, Eli Lilly Co. (Indianapolis, Ind.)

Na

I2S ! (carrier

4
free), [1_3H]UDP-glucose, D-[U_1 C]glucose, [1,2- 3 H]2-deoxy-D-glucose,

and [U_1 4 C]sucrose were purchased from New England Nuclear (Boston, MA).
Oyster glycogen, bovine serum albumin (Fraction V), and 1(-)
epinephrine(+)bitartrate were from Sigma (St. Louis, MO).
Lactoperoxidase beads were from Bio-Rad Laboratories (Richmond,
glucose-6-phosphate dehydrogenase (Type

CAl and

XII) from Boehringer-Mannheim

(Indianapolis, IN). Stainless steel clips (Autoclips) and Scintiverse

were purchased from Fisher Scientific Co. (Pittsburgh, PA).
Statistical Analysis.

Data are presented as Mean ± SE.

Statis-

tical analysis was performed by paired or unpaired Student's t test

where appropriate.
RESULTS
Glycogen Synthesis.

Fig.

lA illustrates the insulin dose response

curves of intact and denervated solei, isolated following a 24 hr fast
and 24 hrs after cutting one sciatic nerve.

Control muscles showed a

three-fold stimulation of [14C]glucose incorporation into glycogen in
response to physiological concentrations of insulin (50 J-JU/ml) .
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Denervated solei synthesized less glycogen than controls in the absence
of insulin (p < 0.01).

While insulin at concentrations of 250 IJU/ml or

greater caused a significant stimulation of glycogen synthesis in
denervated solei, both the relative stimulation C% of baseline) and the
absolute increment over baseline

(~

insulin) were significantly smaller

in denervated than control solei, e.g. maximal rates of glycogen
synthesis in the presence of 500 IJU/ml insulin were five-fold greater in
control than denervated muscles.

The insulin dose required for

~

maximal stimulation was - 30 IJU/ml in control muscles and - 100 IJU/ml in
their denervated pairs.

Increasing the insulin concentration to 2.5 and

5 mU/ml failed to cause further stimulation in intact or denervated

muscles (data not shown).
Similar results were obtained in rats fed ad libitum (Fig. 1B).
Although basal rates of glycogen synthesis were lower in 24 hr
denervated solei, they were not significantly different from controls.
Insulin (500

~U/ml)

increased glycogen synthesis four-fold in control

solei, while no significant stimulation was observed in their denervated
pairs up to 1 mU/ml, the highest dose tested.
The impaired insulin response was already detectable 6 hrs after
denervation using rats fed ad lib (Fig. Ie).

Stimulation of glycogen

synthesis by insulin in control solei was less than that observed in the
preceding studies (Fig. 1A and IB), which may be attributed to the
relatively recent stress of anesthesia and surgery_

Basal rates of

glycogen synthesis were identical in denervated and control solei, while
stimulation by insulin was greater (p < 0.05-0.01) in controls than in
denervated muscles at all insulin concentrations tested.
dose of insulin tested (100

~U/ml)

The lowest

was ineffective in denervated
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muscles, while it caused 70% of apparent maximal stimulation in
controls.
We used the non-denervated contralateral leg as control, to
minimize rat to rat variation, and expose the denervated and control
limbs to the same nutritional and hormonal milieu.

In preliminary

experiments we compared glucose incorporation into glycogen by nondenervated solei of unilaterally denervated rats 24 hrs. after operation
to those of sham operated controls and found no difference in either
basal or insulin stimulated glycogen synthesis (data not shown).
Soleus muscle contains predominantly slow-twitch red fibers (19).

To determine whether or not insulin resistance after denervation
occurred in a muscle with predominantly fast-twitch white fibers (19),

EDL muscles were studied 24 hrs after unilateral denervation (Fig. 2).
Control EDL appeared to be less responsive to insulin than solei; and
this was particularly apparent in muscles obtained from fed rats.

Such

differences in insulin responsiveness between red and white muscles have
been reported (20).

Basal rates of glycogen synthesis were lower in

denervated EDL than in their control pairs (p < 0.01) in fed and in
fasted rats.

The most significant finding was that while insulin

stimulated glucose incorporation into glycogen

~2

fold in control EDL,

insulin was completely ineffective in their denervated pairs, in both
fed and fasted rats.
Effect of denervation on the uptake of 2-deoxyglucose.

Resistance

of glycogen synthesis to stimulation by insulin could represent the
inability of insulin to stimulate the transport of glucose and/or a
block in a subsequent reaction e.g. phosphorylation of glucose or
activation of glycogen synthase.

2-deoxyglucose uptake was measured to
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assess the response to insulin of the glucose transport system, since

this analogue enters muscle on the same transporter as d-glucose, and
upon entry is phosphorylated to 2-deoxyglucose-6-P0

metabolized.
in the medium.

4

but not further

The analogue was tested at 0.1 and at 5 roM concentrations
Pyruvate was substituted for glucose ,as an energy

source, to avoid competition of glucose with the labelled analogue for

the transport system.
The highest dose of insulin tested (1 mU/ml) increased
2-deoxyglucose uptake

2-fold in control solei of fasted rats during

incubations with 0.1 roM or with 5 mM 2-deoxyglucose (Fig .. 3A and 3B).
Their denervated pairs showed decreased uptake in the absence of

insulin, as well as decreased insulin sensitivity (p < 0.01) when
incubated in the presence of either 0.1 mM or 5 mM 2-deoxyglucose.

While a complete dose-response curve was not obtained decreased insulin
sensitivity in denervated solei is suggested by the fact that - 40 IJU/ml

insulin was required for

~

maximal stimulation of 2-deoxyglucose uptake

in control muscles, while only the highest dose tested (1000 IJU/ml)

caused a significant stimulation in denervated solei.

With 0.1 roM

2-deoxyglucose the maximal insulin response over baseline

(~

insulin)

was not significantly different between control (83 ± 15nmol/g/30 min)
and denervated muscles, (60 ± 16nmol/g/30 min).

After 15 min.

incubation in 5 roM 2-deoxyglucose the increment in 2-deoxyglucose uptake

induced by 1 mU/ml insulin was significantly greater in controls than in
denervated solei, (1150 ±224 vs. 310 ±186nmol/g/15 min., p < 0.01).
Hexokinase activity did not appear to be limiting 2-deoxyglucose
uptake by denervated solei,since the ratio of2 .... deoxyglucose-6-P0 4 /
[free + phosphorylated 2-deoxyglucose] in the intracellular compartment
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was essentially identical in intact and denervated muscles. In all
experiments more than 80% of the intracellular analogue was in the
phosphorylated form (Fig. 3C and 3D).
Denervation for 24 hrs affected 2-deoxyglucose uptake in EDL
muscles similarly to solei (Table 1).

Using 5 roM 2-deoxyglucose insulin

sensitivity and insulin response were significantly decreased.

In

control muscles 50 JJU of insulin caused near maximal stimulation, while
this dose was ineffective in their denervated pairs.

1000

~U

stimulated

2-deoxyglucose uptake by denervated and control EDL but the response of
denervated muscles was smaller than that of the controls (p < 0.01).
Basal uptake was lower than that of controls, although the difference
was not significant.
Glucose-6-phosphate content was measured in control and 24 hr
denervated solei of fasted rats following incubations in 5 mM glucose
identical to those used in studies of glycogen synthesis.

Since

phosphorylation at C-6 is the first and obligatory reaction for glucose
metabolism after entry into the cell, impaired glucose transport may
result in decreased intracellular G-6-P.

Following incubation without

insulin, G-6-P in denervated muscles was 45% lower than in controls
(p < 0.05).

Following incubation with 1 mD/ml insulin, G-6-P increased

in control muscles more than two-fold (p < 0.01) while there was no
significant change in their 24 hr. denervated pairs (Table 2).
Activation of glycogen synthase by insulin.

(Table 3)

While

impaired stimulation of glucose transport by insulin could account for
the observed insulin resistance of glycogen synthesis in denervated
muscles, the magnitude of the defect suggested that a second step may
also be involved such as the activation of glycogen synthase by insulin.
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Total glycogen synthase activity was greater in soleus than in EDL and
was not affected by 24 hrs denervation in either muscle.

The fractional

velocity of the enzyme was lower in denervated than in control solei
after incubation without insulin (p < 0.05); while the trend was similar
in EDL muscles, it was not significant.

When solei and EDL were

incubated with 10 mU/ml insulin both the activity ratio and the
fractional velocity of glycogen synthase increased slightly (20-30%) but
significantly (p < 0.05) in control muscles whereas changes were not
significant in their denervated pairs.
Glycogen content.

The glycogen content of muscles may control the

rate of glucose transport and glycogen synthesis, possibly through a
feedback mechanism (2,21).

Since work induced glycogenolysis is

abolished in denervated muscles, they may contain more glycogen than
controls before incubation.

Table 4 shows that this was the case in

denervated solei, obtained from fed or 24 hr fasted rats. However, in
EDL the glycogen content of control and 24 hr denervated muscles was not

significantly different either in the fed state or after a 24 hr fast.
Since glycogen synthesis and glucose transport in denervated EDL and
solei was equally resistant to insulin, increased initial glycogen
content does not appear to be the cause of the insulin resistance.
Effect of denervation on the binding of insulin (Fig. 4).

Specific

insulin binding by intact and 24 hrs denervated solei of rats fasted
overnight was studied.

In initial experiments half-solei of the intact

and the denervated leg of 6-9 rats per experiment were randomly
distributed between media containing increasing concentrations of
insulin, 3 control and 3 denervated muscles were used in each experiment
for determination of non-specific binding.

Each dose was tested in at
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least 6 separate muscles.

While denervated muscles tended to bind

slightly less insulin than controls at all concentrations up to 50 ng/ml
(1.3 mD/ml) using this experimental design differences between control
and denervated muscles were not significant.

In one series of experi-

ments (Insert, Fig. 4) a paired experimental design was used; only one
dose of insulin was tested (1 ng/ml) and one hemisoleus of each control
and each denervated leg was used for measurement of non-specific
binding.

The means of 13 paired measurements yielded a significant

difference (p < 0.05), demonstrating that in the presence of a
physiological insulin concentration (26
30% less insulin than the controls.

~U/ml),

denervated muscles bound

Scatchard analysis of the data (not

shown) yielded the classical curvilinear plot reported for insulin
binding in a number of tissues.

The differences in binding between

control and denervated muscles are not large enough to allow meaningful
kinetic analyses; the data would be compatible with a small decrease in
binding affinity or decreased number of high affinity binding sites in
denervated muscles.
Effect of epinephrine in denervated muscles.

To assess whether or

not the insulin resistance of denervated muscles extends to other
hormones we examined the response of control and denervated solei to
epinephrine in vitro.

Two well-characterized effects of the hormone

served as end points: the ability to accelerate glycogen degradation in
vitro and to inhibit the incorporation of [

14

C]glucose into muscle

glycogen (22).
Intact and 24 hrs denervated solei were removed from ad lib fed
rats and half-solei incubated with or without increasing concentrations
of epinephrine (10- 9 - 10-6M) in 5 roM [U_

14

C]glucose (Fig. 5).

The
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glycogen content of intact and denervated solei was similar following
incubation without epinephrine.

Increasing concentrations of epine-

phrine resulted in progressive depletion of tissue glycogen.

The sensi-

tivity and the response of glycogenolysis to epinephrine appeared identical in control and denervated muscles (Fig. SA).
As shown previously (Fig. 1), denervated solei incorporated less

glucose into glycogen during incubation than controls.

However, signi-

ficant inhibition by epinephrine was observed with identical doses

(IO-7 M).

The highest dose of epinephrine used (IO-6 M) decreased glucose

incorporation into glycogen to approximately 50% of that observed in the
absence of epinephrine in both intact and in denervated muscles respec-

SB).

tively (Fig.

DISCUSSION
Short-term denervation affects multiple parameters of glucose
metabolism in skeletal muscle.

We observed diminished incorporation of

glucose into glycogen, decreased transport of 2-deoxyglucose reduced
glucose-6-P0

4

content and decreased activation of glycogen synthase.

While in many instances these effects were demonstrable without insulin,
insulin resistance was the most salient characteristic of denervated
muscles.
Isolated solei and EDL seemed to be appropriate models for studies
of insulin responsiveness, since control muscles responded to physiological doses of insulin, and the sensitivity and magnitude of the
responses were similar to those reported for perfused hindlimbs (2).
Yet, after 24 hr. denervation, when assessed by glucose incorporation
into glycogen, solei of fed rats, and EDL of fed and fasted rats showed
no response to even pharmacological doses of insulin and the response of
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solei from fasted rats was greatly diminished.

Thus, insulin resistance

after denervation is a feature of both red and white muscles.

Whether

or not the decreased baseline observed in a number of experiments in
denervated muscles represented an impaired response to endogenous

insulin which persisted during incubation or an insulin-independent
deceleration of glucose transport following denervation) needs further

investigation.

Vigorous exercise has been reported to stimulate glucose

transport in skeletal muscle by an insulin-independent mechanism and the

effect persists for many hours after the cessation of work (21).
However, insulin may playa permissive role, since no stimulation of
glucose uptake is observed when hindlimbs of diabetic rats are exercised
without insulin in the perfusion medium (23).
The insulin resistance of denervated muscles seemed to entail both
decreased sensitivity and impaired maximal response to the hormone.
This seemed evident in those studies of glucose incorporation into
glycogen, where a significant response to supraphysiological doses of
insulin was obtainable in denervated mus·cles (Fig. lA and Ie).

In

studies of glucose transport, the decreased sensitivity to insulin of
denervated solei was evident using 0.1 or 5 roM 2-deoxyglucose.

3A, 3B, and Table 1).

(Figs.

Using 5 mM 2-deoxyglucose a significant

diminution of the maximal insulin response was also demonstrated in
denervated muscles incubated with 1 mU/ml insulin (Fig. 3B and Table 1).
Since this dose exceeds the in vivo physiological range -S-fold, and
since further increments in insulin concentration were ineffective in
our in vitro studies of glycogen synthesis, higher doses were not
tested .
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In contrast to the markedly impaired insulin response, we observed a
small decrease in insulin binding which was demonstrable only in paired
experiments.

Since denervated muscles were resistant to 20-50 fold higher

doses of insulin than those which elicited maximal response in control muscle,
it seems likely that the major defect caused by denervation is not decreased

insulin binding, but a defect in Signal transmittal from the receptor to
intracellular events.
insulin

bi~ding

Note however that because of technical considerations,

was measured after longer incubations ata lower temperature

(25°C vs 37°C) than was used to test metabolic responses; therefore the above
conclusions need further validation_

Forsayeth and Gould (6) obsetved no

significant change in insulin binding by solei after 7 days denervation,
although binding by denervated muscles was slightly lower.

The values of

fmoles insulin bound per mgmuscle in their study and ours are in remarkable
agreement.
The results presented here are in essential agreement with our earlier
studies in denervated diaphragms (3,4) and with a recent study of Forsayeth
and Gould (19) who reported that in solei, 3-7 days after denervation
insulin-stimulated sugar transport was inhibited at some early post-receptor
step.

In contrast to the latter study (6), we found that insulin resistance

develops very early after denervation in muscles, is detectable after 6 hrs.,
and profound at 24 hrs.
Our results also indicate that 24 hrs after denervation total glycogen
synthase activity in red and white muscles is unchanged, but there is a
significant decrease in the enzyme's basal activation state in the soleus as
well as impaired activation in response to insulin in soleus and EDL.

These

observations differ from those in Ref. 19 but are congruent with a preliminary
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report of Smith and Lawrence who studied glycogen synthase activity of
rat diaphragms 24 hrs after denervation (24), and with the reported
increase in glycogen synthase kinase activity in denervated muscles
(25).

The total glycogen synthase activity of incubated solei measured

here at saturating substrate concentrations is similar to that reported
for red vastus lateralis muscles of rats in vivo (14).
The measured changes in the activity ratio of glycogen synthase
following incubation of control muscles with insulin were relatively
small, in view of the marked stimulation of [
into glycogen by insulin.

14

C]glucose incorporation

Similar discrepancies have been noted using

the perfused rat hindlimb (26) as well as a number of isolated tissues
(for additional references and theoretical considerations see 14, 15,
26).

Relatively small changes in the activity ratio reflect larger

changes in the phosphorylation state of the enzyme, the effects of which

may be magnified under the conditions prevailing in the intact tissue.
Further optimization of incubation or assay conditions may have yielded
larger responses.

However, since all measurements in denervated and

control muscles were carried out in parallel, we believe the data
demonstrate the denervation induced relative insensitivity of glycogen
synthase to activation by insulin.
Seider et ale

(5) reported severely impaired sensitivity and

response to insulin in disused mouse solei as assessed by 2-deoxyglucose
uptake and glucose incorporation into glycogen 24 hrs. after hindlimbs
were immobilized in a plaster cast.

The striking similarity between our

results indicate that the insulin resistance which develops rapidly
after denervation is not due to the lack of a "neurotrophic factor" but
to decreased electromyogenic and/or contractile activity.

Note that
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when solei are immobilized at resting or shorter than resting length,
their electromyogenic activity decreases to 10·15% of normal resting
activi ty (27).
Other changes that occur rapidly in immobilized or denervated
muscles include an increase in the number of cytosolic cortisol
receptors (28,29) as well as an increase in the number of extrajunctional acetylcholine receptors (30).

We postulated that a denervation

induced change in membrane fluidity and/or permeability may cause generalized non-responsiveness of membrane associated hormone receptors.
This appears not to be the case since epinephrine mediated glycogenolysis in isolated solei was not affected by 24 hours denervation.
Impaired glucose tolerance with peripheral insulin resistance has

been demonstrated in healthy humans after one week bed rest (reviewed in
31) as well as in patients with spinal cord injuries (32) and with a
number of musculoskeletal disorders. (33).

It is tempting to speculate

that the early morning insulin resistance observed in insulin dependent
diabetic patients (34) may be related in part to decreased muscular tone

and activity during sleep.

On the other hand, physical activity de-

creases the insulin requirements of diabetic patients (for review see

35).

Antecedent work enhances glucose transport in muscles (21) in-

creases muscle sensitivity to insulin (21,26,35) without affecting
insulin binding to muscle (36,37) and induces activation of glycogen
synthase (1).

All of these findings taken together suggest that nervous

stimuli and/or contractile activity regulate the insulin response of
skeletal muscle, resulting in a continuum of graded responses, which
include at the two extremes the insulin resistance observed shortly

after denervation or immob.ilization, and enhanced sensitivity after
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work.

Such a mechanism would assure the rapid replenishment of glycogen

stores after exhaustive work, and spare glucose, by limiting its supply
to non-working muscles; it appears to operate primarily at the level of
receptor-function coupling (36,37).

The observed inverse relationship

between insulin response and glycogen levels in control and denervated
solei would support the proposed negative feedback of muscle glycogen
content on the insulin response (2,21); however, since severe insulin
resistance was observed in EDL muscles 24 hrs after denervation without
a detectable change in glycogen content, it appears that, at least in
the EDL, glycogen content is not the major regulator of the insulin
response .
The mechanism by which nervou.s stimuli and/or contractile activity
modulate the response to insulin in muscle is conjectural.

Denervation

may inhibit the generation or the propagation of a signal(s) from the
occupied receptor or, alternatively, changes in the intracellular milieu
may impair the response..

Since at least three separate insulin regu-

lated systems appear affected (glucose transport, glycogen synthase
activation and in Ref.19 amino acid transport), impaired signaltransmission seems to be the more attractive hypothesis.
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TABLE 1

3

Uptake of [ H]-2-deoxyglucose CSmM) by control and denervated EDL.

2-deoxyglucose uptake Cnmoles/mg wet weight/IS min)

Insulin CfJU/ml)

Control

Denervated

0

1.42 ± 0.12

1.22 ± 0.08

50

+
2.37 ± 0.22+

1.36 ± 0.13*

1000

2.56 ± 0.21+

+

1.81 ± 0.09*+

Half EDL from fasted rats, unilaterally denervated for 24 hrs, were
preincubated, incubated and processed as described in Fig. 4 for solei.
*p < 0.01 vs. nondenervated pairs.

insulin.

+ p < 0.01 vs. muscles incubated without
+
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TABLE 2

Effect of insulin on glucose-6-phosphate content of control and denervated

solei.

Insulin

Glucose-6-phosphate

uD/ml

nmol/g tissue

Denervated

Control

87 ± 19

159 ± 25 (9)

.

~

0

(9)

1\

L~
1\

50

94 ± 40 (4)

207 ±

1000

98 ± 33 (4)

351 ± 52 (5) 'i"t

24 (5)

Control and 24 hr denervated solei from 24 hr fasted rats were
preincubated for 30 min in 5 mM glucose with or without insulin and for an
additional 60 min in identical medium.

Means ± SE are shown.

observations is in parentheses.

*p

< 0.05 vs. non-denervated pairs

t p < 0.01 vs. control without insulin

The number of
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TABLE 3
Effect of denervation and insulin on glycogen synthase activity.
Solei
Muscle

Total Activity
(pkat/mg protein)

Activity Ratio

Fractional Velocity

Control, -I

297 ± 18 (656 ± 71)

0.14 ± 0.02

0.50 ± 0.03

Control, +1

297 ± 25 (668 ± 110)

+
0.18 ± 0.02+

+
0.61 ± 0.04+

Denervated, -I

285 ± 18 (733 ± 93)

0.11 ± 0.01

0.43 ± 0.03·"

Denervated +1,

290 ± 25 (688 ± 87)

0.12 ± 0.02*

0.48 ± 0.04*

EDL
Control, - I

155 ± 25

0.16 ± 0.01

0.57 ± 0.03

Control, +1

121 ± 18

0.19 ± 0.01++

+
0.66 ± 0.03+

Denervated, -I

129 ± 15

0.12 ± 0.02

0.52 ± 0.03

Denervated, +1

144 ± 22

0.14 ± 0.02*

0.58 ± 0.04

Muscles were obtained from fasted rats 24 hrs after unilateral denervation.
They were preincubated for 15 min in buffer containing pyruvate without insulin or
albumin and incubated for 30 min ± 10 mU/ml insulin.

Glycogen synthase activity of

the 15,OOOxg supernate of muscle homogenates was measured, and activity ratios
(-G-6-P/1mM G-6-P) and fractional velocities (0.1 roM G-6-P/1mM G-6-P) calculated as
described in Methods.

pkat

=pkatals,

amount of enzyme activity converting 1 pmol

of glucose from UDP glucose into glycogen per second under standard assay conditions.

All data shown are measurements made using subsaturating concentrations of

UDP glucose (0.075 mM) except for data in parentheses where UDP-glucose was 4.4 mM.
Total activity was measured as described in Methods.

Results are expressed as mean

± S.E. of 6-7 observations.

*p < 0.05 vs. non-denervated pairs.

incubation without insulin.

I

= insulin,

10 mD/ml.

+
+ p < 0.05 vs.
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TABLE 4
Initial glycogen content of muscles
Glycogen (glucose equivalents)
nmol/mg wet weight
Soleus
24 hr. Fasted Rats
Control

17.5 ± 1.38

Denervated

34.8 ± 1.38*

Ad Lib. Fed Rats
Control

22.3 ± 1.42

Denervated

27.5

± 1.60-;'\"

EDL

24 hr. Fasted Rats
Control

19.1 ± 1.46

Denervated

17.7 ± 1.21

Ad Lib. Fed Rats
Control

•

Denervated

24.0 ± 2.00
23.3 ± 1.82

Control or 24 hr. denervated soleus and extensor digitorurn longus
muscles from fasted or fed rats were dissected and glycogen extracted
immediately as described in Methods.

Values are Means ± SE of 8-24

observations.

*

p < 0.05 vs. paired control.

in separate experiments.

Fed and fasted animals were studied
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FIGURE LEGENDS

Fig. 1.

Glucose incorporation into glycogen by solei.

Half solei were

preincubated for 30 min in 5 roM glucose with or without increasing
concentrations of insulin and incubated for 1 hr in identical media
supplemented with [U_

14

C]glucose (0.2

the mean ± SE of 6-8 observations.

~Ci/ml).

Controls

Each point represents
, Denervated

Panel

A: Rats fasted and one sciatic nerve severed 24 hrs before experiments.
B: Rats fed ad lib.; one sciatic nerve severed for 24 hrs. C: Fed rats,
unilateral denervation 6 hrs . before experiment.

*

control >denervated, p < 0.01.

Insulin effects were significant

at all doses tested in control muscles in each panel (p < 0.01); in the
denervated, insulin effects were not significant in panel B, but were
significant at 250

~U/ml

or higher doses in panels A and C (p < 0.01).
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Fig. 2.

Glucose incorporation into glycogen by extensor digitorum

longus (EDL)muscle.

Half EDL were incubated as described in Fig. 1.

Bars are Means ± SE of 6 observations.

Panel A: Rats fasted and one

sciatic nerve severed 24 hrs. before experiment.
denervation 24 hrs.

*

B: Fed rats, unilateral

Black bars indicate denervation, clear bars controls.

Control> denervated, p < 0.01.

Insulin effects were significant at both

doses in control muscles in A (p < 0.01) and at 500
insulin effect in denervated muscles.

~U/ml

in B (p < 0.05); no
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Fig. 3.

Uptake and phosphorylation of 2-deoxyglucose.

Half solei from

rats, fasted and unilaterally denervated for 24 hrs, were preincubated
and incubated as described in Fig. 3 but [
extracellular marker and

14

r3H]2-deoxyglucose

C]sucrose served as an
as the transported sugar.

Panel A: intracellular 2-deoxyglucose after 30 min. incubation in 0.1 mM
2-deoxyglucose; B: 15 min incubation in 5 mM 2-deoxyglucose.
Control

; denervated

The

% of

intracellular 2-deoxyglucose

as 2-deoxyglucose-6-phosphate after incubation is shown in Panel C and D
for experiments A and B respectively.
clear bars control muscles.

Black bars represent denervated,

Means ± SE of 6-8 observations are shown in

A and B, 8-10 observations in C and D.

* Control>

denervated, p < 0.05.

In A and B insulin effects in

control muscles were significant at each dose (p < 0.05 - p < 0.001); in
denervated muscles the only significant insulin effect is in Panel A at
1000

~U/ml,

p < 0.05.
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Fig. 4.

Insulin binding by solei.

Rats were fasted and one sciatic

nerve severed 24 hrs before experiment.

Half solei were preincubated

for 30 min in 2 roM pyruvate, then incubated for 2 hrs in identical media
supplemented with 100,000 dpm 125I-insulin and increasing concentrations
of unlabeled insulin.

Specific insulin binding was measured as

described in Methods, each point is the Mean± SE of 6-14 observations
in control

and in denervated

muscles.

Inset: One half-soleus of each side was incubated with 1 ng/ml
insulin, the other with 50

~g/ml

for non-specific binding.

Each bar

represents the mean specific binding ± SE of 13 control (clear bars) and
13 denervated solei (black

bars).

*p < 0.05 VS. control.
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Fig.

s.

Effect of epinephrine on glycogen content and glucose incorporation

into glycogen.

Solei were obtained from ad lib. fed rats 24 hrs. after

unilateral denervation.

Half-solei were preincubated for 30 min in 5 mM

glucose, then incubated for 60 min in identical media supplemented with
[U_1 4C]glucose (0.2
epinephrine.

~Ci/ml), with and without increasing concentrations of

At the end of incubation muscles were processed for measurement of

glycogen content (Panel A) and [14C]glucose incorporation into glycogen (Panel
B).

Means ± SE of 6-10 observations are shown.

incubated without epinephrine.

Control

*p

< 0.05 vs. muscles

; denervated
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CHAPTER 3: PHOSPHORYLATION OF INSULIN RECEPTORS

SOLUBILIZED FROM RAT SKELETAL MUSCLE
Introduction:

Elucidation of the mechanism of insulin action has

advanced significantly with the recent characterization of the structure
of the insulin receptor, and the discovery of its autophosphorylation
and associated protein kinase activity upon binding of insulin.

These

studies have been performed in adipocytes (1), hepatocytes (2), erythrocytes (3), monocytes (4), brain (5), placenta (6), and various cells in
culture (7); however, direct study of the insulin receptor in skeletal
muscle has been hampered by technical difficulties.

In view of its mass, skeletal muscle is the most important target
tissue of insulin action.

Regulation of the insulin receptor in muscle

is of particular interest, since contractile activity modulates its
sensitivity and response to insulin, apparently at an early step after
insulin binding (8).

Furthermore, insulin resistance of skeletal

muscle, a salient feature of several pathological conditions e.g. type
II diabetes, obesity and uremia, appears to involve primarily defective

coupling between insulin binding and response (for review see 9).

The

methods reported nere should provide a system for probing the actions of
insulin and the effect of modulators of insulin action in skeletal
muscle.
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Materials and Methods
Receptor Purification.

Male Wistar rats (Charles Rivers Breeding

Laboratories, Wilmington, Mass.), weighing 60-100g, were decapitated
after an overnight fast.

Hind limb muscles were trimmed of fat and

quickly frozen in liquid nitrogen.

The frozen muscle was finely ground

in a mortar precooled to -SOoC and to it was added ice-cold 3.5 v/w of a
buffer consisting of 25 roM Hepes * , 1% Triton-X 100, 4 mM EDTA, 1 TID/ml
aprotinin and 2 roM PHSF, pH 7.4.

The frozen slurry was homogenized as

it thawed in a Potter-Elvejhem homogenizer then centrifuged at
10,000 x g for 10 min at 4°C.

The resulting supernate was slowly

stirred at 21°C for 60 min. then centrifuged at 4°C (150,OOOxg for 90
min.) and the supernate (ISOK supernatant) applied to an agarose-bound
wheat germ agglutinin column (WGA, approx. 3 g original muscle weight/ml
resin).

The column was washed with 25 mM Hepes, 0.1% Triton X-IOO pH

7.4 (Buffer A, 75 ml/ml settled gel) and receptors eluted with this
buffer supplemented with 0.3 M N-acetylglucosamine (WGA eluate).
Typically 1 ml of WGA eluate/g original muscle weight was collected.
Insulin binding to solubilized receptors was carried out according
to Taylor et a1. (10).

150 K supernatant (20 1J1) or WGA eluate (100 lJ1)

were incubated with either 10,000 or 100,000 cpm of 125I-insulin (11)
(spec. act. 125 IJCi/lJg) in SOmM Hepes (pH 7.8), 0.1% Triton X-100, 150
mM NaCl, 0.1% bovine serum albumin (fatty acid free, Sigma), 100 U/ml

bacitracin and varying concentrations of unlabeled insulin (3xl06
8X10- M) for 16 hrs at 4°C in a final volume of 0.2 mI.

11

-

The receptor

was precipitated by sequential additions of 0.1 ml bovine y-globulin (3
mg/ml) anq 0.3 ml polyethylene glycol (25% wt/vol.).
assayed

i~

triplicate, non-specific binding.

Each point was
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In vitro phosphorylation of purified insulin receptors.

WGA eluate

(50 pI, approx. 0.03 mg protein) was preincubated in 25mM Hepes (pH

7.4), 0.1% Triton X-IOO, 5 roM MnC1

2

and 0.1% bovine serum albumin

(buffer B) with or without varying concentrations of insulin for 40 min.
at 21°C in 75 J..Il final vol. [y_32 p ]ATP was prepared using [32 p ]H P0

3 4
[y_32 p ]ATP

(leN) and Gammaprep vials, (Promegabiotec, Madison, WI.).

(S f,Jl, final conc. Sf.JM, 5-15 mCi/Jjmole) was added to each sample and
incubation continued for 20 min.

The reaction was stopped with 20 J.ll

25 roM Hepes buffer pH 7.4 containing 0.1% Triton X-100, 10 roM Na pyrophosphate, 20 mM ATP and 2 mM PMSF at 4°C.

Polyclonal anti-rat insulin

receptor antibody diluted 1:500 (kindly provided by Dr. Steve Jacobs,

Burroughs-Wellcorne) or control rabbit serum was added and the mixture
incubated overnight at 4°C.

The immune complex was precipitated with

Protein A (Pansorbin, Calbiochem) (6),washed 3 times in buffer A and
boiled for 5 min. in Laemmli's sample buffer (13) with or without 5 roM
2-mercaptoethanol.

In studies of the time-course of autophosphorylation

and of histone phosphorylation, this protocol was modified, as described
in the Legends of Fig. 3 and Fig. 4, respectively.
In situ phosphorylation of insulin receptors from solei.

Solei

from 18 hr fasted (50-70 g) rats were removed, divided longitudinally
and mounted on stainless steel frames at resting length.

Individual

half-solei were incubated for 1 hr at 25°C in 3 ml Earle's Minimal
Essential Medium (MEM) modified to contain 0.1 roM Na HP0 4 .
2

Groups of 6

muscles were then transferred to flasks containing 9 ml of phosphate
free MEM supplemented with 0.25-0.4 mei/rul of 0.1 roM Na 2 [
incubated for 3 hrsat 37°C.

32

P]P0 4 and

After labelling endogenous ATP pools the

muscle groups were incubated for 30 min at 37°C in 9 rol G~y and Gey's
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balanced salt solution (bicarbonate buffer,15) containing 0.1 mM
Na H[
2

32

P]P0

4

of identical spec. act., with or without 10 mU/ml insulin.

All incubations were under 95% 02 + 5% CO

2

atmosphere.

The muscles were

quickly removed from the supporting frames, immediately frozen in liquid
nitrogen, and each group of 6 muscles crushed in a glass Potter-Eljevhem
homogenizer precooled in liquid nitrogen.
roM Hepes, 1.5% Triton X-IOO, 10

Buffer (2 ml) containing 50

mM NaF, 0.2 roM Na 3V0 4 , 10 roM sodium

pyrophosphate, 40 mM ATP, 1 TIU/ml aprotinin, 100 mU/ml Bacitracin and 2
roM PMSF, pH 7.5 at 4°C was added and the frozen slurry homogenized as it

thawed.

The homogenate was centrifuged at 200,000 x g for 60 min at 4°C

and the supernate applied to 0.75 ml WGA.

The column was washed with 75

ml Buffer A containing 5 roM EDTA, 10 roM sodium pyrophosphate, I TIU/ml
Aprotinin and 2 mM PMSF and eluted with 1.8 ml of this buffer supplemented with 0.3 M N-acetylglucosamine.

The insulin receptor was then

immunoprecipitated and washed as described above.
Electrophoresis and Autoradiography.

Reaction samples or immuno-

precipitates were applied to either a 5% (for non-reduced receptors), or
7.5% (for reduced receptor samples) or a 5-25% gradient polyacrylamide
gel (for histone samples) with molecular weight standards (Sigma) according to Laemmli (12).

Following electrophoresis gels were fixed,

stained with Coumassie blue, destained and dried under vacuum.

Auto-

radiography was performed with Kodak AR Film with or without a DuPont
Lightening Plus intensifying screen.

For quantitation of radioactivity

gel slices were digested overnight at 55°C in 1 ml 30% H 0 and then
2 2
counted in Scintiverse (Fisher).
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RESULTS AND DISCUSSION.
Insulin binding by receptors solubilized from hind limb skeletal
muscle display classic curvilinear Scatchard plots (Fig. 1a).

The

150,000 x g supernate reproducibly yielded approximately 0.4 pmoles of
insulin binding activity/mg protein; assuming that each insulin receptor
bound two insulin molecules (17), the calculated yield was approximately

0.5 pmol solubilized receptor/g wet weight of original muscle mass.
Subsequent WGA chromatography resulted in approximately 8-10 fold
purification (per mg protein) and 75-80% recovery of binding activity
(Fig. Ib).
Incubation of WGA purified receptors with increasing concentrations
of insulin and [y_32 p ]ATP followed by immunoprecipitation with polyclonal anti-insulin receptor serum revealed that insulin stimulates the
incorporation of 32p into a 95KD protein when the immunoprecipitate is
electrophoresed under reducing conditions (Fig. 2).

As reported, for

other tissues, this corresponds to the (l-subunit of the insulin receptor
(16).

Autophosphorylation of the 95KD subunit was stimulated

half-maximally at approximately Sx10- 9M insulin with a four-fold

7
".
1ncrease
at 10- M·1nsu I"1n.

Insulin stimulated phosphorylation of the

95KD subunit showed an absolute requirement for Mn

++

(data not shown).

A labelled protein with apparent MW of 130KD (a-subunit) was also
observed in the immunoprecipitate but its phorphorylation was not
stimulated by insulin.

Under nonreducing conditions, receptors

incubated with lO-6 M insulin showed 32p incorporation into bands with
apparent MW of 360, 290, 9sKD;probably corresponding to
~ ~ubunit

stoichometries (17) (Fig. 2,

Lan~s

tl2~2' tl2~f!1

and

I and J).

Determination of the time required for autophorphorylation of the
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insulin receptor

~-subunit

(Figure 3) necessitated rapid quenching of

the reaction, the concommitant denaturation of the receptor precluded
immunoprecipitation.

Since on autoradiograms of reduced gels only the

9SKD protein showed increased labelling after addition of insulin, we
were confident that this was the f3-subunit of the insulin receptor (Fig.
2, lanes G and H).
mM MnC1

2

and 5

~M

The

t~

for autophorphorylation in the presence of 5

ATP was approximately 100 sec; maximal phosphorylation

remained relatively constant between 4 and 10 min. and gradually decreased thereafter.
Insulin induced autophosphorylationof the receptor, probably
through an intramolecular event (18), stimulates its activity as a
kinase towards exogenous substrates (14,19).

This property was also

observed with insulin receptors purified from skeletal muscle, using
histone H2B as the exogenous substrate, (Fig. 4). The incorporation was
linear for 5 min but decreased by 15 min suggesting the presence of
phosphoprotein phosphatase activity.

The phosphorylation events

probably occurred on tyrosine residues since incubation of gels in 0.5 N
NaOH did not diminish the 32p content of the 95KD protein nor that of
histones (data not shown).

Mild base treatment has been reported to

selectively hydrolyse phosphoserine and phosphothreonine residues
leaving most phosphotyrosine residues intact (20).
Long term incubation of soleus muscle in phosphate poor minimal
essential medium supplemented with [32P1P04 was required to equilibrate
endogenous ATP pools with 32p.

Preliminary experiments showed that even

after 4 hrs in low phosphate medium,' solei were still responsive to 10
mU/ml insulin as shown by a 4-fold increase in [
incorporation into glycogen (data not shown).

14

By

C]glucose
quick~y £ree~ing,
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grinding and homogenizing muscles which were incubated for 3.5 hours
with [32P1P04' the last half hour with or without insulin, we were able
to observe an approximately 2-fold increase in 32p labelling of the
insulin receptor fl-subunit of muscles stimulated with insulin (Fig. 5).
As alluded to above, the most common conditions associated with
insulin resistance of skeletal muscle, have been classified as "postreceptor" events, since decreased insulin binding could not account for
the observed decrease in insulin sensitivity and/or response.

However,

intact insulin binding (primarily a function of the a-subunit) does not
preclude the possibility of receptor abnormalities (0£ structure or
function due to an altered microenvirorunent) which may result in impaired propagation of signals.

Indeed, in a subgroup

o~

patients with

type A insulin resistance, insulin binding to monocytes was normal, but
insulin mediated receptor autophosphorylation was impaired (21).

The

demonstration of insulin stimulated in situ phosphorylation of the
fl-subunit of the insulin receptor in intact muscles and the easy availability of solubilized receptors from this tissue should further the
investigation of factors which modulate receptor-functipn coupling in
muscle, such as disuse and exercise.
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Fig. 1.

Scatchard plot of insulin binding by solubilized receptors.

Receptors were solubilized as described in Methods; 20

~l

of lS0,OOOxg

supernatant (A) or 100 J.Jl of WGA eluate (B) were incubated with O.4-4ng
125I-insulin and increasing concentrations of non-labelled insulin.
Non-specific binding (20-25%) was subtracted from each point.

Data
I

represent the mean of 3-7 determinations from 3 separate experiments.

100

2.0

A

1.8

1.4
B
on

o

:.:r

3.2~

2.8

~

..

It

\

.".

-

2.4

LI.

2.0

0

X

ED

o~~--~--~------~--~~--.·~

1.6

0.05 O. t 0.15 0.2 0.25 C: ,30 0.35

1.2

I

,40 0.45 0.50

Bound Ipmoles/mg protel t

8

o

o

0.2

0.4 0.6

0.8

1.0

1.2

1.4

1.6

1.8

Bound fpmoJes/mg protelnJ

2.0

2.2

2.4

2.6

2.8 3.0

101

Fig. 2.

Identification of muscle insulin receptor.

Wheat germ eluate

(SOIJ1) was incubated with or without insulin for 40 min at 21°C after

which [y32 p ]ATP was added for an additional 20 min.
separated by SDS-PAGE (7.5%).
are shown.

Proteins were

Autoradiographs of 32P-labeled proteins

Lanes A-E:SDS-PAGE under reducing conditions of insulin

receptors immunoprecipitated by polyclonal anti-insulin receptor
antibody or non-immune rabbit serum (Lane F) after incubation with O(A),

lO-9(B), 10-B CC ), lO-7(D), lO-6(E&F) M insulin.

Lanes G and H:SDS-PAGE

under reducing conditions of the complete reaction mixture (without
immunoprecipitation) after incubation without (G) or with (H) lO-6M
insulin.

Lane I: SDS-PAGE under non-reducing conditions of WGA after

incubation with 10-

6

M insulin followed by immunoprecipitation.

Same as I but using non-immune rabbit serum.

Lane J:

Graph represents relative

32p incorporation into the ~-subunit of the insulin receptor incubated
as described for Lanes A-E and immunoprecipitated by anti-receptor
antibody.
~-subunit

Points are means ± SE of 3 observations.
of the insulin receptor.

Arrow indicates the
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. 3.
F ~g

T1me
.
course

insulin receptor.
2xlO-

7

0f

32p 1ncorporat1on
.
. .1nto t h e p-su
~
b un1t
.

Wheat germ eluate (300

~l)

0f

t he

was preincubated with

M insulin for 40 min at 21°C in a final volume of 360 ~l followed

by the addition of 10

~l [y_32 p ]ATP (final conc. 5 ~M, 5-15 mCi/~mole).

At the times indicated 35

~l

aliquots were transferred into 3S

concentrated Laemmli's sample buffer and boiled for 5 min.

~l

twice

After

SDS-PAGE under reducing conditions the 95 KD bands were identified by
autoradiography, excised and counted for radioactivity.
means ± SE for 3 experiments.

Inset: Representative autoradiogram of

first 9 time points plotted on graph.
insulin receptor.

Bars represent

Arrow indicates

~-subunit

of the
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Fig. 4. Insulin stimulated phosphorylation of Histone H2B.
(150

~l)

was preincubated in Buffer B (final volume 700

WGA eluate

~l)

with or

without 2xlO- 7 M insulin for 46 min ~t 21°C; y[32plATP (5~M,
5-15mCi/~mole)

then added to

was included for the last 6 min.
5~1

Aliquots (35

~l)

were

histone H2B (Worthington Biochemical,final concen-

tration 0.4 mg/ml) and further incubated for the times indicated.

The

samples were then either boiled in Laemmli's solution (for subsequent
gel electrophoresis) or precipitated with 40
acid.

~l

of 25% trichloroacetic

The precipitates were hydrolysed at 55°C in 0.5 M NaOH for 1 hr

(14), reprecipitated, collected on
radioactivity.

gl~ss

filter papers and counted for

Points are means of 2 experiments.

Inset: Autoradiogram

of SDS-PAGE (reducing conditions) of incubation mixture after 15 min in
the absence (Lane A) or the presence of insulin (Lane B).
cates

~-subunit

markers of 14

of the insulin receptor.

~pd

20 KD.

Arrow indi-

Histones are between MW
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Fig. 5.

Autoradiogram of insulin receptors phosphorylated in situ.

Half solei were incubated for 3 hours in HEM with Na H[3ZP)P0 and then
Z
4
an additional \ hour in bicarbonate medium supplemented with Na H[3Z p )
Z
without (Lane A) or with (Lane B) 10 mU/ml insulin.
solubilized,

parti~lly

tated as described.

Receptors were then

purified by WGA chromatography qnd immunoprecipi-

Arrow indicates p-subunit of insulin receptor.
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CHAPTER 4: IN VITRO AND IN VIVO ACTIVATION OF THE INSULIN
RECEPTOR KINASE IN CONTROL AND DENERVATED SKELETAL MUSCLE
Introduction:
Antecedent activity modulates the insulin response of skeletal
muscle.

Following exercise the muscle's sensitivity to insulin is

increased as assessed by insulin-stimulated glucose transport (1)
glycogen synthase activation (2) and amino acid transport (3).

Basal

glucose transport into muscle cells is also stimulated following
vigorous exercise (4).

The converse is also true) e.g. muscles which

have been denervated (5-9) or immobilized (10) develop within 6-24 hrs
decreased sensitivity and response to insulin.

The insulin resistance

encompasses mUltiple parameters of insulin action e.g. glucose transport

(5-9)) glycogen synthesis (7-9)) glycogen synthase activation (7-9) and
amino acid transport (7).

Baseline glucose transport and glucose

incorporation into glycogen are also decreased in denervated muscles.
Several changes occur in the membrane of skeletal muscle after
denervation.

Extra junctional acetylcholine receptors appear (11) as

well as sodium channels that are insensitive to tetrodotoxin (12).

The

resting membrane potential is decreased (13) and phospholipid turnover
accelerates (14).

However, no significant change in the binding of

insulin to its receptor has been observed shortly after denervation, to
account for the severe insulin resistance (7)9,15) and thus the defect
in denervated skeletal muscle may be classified as a post-binding
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defect.

It has recently become evident that in some insulin resistant

states there is little or no change in insulin binding yet there is
impaired insulin-stimulated autophosphorylation of the insulin receptor
f3-subunit (16-18).

In the intact cell and in the solubilized insulin

receptor system the initial, insulin stimulated autophosphorylation
occurs on tyrosine residues of the f3-subunit and this intramolecular
event activates an intrinsic, tyrosyl phospho-transferase to exogenous
substrates.

The latter may initiate the cascade of phosphorylation-

dephosphorylation which ensues upon insulin binding to the cell surface
(for review see 19, 20).
Since the insulin resistance in denervated muscles encompasses
multiple parameters, we postulated that the defect involves an early
step in insulints action (9).

The autophosphorylation of the

~-subunit

is the earliest recognized event after insulin binds to its receptor.
We therefore addressed the following questions:

a) Is the insulin

stimulated receptor autophosphorylation and/or insulin-activation of the
receptor tyrosyl kinase (using exogenous substrate) impaired after
denervation in receptors solubilized from skeletal muscle?

b) Is the

insulin-stimulated receptor autophosphorylation affected in situ, in
incubated muscles, after denervation?

c) In the intact animal, is the

activation of muscle insulin receptor exogenous substrate tyrosyl kinase
impaired after denervation?

The latter question led to the development

of methods to assess the in vivo activation of the skeletal muscle
insulin receptor kinase activity by the hormone. Our data indicate that
insulin-mediated receptor-kinase activation is unimpaired in muscle 24
hrs after denervation, suggesting that in this model impaired receptorfunction coupling is a true post-receptor defect.
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MATERIALS
Monoiodinated A[14 I ]insulin was kindly provided by Dr. B.H. Frank
(Lilly Research Laboratories, Indianapolis, IN).

Monocomponent, crys-

talline pork insulin was a gift of Dr. Ronald Chance (Lilly Research
Laboratories).

Polyclonal anti-insulin receptor antibody was a gift of

Dr. Steve Jacobs (Wellcome Research Laboratories).

Wheat germ agglu-

tinin was from Vector, Aprotinin was from FBA Pharmaceuticals, Baci
tracin from Pfizer.
atus from LKB.

Electrophoresis reagents were from Serva and appar_

Protein A bearing S. au reus was from Calbiochem.

activated Sepharose 4B was from Pharmacia.
plates were from Brinkmann Instruments.

CnBr-

Precoated cellulose TLC

Autoradiography Film, X-omat

AR, was from Kodak and Lightening + intensifying screens from duPont.
y[32PJATP was prepared from 32P-orthophosphate (ICN) in Gamroaprep vials
(Promegabiotec) as described by the manufacturer.
New England Nuclear.

[l4C]glucose was from

All other reagents and chemicals were from Sigma

unless otherwise specified.
METHODSl
Animals.

Male rats, of the Wistar strain, weighing 60-110g were

used in all experiments.

They were allowed access to food and water ad

libitum until 24 hr before experimentation when .food was removed.

In

all experiments rats were unilaterally denervated 22-26 hr before experi
ments, by cutting the sciatic nerve through a small incision in the
posterior aspect of the thigh as previously described (9).
Insulin receptor solubilization.

Insulin receptors were solu-

bilized from the muscle groups innervated by the sciatic nerve (lower
leg muscles).

The muscles were rapidly removed and quickly frozen in

liquid nitrogen, powdered and the insulin receptors solubilized by

115
homogenization in 25 roM Hepes, pH 7.4, 1% Triton X-IOO, 1 TIU/ml
aprotinin, 5 mM EDTA, and 2 roM Phenyl methyl sulfonyl fluoride (PMSF) .
After 10 min. centrifugation at 10,000 x

& the

supernatant was stirred

for 30 min at 22°C to complete solubilization and then centrifuged at

150,000 x 8. for 90 min. (Method 1).

The supernatant was passed three

times over an agarose bound wheat germ agglutinin (WGA) column and the
resin washed with 25 bed volumes of 25

mM Hepes, pH 7.4, 0.1% Triton

X-lOa (buffer A) and the partially purified glycoproteins eluted with
buffer A supplemented with O.3MN-acetylglucosamine.

The WGA eluate was

aliquoted and stored at -80°C without loss of binding or kinase

In some experiments the insulin receptors were isolated in

activity.

the phosphorylated state by homogenization in at least 10 volumes of a
buffer containing 50 roM Hepes, pH 7 . 4, 1.5% Triton X-100, 1 TIU/ml
aprotinin, 5 mM EDTA, 10 roM NaF, 10 roM Na pyrophosphate, 1.5 mg/ml
~M

bacitracin, 100
10,000 x

150,000 x

& for
~

Na3V04, and 2 roM PMSF.

After centrifugation at

10 min the supernatant was immediately centrifuged at

for 1 hr (Method 2).

The resulting supernatant was applied

to a WGA column pre-equilibrated with buffer A supplemented with 10 roM
Na pyrophosphate, 5 roM EDTA, 1 TIU/ml aprotinin and 2 roM PMSF (buffer B)
and recycled three times.

The column was then washed with 25 bed

volumes of Buffer B and the insulin receptors eluted with buffer B
supplemented with 0.3 M N-acetylglucosamine .
Insulin binding to the solubilized insulin receptors was according
to Taylor et al.

(21) using A14[125I]insulin.

The binding data were

normalized to the protein content of the wheat germ eluate as determined
by the Bradford reaction using bovine y-globulin standards (22).
studies of receptor-kinase activities were carried out using equal

All
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insulin binding activities from WGA eluates prepared from control and
denervated muscles.

The latter were always prepared and assayed in

parallel with the contralateral control muscle insulin receptors.
Insulin induced autophosphorylation of the solubilized insulin
receptor was performed as previously described (23).

Briefly,

WGA

eluate from control and denervated skeletal muscles were incubated
without or with 10- 9 or 10- 7 insulin in 65 ~l Buffer A supplemented with
5

mM MnC1 2 and 0.05% BSA (phosphorylation buffer), for 1 hr at 25°C.

The autophosphorylation was initiated by the addition of

10

~l

y[32p]ATP

(50 ~M final concentration, 7.5 ~Ci/vial) and the reaction continued for
4 min. when 4X concentrated Laemmli's sample buffer (24) (supplemented
in all experiments with 5 roM 2-mercaptoethanol) was added and the
samples placed in boiling water for 3 min.

The proteins were separated

by NaDodS0 4 polyacrylamide gel electrophoresis

(SDS-PAGE), the p-subunit

was localized by autoradiography, excised and digested, and the
radioactivity determined, as described in "Electrophoresis".
Estimation of exogenous substrate kinase activity of the insulin
receptors purified by Method 1 above was performed with histone H2 b as
the phosphoacceptor after the receptors were bound to insulin-agarose
using the protocol of Yu and Czech (25).

Wheat germ eluates from

control and denervated skeletal muscles were incubated first with 50 1J1
dithiothreitol-heat inactivated insulin-agarose (150 1J1 wheat germ
eluate in a final volume of 500

~l)

at 25°C for 1 hr and the supernatant

then incubated with active insulin-agarose for an additional 1 hr.
After washing twice with 1 ml Buffer A supplemented with 0.5 M NaCl and
once with 1 ml Buffer A alone the exogenous substrate kinase activity of
the insulin-agarose bound receptor was activated by incubating it in
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buffer A supplemented with 5 roM MnC1 2 and 750 IJM unlabeled ATP at 25°C
for 20 min.

After washing twice in 1 ml Buffer A, the resin was

resuspended in 65fJl Buffer A supplemented with 5 mM MnC12, 0.05% BSA
and 1 mg/ml Histone H2b.

The kinase reaction was initiated by adding 10

JJl y[32p]ATP (5 IJM final concentration, 5 IJCi/vial) and continued for 4
min, when 4X concentrated Laemmli's sample buffer was added and the
solution placed in boiling water for 3 min.

After separation of the

proteins on SDS-PAGE the his tones were localized by autoradiography and
the radioactivity incorporated d'etermined as described under "Electrophoresis".
Autophosphorylation of the insulin receptor in the intact soleus
was carried out as previously described (23).

Briefly, hemisolei

(groups of 5-6 muscles) were incubated in Dulbeccots Modified Eagles
Medium (DMEM) containing 0.1 mM Na phosphate for 1 hr at 25°C to lower
endogenous phosphate pools.

The muscles were then transferred to DMEM

with 0.2 mCi/ml (0.1 mM) Na [32p]phosphate and incubated at 37°C for an
additional 3 hrs. (preliminary experiments showed this was sufficient
time to reach steady state labeling of nucleotide pools, as determined
below).

The muscles were then transferred to Gey and Gey's balanced

salt solution (26) which was modified to yield a concentration and
specific activity of phosphate identical to that of the modified DMEM
medium described above, with or without 10 mU/ml of insulin and the
incubation continued for

~

hour.

The individual herni-solei were then

frozen with metal tongs precooled in liquid nitrogen and the insulin
receptors solubilized and partially purified by Method 2 described above
except that 40 roM unlabeled ATP was added to the homogenization buffer .
Immunoprecipitation of -the phosphorylated insulin receptor was achieved
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by incubating the WGA eluate overnight at 4°C with polyclonal antiinsulin receptor antibody (1:250 dilution), followed by protein A
bearing, formalin fixed Staphylococcus for an additional 2 hrs.

After

centrifugation, the precipitated complex was washed 3X in Buffer A, and
the pellet boiled in Laemmli's sample buffer.

Electrophoresis and

quantitation of 32p incorporated into the p-subunit was as described
above.
A parallel set of control and denervated herni-solei were incubated

in an identical fashion in the modified Dulbecco's MEM with 1/100 the
specific activity of 32p, to estimate the concentration and specific
activities of the nucleotide pools prior to the transfer to the insulin
containing medium.

After freezing, the individual muscles were powdered

with a glass rod in a microfuge vial and the nucleotides extracted by
the addition of 60 JJl of 3M perchloric acid and incubated for 20-30 min
at -IOoe (27).

Cold distilled water (200 JJl) was added and incubation

continued for an additional 10

m~n

at 4°C.

The protein precipitate was

removed by centrifugation for 15 min in a microfuge at 4°C and the
supernate neutralized with 65 JJl 2N RHe0 3 , and clarified by centrifugation.

The supernatant was filtered and 20 JJI injected onto a 5 cm CI8

reverse phase column on a Perkin-Elmer Series 4 high pressure liquid
chromatograph.

The nucleotides (ATP, ADP, and GTP) were eluted iso-

cratically using a buffer composed of 350 roM phosphoric acid brought to
pH 6.5 with triethylamine (98%) and methanol (2%) (28).

The location of

the eluted nucleotides was determined by the injection of appropriate
standards monitored by absorbance at 259 nm.

Each peak was collected in

duplicate determinations and counted in a liquid scintillation counter.
The concentration of nucleotides was estimated by the peak area as
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determined by a Perkin-Elmer LCI-IOO integrator.

The specific activity

was calculated as cpm/nmole nucleotide, nucleotide content of the tissue
was normalized to the protein content, mea·sured by the Lowry reaction
using bovine serum albumin standards (29).
In vivo activation of the exogenous kinase activity of the insulin
receptor was studied as follows.

Unilaterally denervated rats were

anesthetized with metophane and divided into two groups.

One group

received an intravenous injection of SU regular insulin (Humulin,
recombinant DNA origin, Eli Lilly Co.) via the femoral vein, the other
received an equal volwne of saline.

Five or 30 min later the hindleg

muscles were exposed, the soleus muscles rapidly removed, mounted on
wire frames and incubated for \ hour in [14C]glucose containing buffer
to estimate glycogen synthesis.

The remaining leg muscles (primarily

gastrocnemius and anterior compartment muscles) were removed, frozen in
liquid nitrogen, homogenized and the insulin receptors solubilized by
Method 2 above.

After elution from the WGA column, the exogenous kinase

activity of the receptors was estimated by incubation in media
containing SO mM MgS0 4 (which was added first to precipitate inorganic
phosphate and EDTA) , 5 mM MnC1 2 , 0.05% BSA, Img/ml histone H2 b, with or
without 10- 7 M insulin for 10 min at 25°C.
or SO

~M

final concentration, 7.5-10

volume of 75

~1.

y[32p]ATP was then added (5

~Ci/vial),

in a final reaction

After 4 min. the reaction was stopped by the addition

of 4X concentrated Laemmli's sample buffer and the solution placed in
•
boiling water for 3 min. The proteins were separated by electrophoresis, autoradiographed and 32p incorporated into histones determined as
described under "Electrophoresis".
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In a second assay WGA eluted receptors were incubated with insulinagarose (50 fJ1/150 1J1 WGA eluate, the latter diluted with 2 vol buffer
A) for 15 min'at 22°C after which the resin was washed twice with 50 roM
Hepes, pH 7.4, 0.1% Triton X-IOO, 0.5 M NaCl and once with the same
buffer without NaCl, according to Yu and Czech (25).

The insulin-

agarose bound receptors were then resuspended in 75 fJl Buffer A, supplemented with 5 mM MnC12, 0.05% BSA and 1 mg/ml histone H2b.

The kinase

reaction was initiated by adding 10 fJl y[ 32 p]ATP (5JJM finalconcentration, 7.5 JjCijvial)..

In a parallel reaction the receptor kinase was

maximally activated by first incubating the washed insulin-agarose bound
receptors in the above phosphorylation buffer (without histone) with 750
IJM unlabeled ATP for 20 min at 25°C..

After washing twice in 1 ml Buffer

A the kinase activity against histone H b was measured as described
2
above.
Plasma glucose determination.

Blood obtained via cardiac puncture

was used for plasma glucose determinations with a Beckman Glucose
Analyzer 2..

Only those animals whose plasma glucose fell below 65 mg%

were considered "treated" in the in vivo activation experiments.

The

mean plasma glucose of insulin treated rats was 39 ± 4 mgldl at 5 min
and 33 ± I1mg/dl at 30 min after insulin injection (n

=4

and 10

respectively), while the mean plasma glucose of saline treated controls
was 85 ± 6 mg/dl.
Glycogen synthesis bI control and.denervated solei..

Solei were

divided lengthWise and mounted on wire frames as described previously
(9) and incubated in 2 ml Gey and Geyts balanced salt solution (26)
supplemented with 0.1% BSA and 5 roM [14C]glucose (0.3 ~Ci/ml) under 95%
O2 /5% CO 2 atmosphere at 37°C for 30 min.

The muscles were then digested
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in 0.5 ml 30% KOH for 20 min at 10QGe and the glycogen precipitated by
the sequential addition of 50

~l

10% Na2S04 and 1 ml 100% ethanol.

The

precipitate was collected by centrifugation, washed twice with 66%
ethanol, dissolved in 1 ml IN Hel and the radioactivity determined by
scintillation counting.
Phosphoaminoacid analysis.

The position of the histone samples for

phosphoamino acid analysis was determined by autoradiography of an
unfixed, undried gel and aligned with fluorescent dye marks (Ultemit,
New England Nuclear).

The desired portion of the gel was excised and

placed in a dialysis bag with 2 ml electrophoresis buffer.

The bag was

closed with dialysis clips and the gel slice trapped between the plates
of the vertical electrophoresis unit, one end plugged with acrylamide.
A voltage of 300 V was applied for 40 min and the eluted protein
precipitated with 20% trichloroacetic acid using 100
globulin as a carrier.

bovine gamma

The precipitate was hydrolysed in 6 N Hel,

lyophilized, absorbed to 500
(30).

~g

~l

Dowex 1-X8 and eluted with 0.25 M Hel

After lyophilization the samples were resuspended in a small

volume of mixed phosphoamino acid standards (0.33 mg/rol each of
phosphotyrosine, phosphoserine and phosphothreonine), spotted on 0.1 rom
cellulose coated plates and electrophoresed at pH 3.5 (pyridine/acetic
acid/water, 1:10:189) at 1000 V for 40 min (30).

The positions of the

phosphoaminoacids were located by ninhydrin staining and the
radioactivity detected by autoradiography.
Electrophoresis was performed using the discontinuous system of
Laemmli (24) under reducing conditions.

For samples identifying only

the f3-subunit of the insulin receptor a 7.5% resolving gel was employed.
For samples identifying both the

~-subunit

of the insulin receptor and
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histone H2 b a linear 6-20% polyacrylamide gel system was used.
cases a 4.5% stacking gel was used.

In all

After electrophoresis, the gels

were stained in 50% methanol, 10% acetic acid with 0.125% Coomassie
brilliant blue R, destained in 30% methanol, 10% acetic acid, and dried
in vacuo with heat.

Phosphorylated peptides were localized by autoradio-

graphy using Kodak AR-S film, in some cases in the presence of a duPont
lightening + intensifying screen.

Phosphorylated bands of interest were

excised and the radioactivity estimated by digestion of the gel slice
for 10 hrs in 1 ml 30% H2 0 2 and subsequent counting in a Beckman LS 7000
f3-counter after dissolving the sample in Scintiverse E (Fisher).

RESULTS
Eguilibrium binding of 125I-insulin to insulin receptors in the WGA
eluate solubilized from control and denervated hind limb muscles yielded
typical curvilinear binding kinetics (Fig. 1).

When expressed per mg of

protein in the WGA eluate, there was no significant difference in the
number of insulin receptors isolated from control and denervated muscles
(although the latter was slightly lower), nor was there a difference in
the apparent insulin binding affinity or in the amount of glycoprotein
eluted from the WGA column/tissue weight.
Solubilized insulin receptor kinase activities.

Upon binding

insulin, the receptor, both in the intact cell and in the solubilized
system, undergoes rapid autophosphorylation (for review see 19,20).
This property of the solubilized receptor was tested, by incubating WGA
eluates, prepared from control and denervated muscles, with increasing
concentrations of insulin, using equal insulin binding activities from
each preparation.

Insulin induced a dose-dependent increase in

incorporation into thef3-subunit of the receptor (Fig. 2a).

32p

The latter
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was identified as the fJ-subunit by its apparent molecular weight
(-97,000), its insulin dependent labeling with

32p

and its precipita-

bility with specific antibodies (23 and Figure 2c). There was no
apparent difference in autophosphorylation between receptors derived
from control and denervated muscles at all insulin doses tested (Fig.
2a).

The metal ion dependence of the autophosphorylation reaction

(Mn++>Mg++»Ca++) was also identical in the two groups, as was the time
course of the autophosphorylation (data not shown).

Similarly, the

exogenous substrate kinase activity of the fully activated insulin
receptor was not altered by denervation using histone H2 b as the
phosphoacceptor (Figure 2b).
Phosphorylation in the intact soleus.

When insulin receptors were

isolated by Method 1, no attempt was made to prevent dephosphorylation
of the receptor.
insulin receptor

In vivo, the basal state of phosphorylation of the
~-subunit,

especially phosphorylation on serine

residues, is thought to modulate the autophosphorylation on tyrosine
residues upon binding of insulin (31,32).

To investigate whether or not

denervation affects the insulin stimulated autophosphorylation of the
receptor in the intact cell, soleus muscles from control and denervated
hind limbs were incubated in [32p]P0 4 containing media for 3 hrs to
label intracellular nucleotide pools and then placed into media with or
without insulin for \ hr to stimulate receptor autophosphorylation. The
muscles were quickly frozen, and the insulin receptors solubilized and
partially purified in a buffer which, as determined in preliminary
experiments, minimized dephosphorylation.

After immunoprecipitation and

electrophoresis under reducing conditions the

~-sub.unit

autoradiography, eXCised, and radioactivity determined.

was localized by
Table 1
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summarizes the results of five such experiments.

While in each case

denervated and control muscles responded to insulin with increased
labeling of the insulin receptor p-subunit,

32p

incorporation in the

presence of insulin was 19% less in the denervated group.

Whenfl.

insulin, e.g. 32P-incorporation above baseline was calculated, the
magnitude of the insulin effect was decreased in denervated muscles, but
the decrease was not significant by paired analysis..

The concentration

and specific activities of ATP, ADP, and GTP were determined immediately
before insulin stimulation.

The concentrations of the three l1ucleotides

were identical in denervated and control solei after three hours of
incubation (Table 1) but in both muscle groups the ATP concentration
decreased 20% from pre-incubation levels (data no"t shown)..

The specific

activity of the ATP pool on the other hand was 11% lower in the
denervated muscle groups. Thus, the slight decrease in insulin
stimulated labeling of the

~-subunit

from denervated muscles may reflect

the decrease in the specific activity of intracellular ATP; this would
suggest, however, that there may be a slight increase in the basal
phosphorylation of the

~-subunit

from denervated muscles.

Unfortu-

nately, the low receptor associated radioactivity precluded the analysis
of the labelled phosphoaminoacids before and after in situ insulin
stimulation.
Kinase activity of in vivo activated receptors.

A method was

developed to solubilize muscle insulin receptors in the presence of
phosphoprotein phosphatase and kinase inhibitors and determine their in
vivo activation state by assessing their ability to phosphorylate exogenoussubstrates, in vitro.

Since the exogenous substrate kinase

activity of the receptor is" dependent on its phosphorylation state (25),
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if the sites on the insulin receptor which were phosphorylated in
response to in vivo insulin remained phosphorylated during receptor
isolation, the exogenous kinase activity should reflect the degree of in
vivo activation.

Rats were anesthetized and one group was given an i.v.

bolus of insulin via the femoral vein.

After 5 or 30 min, the hind limb

muscles innervated by the sciatic nerve were removed and quickly frozen
in liquid nitrogen.

The procedure used to solubilize and partially

purify insulin receptors from hind limb muscles was similar to that used
previously in isolating the autophosphorylated insulin receptors from
incubated soleus muscle (Method 2).

In an initial attempt to quantitate

the exogenous substrate kinase activity MgS04 was added to the insulin
receptor containing WGA eluate to precipitate inorganic phosphate and
EDTA.

The receptor kinase activity was then assessed with 5

y[32P]ATPand 1 rug/ml histone H2 b as the substrate.

~M

Using equal insulin

binding activities the histone kinase activity of muscle insulin
receptors from rats which had been treated in vivo with insulin was
- 2-fold greater than that of untreated controls (Fig. 3) with no
significant difference between receptors isolated 5 or 30 minutes after
the administration of insulin (30 min point not shown).

The insulin

receptor kinase from denervated skeletal muscles activated to the same
level as that derived from the innervated pairs after i.v. insulin (Fig.
3).

When insulin (2xlO-7 M) was added to the incubation mixture for 10

min before initiating the kinase reaction, stimulation of histone kinase
activity was not observed in any group of receptors.
series of experiments were performed with 50

~M

When the same

ATP, the receptor

associated histone kinase activity prepared from rats which had received
insulin was still greater than that of receptors prepared from saline
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treated controls.

However, when WGA eluates were preincubated with

insulin before the addition of 50

ATP, histone phosphorylation by

~M

receptors derived from saline treated controls increased two-fold and a
smaller but significant increase was observed usin.g the WGA eluate
derived from insulin treated animals.

Again no difference was observed

between receptors prepared from denervated and innervated muscles.
These results demonstrate that 5

~M

ATP is too low to allow the in vitro

activation of the exogenous substrate kinase by insulin, at least in the
time frame investigated.

Increasing the concentration of ATP ten-fold

allowed the in vitro activation of histone kinase by insulin in both the
control and denervated derived WGA eluates, but this increase in kinase
activity was not as great as that seen in the in vivo activated receptors.

Phosphoamino acid analysis of histones .showed that the

increase in labeling after in vivo activation of the insulin receptor
occurred exclusively on tyrosine residues (not shown).
The differences in kinase activity between insulin receptors
derived from insulin and saline treated rats may have been due to
insulin carried through the receptor purification procedure or to a
co-purified histone kinase activity that was independent of the insulin
receptor.

To test this, a second assay was performed.

The WGA purified

receptors were incubated with insulin-bound agarose beads and after
centrifugation and washing the kinase activity towards histone H2 b was
assessed in a reaction using 5 )JM y[32p]ATP, a concentration which, as
shown above, does not allow the further activation o£ the insulin
receptor kinase. As in the previous assay, receptors isolated from
insulin treated rats showed increased histone kinase activity, and in
vivo activation by insulin was not affected by denervation (Fig. 4).
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When these insulin-agarose bound receptors were first allowed to
autophosphorylate with 750 JJM unlabeled ATP, the histone kinase activity
increased to identical levels in all groups (Fig. 4).

Histone

phosphorylation after activation with 750 J..IM ATP was slightly lower than
that observed after in vivo activation with insulin, this difference,
although not significant, likely represents small losses of receptors
during washing and/or slight dilution of the labeled ATP,resulting in
decreased specific activity_

When WGA eluates were incubated with

dithiothreitol-heat inactivated insulin-agarose beads the histone kinase
activity observed was less than 10% of that seen in any of the
experiments using fully activated beads suggesting that the bulk of the
kinase activity pertained to insulin receptors bound to the insulin
agarose.

Phosphoamino acid analysis of the histones phosphorylated in

the presence of insulin-agarose bound receptors revealed considerable
32p

incorporation into serine residues, which however was not affected

by pretreating the rats with insulin in vivo, or by preincubating
receptors from saline treated controls with 750 JJM ATP, while both
maneuvers approximately doubled
(Fig. 5).

32p

incorporation into tyrosine residues

Identical increments were observed us.ing receptors prepared

from denervated muscles (not shown).
The intravenous insulin bolus stimulated the metabolism of
innervated muscles, as assessed by the in vitro incorporation of
[14C]glucose into glycogen.

Denervated muscles were resistant to

intravenously administered insulin in the same way as they are resistant
to insulin in vitro (7-9).

Innervated solei from non-treated animals

had a low basal rate of glycogen synthesis (Fig. 6) which was stimulated
by adding insulin in vitro.

The 24 hr denervated solei from saline
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treated controls demonstrated a markedly reduced basal rate of glycogen
synthesis and this did not increase significantly upon addition of
insulin to the incubation medium.

On the other hand, solei from the

innervated legs of insulin treated animals synthesized twice as much
glycogen than those from

s~line

treated controls when incubated without

insulin and this rate was not increased further by adding insulin in
vitro.

Stimulation of glycogen synthesis in non-denervated solei was

apparently complete within 5 min . after the i.v. bolus of insulin (Fig.
6) which correlates with the increase in the exogenous kinase activity
of the receptors isolated from the ipsilateral muscle groups at this
time.

Attempts at investigating the activation after shorter time

periods proved difficult in that at least 1 min. was required to remove
both solei and excise and freeze the remaining muscles.

We could

demonstrate nearly complete activation of both glucose incorporation
into glycogen and exogenous kinase activity within 30-45 sec after the
i.v. injection of insulin, this result was variable, however (data not
shown) .
Discussion.

Insulin resistance of peripheral tissues, including

muscle, is associated with a number of physiological and pathological
conditions which include hormonal imbalance (e.g. excess glucocorticoids, catecholamines or growth hormone), obesity, type II diabetes,
uncontrolled insulinopenic (type I) diabetes, uremia, the catabolic
state which accompanies severe trauma, burns and sepsis, some genetic
abnormalities and in skeletal muscle, denervation and immobilization.
Conditions of insulin resistance associated with increased circulating
insulin levels are usually accompanied by a decrease in the number of
insulin receptors on the cell-surface, a phenomenon termed ftdown-
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regulation".

However, in most conditions, the ensuing decrease in

insulin binding does not account for the magnitude of the insulin
resistance, indicating that post-binding defects play an important role
(for review, see 33).

Recent findings suggest that in some conditions

e.g. a genetic abnormality of the insulin receptor resulting in severe
insulin resistance in man (16,17) as well as in uncontrolled insulin
deficient diabetes in the streptozotocin treated rat (18) and in the
goldthioglucose treated obese, diabetic rat (34) insulin binding (which
involves primarily the a-subunit of the receptor) is unimpaired, but the
insulin activated autophosphorylation and tyrosine kinase activity of
the

~-subunit

are diminished upon insulin binding in vitro.

Thus,

post-binding insulin resistance may include receptor abnormalities
resulting in abnormal signalling by the occupied receptor, as well as
true post-receptor defects.

In the case of denervated muscles, we and

others (7,9,15) found no defect in insulin binding; the current work
demonstrates that in addition, the tyrosyl-kinase activity of the

~

subunit is normally stimulated by insulin, thus the severe insulin
resistance which develops in muscle shortly after denervation appears to
be a

post~receptor

defect.

It is possible, however, that other, undis-

covered properties of the receptor are impaired shortly after denervation.

Whether the insulin unresponsiveness is due to alterations in

membrane potential (13), defects in the generation of second messengers,
development of a metabolic milieu which is unfavorable for the propagation of signals or alterations in the levels or properties of the proposed substrates for the insulin receptor kinase is not known.

Further

studies of this model may provide clues concerning the mechanism of
insulin action and its post-receptor modulation.
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In the course of these studies we developed techniques to assess
the in vivo activation state of the insulin receptor in skeletal muscle.
Rapid freezing of the excised muscles in liquid nitrogen, . solubilizing
and purifying the insulin receptors in the presence of phosphoproteinphosphatase and kinase inhibitors (NaF, Na4PZ07 Na2V04 and EDTA) allowed the demonstration of increased histone H2 b phosphorylation by WGA
eluates from animals which had been treated in vivo with insulin.

Two

methods were used to clear the solution of EDTA and inorganic phosphate
(which would chelate the Mn++ ions required for activ.ation).

In the

first assay, MgS0 4 was added in sufficient quantities to remove the
chelators.

Using 5 IJM ATP no stimulation of histone kinase activity was

seen when insulin waS added to the incubation medium prior to the initiation of the kinase reaction.

The inability to activate the exogenous

substrate kinase of the receptor with insulin at this low ATP concentration has been previously reported (25,35) and is attributed to the
decreased phosphorylation of a critical site on the insulin receptor
~-subunit

(25,35).

By raising the ATP concentration to 50 IJM an in-

crease in the histone kinase activity could be demonstrated in the WGA
eluates in response to maximally stimulating insulin concentrations in
vitro; as expected the increment caused by insulin in vitro was much
greater using receptors prepared from controls, than from insulin
treated rats.

It is noteworthy that while the baseline histone phos-

phorylation occurred predominantly on serine residues, the increment in
histone phosphorylation

elic~ted

by insulin in vivo or in vitro occurred

exclusively on tyrosine.
In the second method the insulin receptors were further purified by
binding them to insulin-agarose, thus removing them from the WGA eluate
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containing Mn++ chelating anions as well as enzymes which may modify
receptor-induced histone phosphorylation.

Preliminary reports described

a similar approach for assessing the activation state of the receptor in
isolated cell systems (36,37).

The results obtained with this method

(Fig. 4) confirmed the preceding ones (Fig. 3).

Insulin-agarose bound

receptors prepared from insulin-treated rats demonstrated - 2-fold
greater histone-H 2 b phosphorylation, in the presence of 5

~M

[y_32p]ATP

than identically prepared receptors from saline treated controls.

When

both sets of insulin-agarose bound receptors were preincubated with
unlabelled, 750

~M

ATP, a concentration which fully activates the

receptor tyrosyl-kinase (25 and our data, not presented), histone
phosphorylation by receptors from saline treated controls was activated
to the same level as that by receptors from rats treated in vivo with
insulin.

The insulin binding activity of the WGA eluates from insulin

and saline treated rats was determined before incubation with insulinagarose, and the beads were incubated with equal binding activities.

In

preliminary experiments insulin binding curves prepared from WGA eluates
derived from insulin treated and saline treated rats revealed no difference in binding kinetics between the groups.

Furthermore, addition

of Mn++ and ATP to binding assays did not alter the apparent affinity of
the insulin receptor.

This confirms previous observations that insulin-

induced receptor phosphorylation does not alter the affinity of insulin
binding (38).
It is unlikely that our data were compromised by insulin carried
125

over through the receptor purification procedure because

a) when

1-

insulin was included in muscle homogenates, with or without unlabeled
insulin (10

~g/ml),

less than 0.1% of the radioactivity was associated
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with the WGA eluate and this was non-specifically bound,
U/ml (20

~g/ml)

b) when 0 . 5

insulin was included in the buffer in which muscles from

saline treated controls were homogenized, no activation of the receptor
tyrosyl-kinase was detected in assays of the WGA eluate.

Similarly,

inclusion of 40 mM ATP in the homogenization buffer did not affect the
subsequent measurements of histone kinase activity in any group.

WGA

eluates prepared from skeletal muscle were devoid of detectable phosphoprotein
phosphatase activity (not shown).

ATPase activity was assayed under a

number of experimental conditions, by measuring the radioactivity associated
with ),[32p]ATP and with inorganic phosphate, separated by HPLC (as
described in Methods) after incubation of the receptor preparations with
),[32p]ATP.

Less than 10% of y[32p]ATP was degraded after 4 min.

incubation in any histone kinase assay (or in assays of receptor
autophosphorylation), and this measurement was not affected by previous
treatments e.g. insulin or denervation.

While significant serine-kinase

activity was associated with the receptor preparations, even in the
assay using insulin-agarose bound receptors, receptor-induced histone
phosphorylation on serine residues was unchanged after treating rats
with insulin in vivo or after activating the receptors in vitro.

On the

other hand, both maneuvers markedly stimulated the phosphorylation of
histone H2b on tyrosine residues (Fig. 5).
Since denervated muscles demonstrate decreased sensitivity as well
as a decreased response to insulin (5-9) we injected high concentrations
of the hormone to elicit maximal responses in both the denervated and
innervated muscles.

In innervated muscles both receptor activation and

the biological response (assessed as glucose incorporation into
glycogen) were essentially fully stimulated within 5 min of such
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injections.

In denervated muscles, identical activation of the receptor

tyrosine kinase by insulin was not accompanied by the biological
response. In experiments where receptor histone-kinase activity and
stimulation of glycogen synthesis were measured in parallel 5 min. and
30 min. after the i.v. injection of insulin, the responses were
essentially identical at the two time points, suggesting that
phosphorylation of the tyrosine, which is critical for activation of the
receptor-tyrosyl-kinase, occurs rapidly and persists in vivo.

Dose

response curves injecting lower doses of insulin have not yet been
tested; they may be required for the quantitative assessment of receptor
activation in different physiological and pathological

conditions~

While skeletal muscle is a major site of insulin action, similar
measurements should be feasible in other tissues as well.

The method

for assessing the activation state of the insulin receptor in skeletal
muscle in vivo is relatively rapid, easily applicable to various animal
models of insulin resistance and in contrast to cell culture systems,
the availability of tissue is not limiting-

It should be useful in

characterizing insulin resistant states, by identifying conditions which
may be associated with defective activation of the fj-subunit
tyrosyl-kinase upon insulin binding in vivo.
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Table 1
A.
solei.

Autophosphorylation of the insulin receptor

~-subunit

in incubated

Groups of 6 hemisolei (from control and denervated hindlimbs)

were preincubated for 1 hr in low phosphate DMEM, then for 3 hrs in this medium
supplemented with [32P]phosphate (0.15-0.25 mei/ml), followed by 30 min
incubation with and without insulin as described in Methods.

Solei were

immediately frozen and insulin receptors solubilized and partially purified
by Method 2, and immunoprecipitated and processed as described in Fig. 2C.
Values represent the mean ± S.E. for 5 experiments.

Cpm incorporated

into the f3-subunit were normalized to the wet weight of the muscles
prior to incubation.
B.
solei.

*

p < 0.05 vs. no insulin, paired analysis.

Nucleotide concentration and specific activity in incubated
Solei from control and denervated hind limbs were incubated

exactly as described in A. except the specific activity of the
[32p]phosphate was decreased to 1.5-2.5 IJCi/ml.

The muscles were frozen

immediately following the 3 hr. incubation in DMEM and nucleotides
extracted and separated as described in "Methods".

The concentration of

the nucleotides was normalized to the protein content of individual
muscles.

Means ± S.E. of 5 different experiments are shown, 6 control

and denervated hemi-solei were assayed individually in each experiment.
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Table 1

A.

cpm incorporated into

Insulin in Media

o
10 mU/ml

B.

mg wet weight

Control

Denervated

242 ± 32

252 ± 37

379 ± 45*

320 ± 25*

Nucleotide levels in soleus

Concentration
(nmoles/mg protein)
Nucleotide

p subunit/IOO

Specific activity
(cpm/nmole)
Denervated

Control

Denervated

Control

ATP

22 . 1 ±2. 8

22.3 ± 1.9

629 ± 116

564 ± 106

ADP

3.9 ± 0.6

4.2 ± 0.6

244 ± 69

233 ± 69

GTP

4.4 ± 0.8

4.2 ± 0.6

107 ± 22

107 ± 25
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Figure 1.

Equilibrium Binding of A14[12 S I]insulin to solubi11zed,

WGA-purified insulin receptors.

Aliquots of WGA eluate (7.5

~g

of

protein) from control and denervated skeletal muscle were incubated with
tracer A14[1 25 I]insulin (specific activity 100-140 ~Ci/~g) and
increasing concentrations of unlabeled insulin in a total volume of 200
1J1 buffer containing 50 mM Hepes, 100 mM NaCl, 0.05 mg/ml BSA, 0.1%
Triton X100 and 0.075 M N-acetyl glucosamine, pH 7.8 for 16 hr. at 4°C.
The receptor and bound insulin were precipitated by the sequential
addition of 100
glycol.

~l

0.3% bovine

~-globulin

and 300

~l

25% polyethylene

Non-specific binding was considered that which occurred in the

presence of 10 JJg/ml unlabeled insulin and was subtracted from each
point.

The main figure shows a Scatchard plot of data from control

(0---0) or denervated muscle (x---x) derived receptors.

Each point is

the mean ± S.E. of three receptor preparations, each point assayed in
triplicate.

Inset shows displacement curve analysis of the same data.
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Figure 2.

A. Insulin induced autophosphorylation of the

solubilized, WGA-purified insulin receptors.

In the standard assay

equal insulin binding activities of control and denervated derived WGA
eluates were incubated in phosphorylation buffer without or with 10- 9 or

IO- 7M insulin for 1 hr. as described in "Methods u

•

y[32P] ATP (50 I-IM

final concentration, 7.5 JJCi/vial) was added and the autophosphorylation
allowed to continue for 4 min. at 25°C.

After electrophoresis and

autoradiography the excised fl-subunit was digested and the radioactivity
quantitated by scintillation counting.
[

[II], control derived receptors;

], denervated muscle derived receptors.

Each value is the mean ±

S.E. of 4 receptor preparations from control and denervated skeletal
muscles respectively, each assayed in triplicate.
B.

Phosphorylation of histone H2 b by the solubilized insulin

receptor activated on insulin-agarose.

Equal insulin binding activity

of control and denervated derived wheat germ eluate (approx. 150 J.ll)
were preincubated with 50 JJl dithiothreitol-heat inactivated insulin
agarose at 25°C for 1 hr and subsequently with 50 1-11 active insulinagarose for 1 hr. at 25°C as described in BMethods ft •

The suspension was

washed and then incubated in the presence of 5 mMMnC1 2 and 750 pM
unlabeled ATP for 20 min. at 25°C.

After extensive washing the beads

were resuspended in phosphorylation buffer with 1 mg/ml Histone H2 b.

The kinase reaction was initiated by the addition of y[32p]ATP (5

~M

final concentration) and incubated at 25°C for 4 min. The samples were
electrophoresed and the histone bands localized by autoradiography,
excised and the radioactivity determined by scintillation counting.

[II], Histone phosphorylation
receptors.

by control or [

], denervated derived
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c.

Immunoprecipitation of the autophosphorylated insulin receptor.

WGA eluates were incubated without or with increasing concentrations of
insulin as described in A.

After autophosphorylation, anti-insulin

receptor antibody (1:400 dilution) was ad.ded and incubated for 16 hr. at

4°C then for an additional 2 hr. with protein A bearing, formalin fixed
S. aureus (final 1% solution).

After washing, the solution was

electrophoresed under reducing conditions and autoradiographed.

Lanes

A and B, control; C and D, denervated derived receptors, without (A and C)
or with 10- 7 M (B and D) insulin.
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Figure 3.

In vivo activation of the insulin receptor tyrosyl-kinase.

Unilaterally denervated rats were anesthetized and injected i.v. with
regular insulin (5U) or with normal saline.

After 5 min. the hindlimb

muscles innervated by the sciatic nerve were removed and immediately
frozen in liquid nitrogen.

The insulin receptors were solubilized and

partially purified on WGA by Method 2 described in tlMethods".

The WGA

eluate was incubated without or with 2XIO- 7 M insulin in phosphorylation
buffer which was made 50 mM in MgS04 to precipitate the phosphatase
inhibitors.
~M

The kinase reaction was initiated by adding

either 5 or 50

y[32p]ATP and terminated after 4 min. After electrophoresis and

autoradiography, the histone bands were excised, digested and the radioactivity determined.

The values plotted are the mean ± S.E. of

duplicate determinations from four different control and denervated
muscle receptor preparations.

The schema for the different treatments

is indicated below the histogram and above the histone H2b containing
area of a representative autoradiogram.
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Figure 4.
insulin-agarose.

In vivo activated insulin receptor kinase assayed on
Treatment of rats and insulin receptor solubilization

is described in Figure 3..

WGA eluate from control and denervated

skeletal muscle (approx. ISO 1-'1, with equal insulin binding activity)
was incubated with 50 ).Jl insulin-agarose and the resin washed as
described in "Methods"..

Part of the samples were allowed to autophos-

phorylate in the presence of 750 IJM unlabeled ATPat 25°C for 20 min.
The samples were resuspended in phosphorylation buffer with 1 mg/ml
Histone H2 b and the kinase reaction initiated by the addition of 10 1-11

y[32p]ATP (5 IJM final concentration), stopped after 4 min. and the
samples processed as described in Fig. 3.

Panel A: Samples obtained

after 5 min. in vivo treatment with either saline or insulin..
30 min. after treatment.

Panel B:

The values plotted are the mean ± S.E. of

duplicate determinations from 4-6 different control and denervated
muscle receptor preparations.

The schema for the different treatments

is indicated below the histograms and above the histone Hzb containing
area of a representative autoradiogram (5 min treatment experiment).
The slightly lower histone phosphorylation in panel A was due to a lower
concentration of insulin binding activity used in these experiments.
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CHAPTER 5: DIABETES INDUCED FUNCTIONAL AND STRUCTURAL CHANGES
IN INSULIN RECEPTORS FROM RAT SKELETAL MUSCLE
Insulinopenic diabetes in man is associated with peripheral insulin
resistance (1-4), which appears to be related to prior glycemic control
(5).

Using a closed-loop subcutaneous insulin infusion system, Mayfield

et al (5) reported a direct correlation between elevated HbA

1c

levels

and increased insulin requirements in Type I diabetic patients.

Strict

control of blood glucose levels increased the subjects' sensitivity to
insulin (5,6,7).

Insulin resistance is also seen in animals with

experimentally induced insulinopenia.

Reaven et a1 (8) observed insulin

resistance in alloxan diabetic dogs when fasting plasma glucose levels
exceeded 150mg/dl while those with lower glycemia responded to insulin
as the controls.

In rodents, streptozotocin-induced diabetes results in

a diminished response to insulin in isolated adipocytes (9,10,11), liver
(12,13) as well as skeletal (14) and heart muscle (15), while insulin
binding (e.g. the apparent number of insulinrecepto:rs) is increased
(9,10,13).

This has led to the suggestion that the insulin resistance

associated with poorly-controlled Type I diabetes is primarily a
post-receptor defect.

Alternatively, it may represent a defect in

signal transmission by the occupied -insulin receptor.
The initial event in insulin action on target tissues is its binding to specific cell surface receptors.

The insulin receptor is a
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heterotetramer glycoprotein, consisting of two a and two
The a subunit with

a MW

app

primarily involved in signal transmission.

free systems (16-23).

subunits.

- 135000 daltons appears to contain the

insulin binding domain, while the (3-subunit MW
app

autophosphorylation of the

~

~

95000 daltons may be

Insulin binding induces the

subunit in both intact cells and in cell-

Subsequent to this autophosphorylation, the

insulin receptor acquires the ability to act as a kinase towards exogenous substrates (18,21,23).

These phosphorylation events occur on

tyrosine residues and have been suggested to trigger the phosphorylationdephosphorylation cascade seen in cells upon exposure to insulin
(16,20,22).
Since skeletal muscle is an important site of insulin action, we
investigated the effect of streptozotocin-induced diabetes on the
functional and structural properties of the solubilized rat skeletal
muscle insulin receptor.

We found that the insulin-stimulated autophos-

phorylation and exogenous substrate kinase activity of diabetic derived
receptors was impaired.
treatment.

This alteration was reversed by in vivo insulin

The functional changes were paralleled by the appearance of

a subpopulation of insulin receptor

~.-subunits

in diabetic skeletal

muscle with a slower electrophoretic migration; the latter may reflect
altered glycosylation of the f3-subunit.
Materials:

Streptozotocin was a gift from Dr. William Dulin,

Upjohn Research Laboratories, Kalamazoo, MI.

Polyclonal anti-insulin

receptor antibody (A410) was a gift from Dr. Steven Jacobs (Wellcome
Research Laboratories, Research Triangle Park, NC) and from Dr. C.
Ronald Kahn (B9) (Joslin Research Laboratories, Boston, MA).

Mono-

component, crystalline pork insulin was a gift from Dr. Ronald Chance,
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Lilly Research Laboratories, Indianapolis, IN.

Monoiodinated

A14[125 I ]insulin used in some studies was kindly provided by Dr. B. H.
Frank, Lilly Research Laboratories.

Wheat germ agglutinin was from

Vector (Burlingame, CA); Aprotinin from FBA Pharmaceuticals (New York,

NY); Bacitracin from Pfizer (New York ,NY).

Electrophoresis reagents

were from Serva (Heidelberg, Germany) and the apparatus from LKB
(Houston, TX).

Protein A-bearing S. Aureus (Pansorbin) and neuramini-

dase (Vibrio Cholera) were from Calbiochem (San Diego, CA).

S. Aureus
1251_

VB protease and endoglycosidase H were from Miles (Elkhart, IN).
iodine was from New England Nuclear (Boston, MA).

",[32p]ATP was pre-

pared from 32p orthophosphate (ICN, Cambridge, MA) in Gammaprep Vials
(Promegabiotec, Madison, WI) as described by the manufacturer.
Sepharose-4B beads were from Pharmacia (Piscataway, NJ).

CNBr-

Thin layer TLC

plates, Polygram CEL300, were from Brinkmann Instruments (Westbury, NY).
Autoradiography film, X-Omat AR was from Kodak (Rochester, NY).
Lightening + intenSifying screens were from Dupont (Wilmington, DE).
All other reagents and chemicals were from Sigma (St. Louis, MO) unless
otherwise specified.
Animals:

Male Wistar rats (Charles River Breeding Co., N.J.)

100-140 g initial body weight were used in all experiments.
allowed food and water ad libitum.

They were

Diabetes was induced by i.p. injec-

tion of streptozotocin in citrate buffer, pH 4.5, 130 mg/kg body weight,
to overnight fasted animals.

In insulin reversal experiments diabetic

rats were initially treated with 2U regular and 2U protamine zinc
insulin (PZI) s.c. at 1700 hr on the fifth day after streptozotocin and
subsequently with 2U PZI at 0900 hr and 1700 hr. the next two days for a
total of five treatmen.ts.

Glycosuria was monitored by Tes-Tape (Lilly)
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and was 4+ in untreated diabetic rats, and trace, or negative in insulin
treated rats by the second day of treatment.

Plasma glucose levels were

determined with a Beckman Glucose Analyz.er 2 on blood samples obtained
at sacrifice.

Diabetic rats with or without insulin treatment were

studied on the 7th day after streptozotocin, and compared to control
animals.

Rats were killed by decapitation, the hindlimb muscles were

rapidly removed and frozen in liquid nitrogen.

Insulin receptors from

control and experimental animal groups were always processed on the same
day and analyzed in the same experiments.
Solubilization and partial insulin receptor purification were performed as previously described (23).

Briefly, the frozen muscles,

approx. Sg, were powdered and membrane components solubilized by homogenization as a frozen slurry in 4 vol . 25mM Hepes, pH 7.4, SmM EDT-A,
1 TIU/rol aprotinin, 2mM phenylmethyl sulfonylfluoride (PMSF) and 1%
Triton X-IOO.

The homogenate was centrifuged at 10,000 x g for 10 min

and the supernate stirred at room temperature for 1 hr.
then centrifuged at IS0,OOOxg for 90 min.

The mixture was

The receptors were further

purified by adsorption to a<nd elution from Agarose-bound wheat germ
agglutinin (WGA).

Receptors were eluted from the ·WGA column with 2SmM

Hepes pH 7.4, 0.1% Triton X-IOO containing 0.3 M N-acetylglucosamine
(approx 1 ml/gm original tissue weight) and used directly or further
purified by precipitation with polyclonalanti-insulin receptor antibody.

In some preparations 125I-insulin (-1.5 ~Ci) was added after

homogenization of muscles with or without 50 f.Jg/ml unlabeled insulin.
Aliquotswere taken at various times during the isolation procedure and
125I-insulin specifically bound was determined by polyethylene glycol
precipitation.

Recovery and trichloroacetic acid (TCA) precipitability
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.
1"1n were d eterm1ne
. d .by CQUnt1ng
~
. a y-counter
of the 125 1 -1DSU
a 1"1quots 1n
as described below.
Insulin Binding:

WGA eluate (50 IJl) was incubated with 10,000 cpm

125I-insulin (sp. act. 125-175 IJCi/lJg, prepared by the lactoperoxidase
method as described in 24) and increasing concentrations of unlabelled
insulin for 16 hrs at 4°C in a buffer containing 25 mM Hepes, 0.1%
Triton X-100, 150 roM NaCl, 0.1% bovine serum albumin and 100 U/ml
Bacitracin as described by Taylor et al (25).

The receptor and bound

insulin were precipitated by the addition of 100 IJl 0.3% bovine yglobulin and 300 IJl 25% polyethylene glycol and collected by
centrifugation.

The resulting pellet was washed with 300 IJl 12.5%

polyethylene glycol and counted in a Beckman Gamma 4000 y-counter.
Non-specific binding (10-15%) waS estimated as that occurring in the
presence of 10lJg/ml unlabelled insulin.

Binding was related to the

protein concentration in the WGA eluate estimated by the Bradford
reaction (26).
Equalization of receptor number:

In all experiments assessing

functional and structural properties of solubilized insulin receptors
derived from experimental and control animals, approximately equal
insulin binding activity was used in comparing groups.

Since no change

in insulin binding affinity was apparent in receptors from diabetic
animals (see results) equal numbers of insulin receptors were estimated
as follows:

125I-insulin binding per 50 1-11 WGA eluate was determined in

the presence of 1, 5, 25, 100, 1000 and 10,000 ng/ml unlabelled insulin
(the latter used as estimate of non-specific binding after overnight
incubation at 4°C or 45 min at 25°C). Ratios of the specifically bound
counts in the experimental group vs. the control were determined at each
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insulin concentration, these ratios were averaged and the mean value
used as an estimate of relative number of insulin receptors.
values were within 10-15% of this mean.

Individual

Appropriate volumes of the WGA

eluate were then used in subsequent experim.ents.

Identical ratios were

obtained after overnight or 45 min incubation with 125I-insulin; the
latter resulted in approximately 60-70% of the equilibrium binding
obtained in the former.

All dilutions of WGAelute were made with 25 roM

Hepes pH 7.4, 0.1% Triton X-IOO.

The presence of 0.3 M N-acetylgluco-

samine had no effect on the functional properties of the insulin
receptor (18, and our data).

Experimental groups were always compared

to control insulin receptors prepared the same day from untreated
animals.
Insulin specifically bound to receptors in the wheat germ eluate
was linear between 12.5 and 7S fJl of the eluate assayed in a constant
volume (r

= 0.97

respectively).

and 0.96 for control and diabetic receptor preparations
The 32p incorporated into the f3-subunit of the insulin

receptor, after exposure to maximally stimulating insulin concentrations
_7

(10

), was also linear between 10 and 50 ... 1 of the wheat germ eluate,

(r = 0.98 and 0.97 for control and d.iabeticreceptor preparations respectively).

These values were derived from three different pairs of

receptor preparations (diabetic and control), each point assayed in
duplicate or triplicate.
Receptor autophosphorylation.

Fifty

~l

of WGA eluate from control

animals and appropriately diluted receptors from diabetic or insulintreated diabetic animals were incubated in 25 roM Hepes pH 7.4, 0.1%
Triton X-100, 5 roM MnC1 , 0.05% bovine serum albumin (Buffer A) with
2
increasing insulin concentrations in 75

~l

final volume for 4S min at
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The reaction mixtures were then cooled to 4°C and y[32 p ]ATP

25°C.
(10

~l

- 15

~Ci,100 ~M

final concentration) was then added and after 30

min at 4°C the phosphorylation reaction was terminated by the addition
of 28

~l

4X concentrated Laemmli's sample buffer, heated at lOQGe for 3

min and the proteins separated by SDS-PAqE (see below) '.

The f3-subuni t

of the insulin receptor was localized by autoradiography, excized and
digested in 1 ml 30% H 0 at 60°C for 10 hrs and 32p content determined
2 2

by counting in 10 mlScintiverse II (Fisher Scientific, Norcross, GA) in
a Beckman LS7000 scintillation counter.

Insulin degradation by the

receptor preparation during incubation at 25°C in buffer A was estimated
by TCA precipitability of added 125I-insulin tracer; less than 2% of
added insulin became TGA soluble after 2 hours of incubation.
Exogenous substrate kinase activity was determined using Angiotensin II as the phosphoacceptor, as described by Rosen et al.

(18).

Approximately 10-20 fmoles insulin binding activity was incubated with
or without insulin at 25°C forI hr in 225

~l

buffer A.

Autophosphory-

lation was initiated by the addition of y[32pIATP (50 tJCi, 100 tJM final
concentration) and allowed to proceed for 30 min at 4°C.
~l)

Aliquots (35

were then added to 5 J.Jl of buffer A or buffer A containing 2 roM

angiotensin II and the phosphorylation carried out at 4°C for 5 min
which was in the linear part of the velocity curve as determined in

preliminary experiments.
~l

The reaction was stopped by the addition of 5

1.5% BSA and 50 J.Jl 5% TCA.

After centrifugation, duplicate 40 IJl

aliquots were spotted onto phosphocellulose paper, washed and counted as
described (18).
Kinase activity of insulin·receptors bound to. insulin-agarose.
Control receptors (120 J.Jl) and equal binding activity of diabetic
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derived receptors were diluted to a final volume of 320

~i

with buffer

consisting of 50 roM Hepes, pH 7.4, 0.1% Triton X-100, 1 Jj&/ml leupeptin,
and 2 mM PMSF (buffer B); 50 1J1 insulin-agarose beads or agarose-beads
inactivated with hot dithiothreitol (27) were added and the mixture
incubated for 1 hour at 25°C..

After centrifugation the pellet was

washed twice with 1 ml buffer B supplemented with 0.5 M NaCl and then
with buffer B alone.

The pellet was then resuspended in 75 1J1 50 mM

Hepes, pH 7.4, 0.1% Triton XI00, 0.025% BSA, 5 roM MnC1

2

(phosphorylation

buffer) supplemented with 750 J..IM ATP and incubated for 15 min at 25°C to
induce maximal receptor autophosphorylation (27) .

The mixture was then

diluted with 1 ml of salt supplemented buffer B, centrifuged, the pellet
washed with 1 ml buffer B, and then resuspended in 751J1 phosphorylation
buffer, supplemented with 1 mg/ml histone H b and 50 .... M ),[32 p ]ATP (2.5
2
~Ci/vial)

and incubated for 4 min at 25°C.

The reaction was stopped by

the addition of hot 4X Laernmlits sample buffer and the sample separated
on SDS-PAGE and autoradiographed as described below.
The bands corresponding to Histone H b were excized and the 32p quanti2
tated as described above for the insulin receptor fj-subunit.
ATPase activity:

Equal binding activities of control and diabetic

derived wheat ge.rm eluates were incubated as described for the autophos-

phorylation assays except that the specific activity of the ATP was
decreased (- 6 IJCi/ml, ATP final concentration 10-100 J.lM).

At various

time intervals (30 sec-120 min) the reaction was stopped by the addition
of 65 pl of 3M perchloric acid and after 5 min equilibration at 4°C 200
fJl of dH 0 were added and the protein removed by centrifugation.
2

The

supernatant (300 }Jl) was neutralized with 60 1J1 2 M KHC0 , clarified by
3
centrifugation, supplemented with 2 1J1 of a 2 M solution of unlabeled
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carrier ATP and 20 pI were analysed on a Perkin-Elmer High Performance
Liquid Chromatograph using a 5 em CIS reverse phase column.

ATP was

eluted isocratically in a buffer composed of 20 roM phosphoric acid (pH
to 6.5 with triethylamine, 98%) and methanol (2%) ata flow rate of 2
ml/min (28).

The first 1.5 min of the run (containing inorganic

phosphate) and the ATP peak were collected separately and
quantitated by liquid scintillation counting.

32

P cpm

These assays were

performed in parallel with assays of insulin-receptor kinase activities .
All kinase assays reported here were carried out under conditions where
ATP degradation was less than 10%.
125

Cross-linkage of solubilized insulin receptors with [

I]insulin:

Wheat germ eluates (1 ml) from control and diabetic derived muscle
extracts were dialyzed against 25 mM Hepes pH 7.6 and concentrated
approximately four-fold with Aquacide (Calbiochem). Equal binding
activities were incubated for 15 hrs at 4°C with A14[125 I ]insulin (0.5
J,lCi) with or without 10 JJg/ml unlabeled insulin in 250 tJ1 final volume,
then disuccinimidyl suberate was added in DMSO to a final concentration
of 2 mM at 4°C, for 15 min (29).

After addition of 4X concentrated

Laemmli's sample buffer the mixture was boiled for 3 min.

Electro-

phoresis and autoradiography were performed as described below.
Immunoprecipitation and partial proteolytic digestion of
phosphorylated insulin receptors.

WGA eluate was incubated in the

presence of IO-7 M insulin for 45 min at 25°C in Buffer A (lOOJJl final
volume) and y [32P1ATP (10JJM, l0J..lCi) added for an additional 10 min.
The reaction was stopped by addition of 20 )..11 40 mM ATP, 10 mM Na PO '
4 S
2mM PMSF, in Buffer A.

Anti-insulin receptor antibody (1:400 dilution)

was added and incubated overnight at 4°C.

Protein A bearing formalin-
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fixed

aureus was added and incubated for an additional 2 hrs and the

S~

precipitated complex washed three times with 25 roM Hepes, 0.1% Triton
X-lOO.

Partial proteolytic digestion of the immune complex was achieved

by resuspending it in SO roM sodium acetate pH 5 buffer (10
ing 75

~g/ml

contain-

~l)

V8 protease and incubating for 5 min at 37°C.

The reaction

was stopped either by the addition of an equal volume twice concentrated
Laemmli's sample buffer or by the addition of 10
Cocktail I (PIC I) and 5

~l

PIC II (PIC I

= 1.5

~l

Protease Inhibitor

mg/ml Benzimidine, 1.5

mg/ml leupeptin, 1.5 mg/ml Benzoyl arginine ethyl ester in 10 TIU/ml
PICII = 1 mg/ml PMSF and 1 mg/ml antipain in DMSO).

aprotinin.

The

protease inhibited mixtures were then treated with glycosidases as
described below.
Phosphoamino acid analysis:
~-subunit

The phosphorylated, immunoprecipitated

was identified by autoradiography of the wet, unfixed gel

after SDS-PAGE and solubilized by electroelution as follows:

A 2x2cm

gel slice was placed in a dialysis bag containing electrophoresis buffer
(1.5M Tris, 58mM glycine, pH 8.8) and immobilized between the glass
plates of the vertical gel electrophoresis apparatus, immersed in this
buffer.

One end of the sandwich was plugged with 15% acrylamide and a

potential of 500 V was applied for 1 hour.
removed, 30

~g

The contents of the bag were

bovine y-globulin added and the protein precipitated by

making the solution 20% in TCA.

The precipitate was dissolved in 250

6N HCI and hydrolyzed at 110°C for 60 min under N2 atmosphere.

~l

The

hydrolysate was adsorbed to 0.5 ml Dowex 1-X8, washed with 2 ml dH 0 and
2
eluted with 1 ml O.IN Hel (30).
in 5

~l

The lyophilized sample was redissolved

of a mixed phosphoamino acid standard containing 0.33 mg/mi each

of phosphoserine, phosphothreonine and phosphotyrosine and spotted on
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thin cellulose TLC plates (0.1mm thickness).

The plates were electro-

phoresed at 1000 V for 40 min in pyridine:acetic acid:H 0 (5:15:945)
2
towards the anode (30).

Thephosphoamino acids were localized by ninhy-

drin staining and by autoradiography at -80° with intensifying screen.
Tryptic phosphopeptidemapping:
precipitated at 4°C in 10% TCA with 30

Electroeluted receptors were
~g

the precipitate extracted 3 times with 750

carrier bovine y-globulin and
~l

1:1 ether: ethanol (31).

The washed pellet was oxidized at 25°C for 2 hrs by the addition of
200 JJl 9:1 formic aCid:H 0 , diluted to 2 ml with water and lyophilized.
2 2
The lyophilizate was resuspended in 0.3 ml 50 mM (NH4)2C03' pH 8.0,
containing 75 f.Jg/ml TPCK treated trypsin and incubated at 25°C for 12
hrs when an additional 40 tJg trypsin was added and incubation continued
for another 12 hrs.

The mixture was brought to 3 ml with water and

lyophilized three times, resuspending in 3 ml water each time (31).
Phosphopeptides were separated in 2 dimensions on 20cm X 20cm X O.lmm
TLC plates by electrophoresis in 1% auunoniumbicarbonate, pH 8.9, for 40
min towards the anode and then by ascending chromatography in pyridine:
butanol:acetic acid:water (70:50:15:60) in the second dimension (32).
Phosphopeptides were localized by autoradiography at -BOoC for 4 with
intensifying screens.
Treatment of immunoprecipitated receptors with Endoglycosidase H.
Washed, immunoprecipitated receptors with or without prior partial
protease digestion were made 0.1% in sodium dodecylsulfate and heated
for 1 min in boiling water.

After cooling, 10

~l

PIC I and 5

~l

PIC II

were added, followed by 50 tJl 30 mU/ml endoglycosidase H in 50 roM sodium
acetate, pH 5 . 5, 10 mM Cae1 , 0.01% bovine serum albumin and incubated
2
for 4 hours at 37°C.

The samples were boiled in Laemmli's sample buffer

(4X concentrated) and separated on SDS-PAGE.
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Neuraminidase:

Immunoprecipitated receptors with or without prior

partial VB digestion were resuspended in 10

~l

PIC I and 5

~l

PIClI,

followed by the addition of 40 mU/ml neuraminidase in 50 mM sodium
acetate, pH 5.0, 10 mMCaC1 , 150 mM NaCl and incubated 4 hours at 37°C.
2
As above the reaction was stopped by the addition of 4X Laemmlits sample
buffer and proteins separated on SDS-PAGE.

Methods for treatment of

insulin receptors with glycosidases were modified from those described
by Ronnett et ale (33).
Electrophoresis:

SDS-PAGE was performed under reducing condition

using the discontinuous buffer system of Laemmli (34) with a 7.5% polyacrylamide resolving gel for non-protease digested samples, a 9% polyacrylamide resolving gel for samples previously treated with VB protease
and a linear 6-18% polyacrylamide resolving gel for reactions containing
Histone H b.
2

ples.

A 4.5% polyacrylamide stacking gel was used for all sam-

Samples were electrophoresed at 150-170 volts, constant voltage.

Gels were stained, unless indicated, in 50% methanol, 10% acetic acid
and 0.125% Coomassie blue Rand destained in 30% methanol and 10% acetic
acid.

The gels were dried in vacuo and autoradiography performed with

Kodak AR autoradiography film with or without Dupont Lightening +
intensifying screens at -BOoC.
Results
Animal condition:

Rats rendered diabetic by i.p. injection of

streptozotocin gained little or no weight during the subsequent 7 days.
Final weights of the diabetic rats were 111 ± 4 gm (N
gm (N

= 15)

for the controls.

= 23)

vs 164 ± 4

Insulin treatment (60 hrs) of diabetic

rats resulted in rapid weight gain (final weight 145 ± 5 gms; N

= 10).

At the time of sacrifice the plasma glucose concentration of control
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rats was 130 ± 4 mg/dl (N
± 14 mg/dl eN

= 17),

94 ± 6 mg/dl; (N

= 15),

that of untreated diabetic rats was 510

and that of insulin treated diabetic rats was

= 12).
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tially purified insulin receptors extracted from hind limb muscles of
diabetic rats increased approximately two-fold per mg protein in the
wheat germ eluate as compared to controls (Figure 1).

When calculated

per gm muscle the increase in receptor number was 60-70%

(~

100-125

pmoles insulin bound/gm in control vs. 180-250 pmoles bound/gm in the
diabetic).

Administration of insulin for 60 hours caused a reduction in

insulin receptor number per mg protein and per gm tissue weight to
nearly that of controls.
diabetic rats was
0.06

VS.

~

The yield of glycoprotein mg/gm muscle from

25% less than that obtained from controls, 0.55 ±

0.72 ± 0.07 respectively, (N=10/group, p < 0.01, paired

analysis).

The increase in receptor number solubilized from muscles of

diabetic rats occurred without an apparent change in the affinity of the
insulin receptor.
f or 16 h rs.

These values were obtained after incubation at 4°C
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insulin receptors for 45 minutes at 25°C showed that 65-75% of
equilibrium binding occurred in this time frame in both groups and the
ratio of insulin bound by diabetic vs. control preparations was
identical to that obtained with incubations for 15 hrs at 4°C.

Since

the kinetics of insulin binding were identical in diabetic and control
animals, the tyrosine kinase activity of the solubilized insulin receptors was routinely studied after 45 min to 1 hr incubation with insulin
at 25°C.

Experiments performed following incubation with insulin for 16

hrs at 4°C yielded identical results to those shown below.
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Insulin stimulated autophosphorylation:

Insulin stimulates the

autophosphorylation of the insulin receptor through an intramolecular
event (20,35).

As previously reported (23) when the WGA purified

insulin receptors from rat skeletal muscles were incubated with
32

y[

P]ATP, 5 mM MnC1 2 and increasing concentrations of insulin there was
32

an insulin dose-dependent increase in the amount of

P incorporated

into a -97,000 dalton peptide when the reaction mixture was analysed by

SDS-PAGE and autoradiography.
~-subunit

This peptide was identified as the

of the insulin receptor by its apparent molecular weight, its

ability to increase labelling after incubation with insulin, and its
specific immunoprecipitability with anti-insulin receptor antibodies
(see ref. 23).
When equal binding activities of control and diabetic derived
receptors were allowed to autophosphorylate at 4°C for 30 min in the
presence of 100
the amount of

32

~M

ATP, there was a significant decrease (p < 0.05) in

P incorporated into the f3-subunit of the insulin re-

ceptor derived from diabetic animals incubated without insulin and at
all insulin concentrations tested (Fig. 2).

At maximally stimulating

insulin concentrations, the mean autophosphorylation of control receptors was 40% greater than that of the diabetics, however the insulin
stimulated autophosphorylation over baseline (6 insulin) was only 20%
greater in controls than in diabetics.

Although the latter difference

was not significant,as will be shown below, it resulted in marked
Half-

impairment of insulin stimulated exogenous kinase activity.
_9

maximal activation of autophosphorylation occurred at - 2xl0
in controls and diabetics.

M insulin

When diabetic rats were treated with insulin

to normalize their blood glucose levels, the insulin receptors derived
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from these animals showed nearly identical autophosphorylation kinetics
as controls (Fig. 2).
Exogenous substrate kinase activity:

The insulin receptor displays

exogenous substrate tyrosyl kinase activity that is activated by the
autophosphorylation event (18,21).

To investigate this property insulin

receptors from control, diabetic or diabetic-treated animals were incubated for 1 hr at 25°C with the indicated concentrations of insulin and
then allowed to autophosphory1ate in the presence of 100 fJM Y[

32

P]ATP at

4°C for 30 min; exogenous kinase activtiy was then assessed for 5 min at
4°C using Angiotensin II as the phosphoacceptor.

Little exogenous

kinase activity was observed in any of the groups in the absence of
_9

added insulin.

At 10

_7

and 10

M insulin, a significant decrease in the

exogenous substrate kinase activity was seen in the diabetic derived
receptors (p < 0.01, Fig. 3).

The ability of insulin to stimulate the

exogenous kinase activity over basal was significantly less in diabetic
derived receptors than in controls (p < 0.01).

Treatment of diabetic

rats with insulin restored the exogenous substrate kinase activity of
the receptors toward normal (Fig. 3).
The decreased ability of diabetic derived receptors to phosphorylate exogenous substrates was not temperature dependent nor substrate
specific, since similar decreases in the diabetic derived receptor
kinase activity were observed at 25°C using histone H b as the phospho2
acceptor.

In these experiments the wheat germ eluates were preincubated

with insulin coupled to agarose, the agarose-bound receptors were extensively washed and then allowed to fully autophosphorylate in the
presence of 750

~M

ATP.

using 50 ~M y[32 p ]ATP.

The exogenous kinase activity was then assessed
While equal insulin binding activities derived
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from control and diabetic muscles were incubated with the beads, there
was again a significant decrease in the amount of label incorporated
into the histone by the diabetic derived receptors as compared to the
controls (Fig. 4).

When receptors were bound to insulin-agarose beads

which had been inactivated with hot dithiothreitol (27), histone-H b
2

phosphorylation was - 10% of that observed with fully activated agarosebound receptors (data not shown).
A number of mechanisms may explain the decreased kinase activity of
the diabetic derived receptor population, including errors in the
estimation of insulin receptor number or contaminants in the wheat germ
eluate altering insulin receptor phosphorylation.

Insulin that was

"carried over tt in the preparation of the insulin receptor could lead to
an underestimate of the true insulin receptor number, especially in the
control derived preparations.
addition of

125

This possibility was examined.by the

I-insulin to the muscle homogenate and following its

recovery during different stages of purification.

We found that ~ 0.1%

of the added radioactivity was recovered in the final wheat germ eluate
and this was entirely nonspecific binding since an identical homogenate
which was supplemented with 50 J.Jgjml unlabeled insulin showed identical

recovery of

125

I-insulin.

A second approach was to exhaustively dialyse

the insulin receptors in the wheat germ eluate to remove insulin.

Upon

rebinding, identical ratios of estimated insulin receptor numbers from
control and diabetic animals were obtained as those before dialysis.
Furthermore, no change in basal or insulin stimulated autophosphorylation was observed in the dialysed receptors.
The alterations in insulin receptor kinase activities did not

appear to be due to contaminating insulinases in the diabetic derived
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receptors nor to contaminating phosphatases since less than 2% of added
125

I-insulin was degraded by the WGA eluates over a two hour period and
no change in the amount of

32

P associated with the insulin receptor

fJ-subunit or with Angiotensin II or histone H b were. seen for 30 min
2
after the addition of unlabeled ATP to previously phosphorylated insulin
receptors and kinase substrates in either the control or diabetic
derived preparations (data not shown).

While significant ATPase

activity was detected in the wheat germ eluates under some conditions,
the results shown here were derived from assays, where less than 10% of

y[ 32 P]ATP was degraded.
Figure 5 shows the phosphoamino acid analysis of control and

diabetic derived insulin receptor f3-subunits which were maximally
stimulated by insulin and then exposed to 10
25°C.

~M

y[

32

P]ATP for 10 min at

As with other insulin receptors phosphorylated in vitro (18,19)

labeling occurred predominantly on tyrosine residues in both groups.
Although a small amount of serine phosphorylation was observed, it
contributed little to the total amount of phosphoamino acid present in
either group.

Two dimensional phosphopeptide maps generated from trypsin
digestion of the f3-subuni't of the insulin receptors derived from control
and diabetic animals and autophosphorylated at 25°C are shown in Figure
6.

Although slight variations occur in the relative labeling of the

various phosphopeptides generated by this procedure, no consistent
changes occurred in a number of maps analysed, to suggest that a site or
sites are eliminated from the diabetic derived
account for the decrease in overall labeling.

population that would
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Structure of the Insulin Receptor subunits.

Incubation of wheat

germ eluates from control and diabetic animals with A14 [12S I ]insulin
with subsequent addition of disuccinimidyl suberate specifically labeled
a protein ofMWapp 131kD (Fig 7), which corresponds to the approximate
molecular weight of the a-subunit of the insulin receptor.

No dif-

ferences were observed in the electrophoretic migration of the insulin
cross-linked (X-subunit between control and diabetic derived insulin
receptor populations.

Furthermore, the amount of label bound per

receptor was identical when diabetic or control derived wheat germ
125

eluates were cross-linked with

I-insulin.

Exploiting the property of autophosphorylation to localize the
~-subunit

of the insulin receptor, we investigated the possibility that

the functional alterations observed in the insulin receptor from
diabetic animals could stem from an identifiable structural alteration
in this subunit.

Insulin receptors were phosphorylated, immunoprecipi-

tated and separated under reducing conditions by SDS-PAGE.
graphy revealed that the

~-subunit

Autoradio-

of the insulin receptor derived from

diabetic animals included a component that showed a small but reproducible slowing in electrophoretic migration as compared to controls (Fig.
8 lanes A and B).

This change in electrophoretic migration became more

prominent after short proteolytic digestion of the phosphorylated,
immunoprecipitated receptor with V8 protease (Fig. 8 lanes C and D).
protease treatment reproducibly generated 2-4 major phosphorylated
species each of which showed this altered migration when derived from
diabetic muscle.
The major phosphorylated peptides seen after V-8 digestion were
shown to be derived from the

~-subunit

(as opposed to the variably

VB
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phosphorylated ex subunit) in the following manner.

Phosphorylated,

immunoprecipitated insulin receptors were electrophoresed under reducing
conditions and the unstained, unfixed gel autoradiographed at 4°C.

The

f3-subunit was localized and excised, the gel slice placed in a dialysis
bag and the phosphoprotein eluted as described in "Methods".

The

dialysed, lyophilized protein was then subjected to partial V8
digestion, equal numbers of counts from each treatment group (-4000 cpm)
were loaded in each lane and reelectrophoresed.

The autoradiograph,

(Fig. 8, lanes F and G) shows the same major phosphorylated species as
were generated by partial digestion of the immunoprecipitated intact
receptor (lanes C and D) - with the fragments generated from diabetic
derived

~-subunits

again showing a component with retarded mobility when

compared to controls.
As shown in Figure 8, Lanes E and H, the diabetes associated
alteration in electrophoretic mobility was reversed by 60 hrs of in vivo
insulin treatment that normalized blood sugar.

Lanes I and J show

autoradiograms of control and diabetic derived insulin receptors that
were immunoprecipitated and partially digested with V-8 protease.

Brief

autoradiography revealed the diabetic derived f3-subunit (Lane J) to
consist of two distinct populations, one that comigrates with the
control receptor (Lane I) and one with retarded migration.
We next investigated the possibility that sugar side chains associated with this glycopeptide could be altered in the diabetic state.
Considering the difficulty in metabolically labeling the sugar side
chains and the minute amounts of insulin receptors available for chemical modification, we used enzymatic digestion of the insulin receptor
with glycosidases in an attempt to characterize the structure of the
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glycosyl residues.

Incubation of the immunoprecipitated insulin re-

ceptor with endoglycosidase H caused an ,..., SkD decrease in MW

app

in

control and diabetic derived insulin receptors (Fig. 9a, Lanes A, Band

E, F) but did not correct (and actually accentuated) the difference
between the control and diabetic.

Endoglycosidase H digestion of the

immunoprecipitated receptor after partial

VB proteolysis was

accomplished by adding an excess of protease inhibitors before the
addition of the endoglycosidase.

Again a decrease in MW

app

of ,..., 4-5 kD

occurred in the major phosphopeptides generated from control and
diabetic derived

~-subunits

and allowed the separation of the diabetic

derived receptors into two distinct .populations (Figure 9b, Lanes E &

F), one that comigrates with the control and one with retarded
electrophoretic migration.

The decrease in MW

app

of the l3-subunit after

endoglycosidase H treatment suggested that this glycoprotein contains
'high mannose' sugar side chains.
Neuraminidase is an exoglycosidase that removes terminal sialic
acid residues from the sugar side chains of glycoproteins.

When the

immunoprecipitated insulin receptor was digested with this enzyme a
decrease in MW

app

of approximately 2 kD occurred in control lanes (Fig.

9a, lanes A and C).

A similar decrease occurred in the diabetic derived

insulin receptor (Fig. 9a, lanes B and D) and in addition there was an
apparent normalization in the electrophoretic migration o£ this
population as compared to control (Figure 9a, Lanes C and D).
Neuraminidase treatment caused a slight decrease in MW
of the major
app
(- 54 kD) phosphorylated peptide in the diabetic derived population
(Fig. 9b, lanes B and D), and nearly normalized the migration of the
diabetic derived phosphopeptides as compared to control (Figure 9b,
lanes C and D).
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However, double glycosidase digestion i.e. neuraminidase followed
by endoglycosidase H showed that the second, slower migrating band in

the diabetic derived preparation increased its electrophoretic migration
but was not completely eliminated after neuraminidase treatment (Fig 10,
demonstrating the main
digestion).

54 kD phosphopeptide generated by VB protease

This result raises the possibility that an additional

component, possibly 'core t sugars, may contribute to the heterogeneity
in electrophoretic migration of the diabetic de-rived

~-subunit.

DISCUSSION
An increase in the number of insulin receptors associated with
insulinopenia has been observed in adipocytes (9,10), and hepatocytes
(13,36).

In the present study the number of insulin receptors solu-

bilized per gram hindlimb muscle was increased 60-70% after 7 days of
diabetes, without an apparent change in affinity.

Insulinopenic

diabetes in rats has been reported to cause no change (10,36) or to
increase the affinity of insulin receptors (10,37) in adipocytes and
liver..

Studies of insulin binding to intact, incubated soleus muscles

from streptozotocin diabetic mice reported increased binding affinity
without a change in receptor number (3.8).

These discrepancies may

reflect the difficulty in interpreting changes in insulin binding
kinetics, especially when intact tissues are used, as well as possible
differences between solubilized, total receptors assessed in the present
study versus surface receptors on intact muscle cells studied in Ref.38.
It should be noted that the increased receptor number observed in
muscles after 7 days diabetes in this report reflects in part
differences in growth rate and muscle weight between control and
diabetic rats and the - 25% decrease in the amount of

glycoprote~n
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eluted from the wheat germ affinity column in the isolation of insulin
receptors from diabetic rats as compared to controls.
The decrease in the ability of the diabetic derived insulin re32

ceptors to incorporate

P from y[

32

P]ATP into its ~-subunit and into

exogenous substrates (angiotensin II or histone H2 b) was a consistent
finding and does not appear to reflect biased estimates of insulin
receptor number nor contaminating insulinase, phosphatase or ATPase
activities.

Note that cross-linking experiments revealed identical

labelling of a-subunits in diabetic and control receptor preparations
(see Fig. 7).

The decrease in autophosphorylation was presumably not

due to a decrease in the number of J3-subunits in the diabetic derived
wheat germ eluate since similar binding kinetics were observed and
removal of a significant proportion of the insulin receptor J3-subunits
would likely result in a noticeable change in receptor affinity.

The

impairment of insulin stimulated exogenous kinase activity of diabetic
derived receptors

(F~g.

3) was more evident than that of the insulin

activated autophosphorylation (Fig. 2).

Preliminary data (41) suggest

that phosphorylation of different tyrosyl-sites on the p-subunit may not
be equally important for the activation of the exogenous kinase.
Our results are in essential agreement with those reported by
Kadowaki et a1.

(36) who showed impaired autophosphorylation of the

insulin receptors derived from livers of strepto2otocin-diabetic rats
and by the recent report of decreased autophosphorylation in skeletal
muscle from rats rendered diabetic by gold thioglucose treatment (39).
The latter report suggests that the defect in the insulin receptor
kinase activity is secondary to the diabetic state and not due to
insulinopenia per se since the rats ioref. 39 were hyperinsulinemic.
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However, Amatruda et al. isolated hepatic plasma membranes from diabetic
rats and found no defect in insulin stimulated receptor autophosphorylation (40).

Whether or not the insulin receptor population which

manifests diabetes related structural and functional alterations is
actually present on the plasmalemma or represents an intracellular
species requires further investigation.
The phosphopeptides generated by treating the isolated

~-subunit

with TPCK treated trypsin appeared identical in the diabetic and control
muscle derived receptors.

We consistently generated 10 or more phospho-

peptides from immunoprecipitated, electroeluted f3-subunits even after
digesting for 72 hours.

Previous studies utilizing high performance

liquid chromatography to separate the products of trypsin digestion
reported the isolation of 3-5 phosphopeptides (27,35).

Whether the

larger number observed in our system is due to incomplete digestion or
to receptor heterogeneity or to the higher sensitivity of autoradiography after 2-dimensional peptide separation is not clear.

Visual

analysis of these maps failed to reveal salient differences in the
relative phosphorylation of these fragments between controls and
diabetics.

The receptors used in generating these maps were phosphory32

lated for 10 min at 25°C in order to maximize
visualization of phosphopeptides.

P incorporation for

However, a more detailed,

quantitative examination of the phosphopeptides separated from receptors
autophosphorylated at lower temperatures or for shorter time periods at
25°C may reveal differences between the two populations.
The presence of a subpopulation of insulin receptor f3-subunits in
diabetic rat skeletal muscle with retarded migration on SDS-PAGE
suggests that diabetes affects the processing of the insulin receptor in
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muscle.

We were able to detect this subpopulation of receptors in some

rats 24 hrs. after streptozotocin injection and in most animals by 3
days.

In some animals this slower migrating species comprised up to 50%

of the phosphorylated

~-subunit

band detected by autoradiography.

It

was difficult to discern this altered population consistently on a 7.5%
polyacrylamide gel; however it became distinct after limited proteolytic
digestion of the insulin receptor with VB protease.

This is likely due

to the inverse logarithmic relationship between molecular weight and
relative mobility on isocratic polyacrylamide gels resulting in improved
resolution of smaller proteins, as well as the increased relative
preponderance of the component with decreased mobility in the fragments.
The changes in the insulin receptor

~-subunit

structure appear to be in

response to insulinopenia and/or resulting changes in the metabolic
milieu rather than to toxic effects of streptozotocin since the slower
migrating component was reduced or eliminated by 60 hrs of insulin
treatment which normalized blood sugar.

It is interesting to note that

approximately 10% of control animals studied demonstrated a small amount
(most less than 10%) of a higher molecular weight subpopulation.
The glycoprotein nature of the insulin receptor has been demonstrated by direct labeling of the sugar moiety
its ability to bind to lectins (43).

(33~42)

and indirectly by

Ronnett et ale (33) observed that

the insulin receptor is synthesized as a single polypeptide chain, which
is cleaved and subsequently glycosylated on both the a and J3 subunits.
These intermediates are sensitive to endoglycosidase H and neuraminidase
resistant.

Salzman et al.

the mature a and

~

(44) and Herzberg et a1. (45) reported that

subunits from 3T3-Ll adipocytes and IM-9 lymphocytes

contain both endoglycosidase H sensitive and insensitive sugar side
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chains.

The latter report also showed that endoglycosidase F could not

remove all the sugar side chains from the f3-subunit but treatment with a
chemical deglycosylating agent resulted in an additional decrease in
molecular weight suggesting the presence of O-linked side chains.

The

insulin receptor j3-subunit isolated here from skeletal muscle of control
or diabetic rats appeared to be sensitive to digestion by endoglycosidase H; on autoradiography the 95 kD band migrated at - 89 kD after
endoglycosidase H treatment, suggesting that the f3-subunit isolated from
skeletal muscle also contains 'high mannose t oligosaccharide side
chains.

The peptides generated after VB digestion, especially the

prominent 54kD band was also endoglycosidase H sensitive.

The diabetic

derived f3-subunit population separated into two distinct bands after V8
protease and endoglycosidase H treatment, one that comigrated with the
control and one with"'" 1 . 5 kD higher MW

app

(Fig. 8b).

The further

improvement in the resolution of the diabetes induced f!-subunit
populations after endoglycosidase H treatment likely reflects the
elimination of oligosaccharides which are known to affect protein
migration on SDS-PAGE (46).

Treatment of the immunoprecipitated,

insulin receptor populations with neuraminidase increased the migration
of the diabetic derived fJ-subunit more than that of the control,
especially that of the prominent 54 kD peptide fragment (Fig. 9).

This

suggested that the heterogeneity of the diabetic derived fJ-subunit was
due in part to an increase in its sialic acid content. When

V8 digested

insulin receptors were treated with neuraminidase followed by
endoglycosidase H, the slower migrating component of the - 54 kD fragment (seen in diabetic derived

~-subunits)

appeared to decrease in

molecular weight while the 'control band· did not change its migratory
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behavior (Fig. 10).

This suggests that there may be an additional sugar

side chain on some diabetic derived

~-subunits

or an alteration in the

structure of one or more normally occuring oligosaccharide side chains.
We encountered similar difficulties as Herzberg et al. (45) in attempting to completely remove the oligosaccharide side chains from the

13-

subunit with Endoglycosidase F or glycanase (broad spectrum N-linked
glycosidases) suggesting that the f3-subunit may have O-linkedsugar side
chains.
Streptozotocin diabetes results in decreased sialic acid and other
carbohydrate content of major glycoproteins on hepatocyte membranes (47)
as well as decreased activity of certain glycosyltransferase enzymes,
without a detectable change in sialyltransferase activity (48).

The

insulin receptor however is spared from the diabetes associated decline
in hepatic membrane glycoproteins, since hepatic insulin binding and
receptor number appear to increase in insulinopenic diabetes (13,36).
The mechanism for the selectivity in hepatic glycoprotein synthesis or
degradation is not understood; to our knowledge there is no information
concerning the effect of diabetes on glycoprotein turnover or sialyltransferase activity in muscle.

We did however see in diabetic rats a

decline in the amount of glycoprotein per gram muscle eluted from the
wheat germ columns in the insulin receptor purification protocol.
In our hands, there appeared to be a relationship between the
appearance of the

~-subunit

population with decreased electrophoretic

mobility and changes in tyrosyl-kinaseactivity, whenever one phenomenon
was detected, so was the other.

It is tempting to speculate that the

metabolic alterations associated with insulin deficiency result in
conformational changes in the receptor that renders the coupling between
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insulin binding and autophosphorylation less efficient.

The precise

relationship, if any, between the observed alteration in the kinase
kinetics in the diabetic derived insulin receptor and the structural
heterogeneity of the f3-subunit remains to be defined.

Yamaguchi et a1.

(49) recently reported that neuraminidase treatment of highly purified
placental insulin receptors increased insulin binding and tyrosine
kinase activity.

This observation suggests that alterations in sugar

side chains may indeed modulate insulin-receptor function.
The insulin resistance which accompanies poorly controlled
insulinopenic diabetes involves both the liver and peripheral tissues;
skeletal muscle has been implicated as the primary site (4).

The work

of Kadowaki in liver (36) and the present work in skeletal muscle
suggest that diabetes induced changes in the

~-~ubunit

receptor may playa role in this insulin resistance.

of the insulin
In recent years

there has been increasing awareness that insulin resistance associated
with different pathological conditions is caused to variable degrees by
a defect in the binding of insulin to its targets, or to defects which
occur after insulin binding.

The latter abnormalities are generally

referred to as post-receptor defects, with the tacit implication that
they are distal to the receptor, involve the intracellular metabolic
milieu, second messengers or their intracellular targets.

Our data as

well as those of others (36,39), including a rare genetic defect of the
insulin receptor (50,51) suggest that post-binding defects may include
"intra-receptor" defects, resulting in defective signalling by the
receptor in response to hormone binding.
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Figure 1

Scatchard analysis of 1251-insulin binding to solubilized,
wheat germ agglutinin purified insulin receptors.
agglutinin eluate (50

~l)

Wheat germ

was incubated for 16h at 4°C in a

. solution containing 25 mm Hepes, 0.1% Triton X-100, 150 roM
NaCl, 0.1 mg/ml bovine serum albumin and 100 U/ml bacitracin
with 1251-insulin (10,000 cpm; 125-175 ~Ci/~g) and increasing
concentrations of unlabeled insulin in a final volume of 200
~l.

The receptor and bound insulin were precipitated by se-

quential addition of 100

~l

25% polyethyleneglycol.

Non-specific binding was estimated as

0.3% bovine y-globulin and 300

~l

the radioactivity precipitated in the presence of 10,000 ng/ml
unlabeled insulin.

Specific binding was normalized to protein

concentration in the wheat germ eluat.e estimated by the
Bradford reaction (26).
diabetic-treated

(a-~)

Control (0-0), diabetic (0-0) and
muscle derived receptor population.

Points are means of 3-5 determinations from two separate
experiments.
of the mean.

SEM of pmole bound/mg protein ranged from 7-17%
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Figure 2

Dose-response of insulin-stimulated autophosphorylation of the
~-subunit

(50-70

~l)

of solubilized insulin receptors.

Wheat germ eluate

from control derived receptors (0-0) and equal

binding activities from diabetic (0-0) and insulin treated
diabetic rats (fi-8) were incubated for 4S min in 25 mM Hepes,

pH 7.4, 0.1% Triton X-100, 0.05% bovine serum albumin,
O.15-0.3M N-actylglucosamine and 5 roM HoCl 2 at 25°C without or
in the presence of 10- 10 to 10- 6 M insulin in a final volume
of 75 1J1. After cooling the vials to 4°C, autophosphorylation was initiated by the addition of y[32Pl ATP (100 ~M, 15
IJCi/vial) and the reaction continued for 30 min at 4°C and
terminated by the addition of 4X concentrated Laemrnli's sample
buffer containing 5 roM 2-mercaptoethanol and heated for 3 min
at 100°C.

The samples were analysed by 7.5% SDS-PAGE, the

f3-subunit was localized by autoradiography, excised, digested
in 1 ml 30% H2 0 2 and counted in a liquid scintillation
counter.

Values are means for 5 separate preparations from

control and diabetic rats respectively and 3 insulin treated
diabetics; preparations were assayed in triplicate in each
group.

All points in the diabetic derived preparation are

different from control, p < 0.05; SEM are 7-12% of the means.
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Figure 3

Angiotensin II phosphorylation by skeletal muscle derived
insulin receptors.

Wheat germ agglutinin eluates were
_9

preincubated with 0, 10

_7

or 10

M insulin for 45 min at 25°C

and then allowed to autophosphorylate for 30 min at 4°C in the
presence of 100 ~M y[32 p ]ATP.

Aliquots (35 ~l) were added to

5 pI of buffer or Angiotensin II (2 mM final cone.) and the
reaction continued for an additional 5 min when 50 IJI
were added.

5%

TCA

After cooling on ice for 30 min the protein

precipitate was removed by centrifugation and duplicate 40 1J1
aliquots were spotted onto phosphocellulose paper.

After

washing, the papers were counted in a liquid scintillation
counter.

Equal binding activities were assayed in each

preparation.

(

diabetic-treated.

), control; (

), diabetic, (

),

Means ± S.E.M. for 3-5 different receptor

preparations are shown, each assayed in triplicate.
significantly different from control, p < 0.05.
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Figure 4

Autoradiogram of Histone H b phosphorylated by skeletal muscle
2
derived insulin receptors.

Wheat germ eluates

from

~',lC )J1.

controls and equal binding activity from diabetics were
incubated with insulin-agarose conjugates for 60 min at 25°C
as described in "Methods".

After washing, the insulin-agarose

bound receptors were allowed to autophosphorylate in the
presence of 750

~M

ATP, 5 mM Mne1 2 and 0.025% BSA for 10 min

at 25°C, then washed and incubated in phosphorylation buffer
with 1 mg/ml of histone H b and 50
2
at 25°C for 4 min.

~M

32

y[

P]ATP (2.5

~Ci/vial)

The reaction was stopped by the addition

of 4 times concentrated Laemmlits sample buffer and the
samples separated by SDS-PAGE and autoradiographed.

Histone

bands were excised, digested and counted as described for the
f3-subunit in Figure 2.

Two separate sets of control and

diabetic derived receptors are shown.

Lanes A and C: H b
2

phosphorylated by control receptors; lanes Band D: H b
2
phosphorylated by diabetic derived receptors.
the position of H b.
2

Inset: Mean ± S.E.M. of

Arrow indicates
32

P cpm

incorporated into histone-H b from 4 different control and 4
2
diabetic derived insulin receptor preparations (all with equal
binding activity) each assayed in triplicate.
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Figure 5

Phosphoaminoacid analysis of the f3-subunit of skel.etal
insulin receptors.

rnu ...-.

'.e

Wheat germ purified insulin receptors from

control and diabetic animals were incubated with IO-7M insulin
as described in Figure 2.

y[32p]ATP

(25~M,

10 ~Ci/vial) was

added for 10 min at 25°C and the reaction stopped with 20 fJl
25 roM Hepes, 0.1% Triton, 40 mM ATP, 10 mM sodium pyrophosphate and 2 roM PMSF, then anti-insulin receptor antibodies
(1:400 dilution) were added and samples incubated overnight at
4°C.

The immune complex was precipitated by the addition of

Pansorbin, washed 3 times and boiled in Laemmli's sample
buffer.

The phosphorylated f3-subunit was eluted from the wet,

unfixed gel as described in Methods, precipitated with 20% TCA
and hydrolysed for Ih at 110°C in 6N HCl.

The hydrolysate was

adsorbed to Dowex l-X8, the phosphoaminoacids eluted with
O.2SN Hel and lyophilized.

After addition of mixed phospho-

aminoacid standards, the mixture was spotted on a TLC plate
and electrophoresed for 45 min in pyridine: acetic acid: H2 0
(5:15:950) pH 3.5.

The phosphoaminoacid standards were

localized by ninhydrin and

32p by

autoradiography.

The

autoradiogram presented shows control derived receptors (C)
and diabetic derived receptors (D).

The interrupted lines

indicate the location of phosphoserine (P-ser), phosphothreonine (P-thr) and phosphotyrosine (P-tyr) standards.

A small

amount of phosphoserine was detected on the autoradiogram but
did not reproduce on the photograph.
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Figure 6

Two-dimensional phosphopeptide analysis and autoradiography
of insulin receptor

~-subunit.

Insulin receptors from control

(A) and diabetic (B) animals were phosphorylated, immunopre-

cipitated, eluted and TCA precipitated as described in Figure
5.

The precipitated protein was washed with ether/ethanol

(1:1), oxidized with formic acidjH 2 0 2 (9:1) and digested with

TPCK treated trypsin in 50 mM (NH4)2C03 pH 8 for 24 hrs.
After removal of (NH4)2C03 by lyophilization the hydrolysate was
spotted on 20 x 20 cm TLC plates, electrophoresed for 40 min.

. th
.
" 1~~ (NH 4 )2C0 3 pH 8.9, and ascended
1n
. e f'1rs t d"lmenSl0n
1n
chromatographically in the second dimension with N-butanol:
pyridine: acetic acid: H2 0 (30:15:7:37.5).

The dried plate

was then auto radiographed for 4 days at -BOoC with
intensifying screens.
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Figure 7

Structural analysis of the insulin receptor a-subunit.
Control and diabetic derived insulin receptors were dialysed
against SO mM Hepes, pH 7.8, concentrated with ttAquacide" and
equal binding activities incubated for 16 hrs with 0.5
A14[

4°C.

125

~Ci

I]insulin with or without 10 IJg unlabeled insulin at

Disuccinimidyl suberate was added in DMSO to a final

concentration of 2 roM and incubated for an additional 15 min
when 4X concentrated Laemmli's sample buffer with 5 roM
2-mercaptoethanol were added.

The samples were separated on

6% SDS-PAGE and the dried gel autoradiographed.

Lane A,

control derived receptors; lane B, diabetic derived receptors,
lane C and D control and diabetic derived receptors
crosslinked in the presence of 10

~g/ml

unlabeled insulin.
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Figure 8

Structural analysis of insulin receptor (3-subunit " Hheat
germ eluates with approximately equal insulin binding
activities, prepared from muscles of control, diabetic and
diabetic treated-rats were incubated with 10- 7M insulin for 45
min and autophosphorylated for 10

~in

in the

pr~sence

of 10

~M

y(32p]ATP, (- 15 fJCi/100 IJl).Receptors were immunoprecipitated with anti-insulin receptor antibody and Pansorbin.

The

precipitates were either boiled in Laemmli's sample buffer and
analyzed by 7.5% SDS-PAGE under reducing conditions or first
digested for 5 min at 37°C in SO roM sodium acetate buffer pH 5
with 75 f.Jg/ml S. Aureus VB protease and then analyzed by 9%
SDS-PAGEunder reducing conditions.

Dried, fixed gels were

autoradiographed with intensifyin;g screens at -80°C for 12-24
hrs.

Lane A represents control, B diabetic derived receptors

without protease digestion.. Lanes C, D, and E,

repres~nt

receptors derived from control, diabetic and insulin-treated
diabetic rats respectively, with prior VB protease digestion.
Lanes F, G and H .r epresent
and diabetic-treated

~-subunitsfrom

respectiv~ly,

7.5% gel by electroelution and
as described in the text.

control, diabetic

that were isolated from a

subsequ~ntly

digested with VB

Lane I represents control and J,

diabetic derived receptors after VB protease digestion, and
short autoradiographic exposure.
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Figure 9

Glycosidase digestion of phosphorylated, immunoprecipitated
insulin receptors.

Autophosphorylated insulin receptors were

immunoprecipitated and incubated

f· r ,;.. ~

, , ' •..

without (9a) or

with (9b) VB protease as described in Figure 8.

After

addition of protease inhibitors samples were incubated with
buffer alone (Lanes A and B) or with neuraminidase (40 mU/ml,
Lanes C and D) or with Endoglycosidase H (30 mU/ml, Lanes E
and F) at 37°C for 4 hours as detailed in "Methods" after
which 4X concentrated Laemmli's sample buffer was added,
samples analysed by SDS-PAGE and autoradiographed.
C, E: Control derived receptors; Lanes B,
derived receptors.

•

Lanes A,

D, F: Diabetic

The numbers on the left indicate the

positions of molecular weight markers.

the
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Figure 10 Sequential neuraminidase and endoglycosidase H treatment of

VB digested insulin receptors.

Insulin receptors were

immunoprecipitated and digested with VB protease as described
in Figure 8.

After addition of protease inhibitors and

incubation with 40 roD/ml neuraminidase for 2 hrs at 37°C
samples were placed in boiling water for 2 min.

After

cooling, endoglycosidaseH (final concentration 30 mU/ml) was

added in 4X concentrated endoglycosidase H buffer (1/3 vol.)
and the sample incubated for an additional 2 hrs at 37°C, then
processed as described in Figure 9.

The major (MWapp S4 Kd)

phosphopeptide generated by VB protease digestion is shown.
Lane A: Control, endoglycosidase H treated; Lane B: Diabetic,
endoglycosidase H treated; Lane C: Control, treated sequentially
with neuraminidase and endoglycosidase H; Lane D: Diabetic,

sequentially treated with neuraminidase and endoglycosidase H.
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CHAPTER 6: SUMMARY
In this dissertation I have attempted to define the role of the
insulin receptor in muscle insulin resistance.

As pointed out in the

introductory chapter, the insulin receptor has two domains: an insulin
binding domain and an insulin stimulatable kinase domain.

It is the

working hypothesis that these two domans work in concert to transduce
insulin's signal from the outside of the cell to the interior.

In

Chapter II investigations were undertaken to define the insulin response
in denervated skeletal muscle.

It was found that after severing the

sciatic nerve, the soleus showed a very rapid onset of decreased insulin
responsiveness and sensitivity.

In as little as 6 hours there was

nearly a 50% decrease in the ability of the denervated soleus to incorporate glucose into glycogen.
at 24 hours.

The insulin unresponsiveness was complete

This effect was not unique to the slow twitch, red muscle

in that the predominantly white, fast twitch extensor digitorwn longus
was also resistant to insulin stimulation of glycogen synthesis after
denervation.

Other parameters of glucose metabolism were also affected.

By 24 hours after denervation there was a decrease in glucose transport
activity in the absence of insulin, as assessed by studies on 2-deoxy·
glucose uptake experiments, as well as unresponsiveness to insulin
stimulation of glucose transport.

As expected, concordant with the

decrease in glucose transport, the levels of glucose-6-phosphate fell
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after denervation and did not increase after insulin treatment as was
seen in the contralateral control muscles.

This did not appear to be

related to a defect in hexose kinase activity since in the 2-deoxyglucose experiments the percent of transported glucose that was in the
2-deoxyglucose state was not different between controls and denervated
muscle.
Activation of glycogen synthase was defective 24 hours after
severing the sciatic in both the soleus and EDL.

It has been suggested

that the ability to activate glycogen synthase is dependent on the
levels of glycogen in the muscle and this may be true in the case of the
denervated soleus in that there was a significant increase in the content of glycogen in solei after 24 hours denervation.

However, there

was no significant difference in the glycogen content of the EDL after
denervation which suggests that the insulin unresponsiveness of the
glycogen synthase system is due to factors other than an increase in
glycogen stores secondary to inactivity.
Even with the severe insulin unresponsiveness of the denervated
muscle, there was not a parallel change in the muscle's response to
adrenergic agents.

Add~tion

of epinephrine to incubation media resulted

in a decrease in glycogen synthesis as well as a decrease in the glycogen content of both control and denervated solei.

No detectable

differences in the sensitivity to the adrenergic agent between the
groups was observed.
Despite the many reported changes in the membrane of muscles after
denervation there was no alteration £n insulin binding that could
account for the insulin resistance that was observed in the studies of
Chapter II.

I was only able to demonstrate a statistically significant
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change in insulin binding at low insulin concentrations using repeated
determinations.

This is unlikely to account for the insulin resistance

since there was no difference in binding at high insulin concentrations
while the denervated soleus was still unresponsive at supra-physiological concentrations of insulin.

Since mUltiple metabolic pathways

that are responsive to insulin are affected by denervation it appears
that the defect of denervated skeletal muscle occurs at a proximal step
in insulin action.

This led us to speculate that the other functional

end of the insulin receptor, that of the insulin-sensitive kinase
activity, may be affected by denervation.

Investigation of this

possibility required the development of a technique for the isolation of
functional insulin receptors from skeletal muscle.
The objective of Chapter III was to isolate and purify insulin
receptors in sufficient quantities to allow the assessment of binding
and enzymatic properties.

The main difficulty to overcome was the

resistance of muscle to homogenization which makes cellular fractionation difficult.

Initial attempts at isolation of membrane fractions

with subsequent solubilization of insulin receptors with non-ionic
detergents proved unsuccessful.

It was discovered that by freezing the

tissue in liquid nitrogen, finaly powdering with a mortar and pestle and
homogenizing in a buffer containing protease inhibitors and Triton XIOO,
it was possible to obtain a solution that contained insulin receptors
which gave typical curvilinear Scatchard binding curves.

Further

purification on agarose-bound wheat germ agglutinin purified the binding
activity lO-fold and resulted in a solution that again showed specific
insulin binding as well as an intact kinase activity.
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The properties of the insulin receptor kinase were similar to those
reported for other tissues.

Incubation of the solubilized, wheat germ

agglutinin purified fraction with [32p]ATP resulted in the labeling of a
- 95,000 dalton protein which was immunoprecipitable with anti-insulin
receptor antibodies.

Addition of insulin increased phosphorylation of

this protein which identified it as the
receptor.

~-subunit

of the insulin

Addition of insulin to the wheat germ agglutinin eluate also

increased the rate of phosphorylation of added exogenous substrates.
In Chapter III the feasibility of assessing the in situ
phosphorylation of the insulin recepto.r in incubated solei was demonstrated.

Incubation of the solei in inorganic [32p]phosphate containing

medium resulted in the equilibration of the ATP pools with labeled
phosphate.

After stimulation of the intubated muscles with insulin and

subsequent homogenization in buffer containing phosphatase inhibitors,
we could demonstrate the increase in labeling of the J3-subunit of the
insulin receptor.

The methods developed in Chapter III were then used

in studying the insulin receptor in denervated versus control muscles.
Equilibrium binding studies of the insulin receptor solubilized
from 24 hour denervated skeletal muscle showed a slight but not
significant decrease in the number of insulin receptors when normalized
to the protein content of the final wheat germ eluate.

This is

consistent with the finding presented in Chapter II where binding of
insulin to whole muscles showed only a small decrease after denervation.
Likewise, the purified insulin receptors from denervated skeletal muscle
showed no change in the ability to autophosphorylate in response to
insulin nor was there a change in the exogenous substrate kinase
activity of the fully activated insulin receptor.

The activation of the
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insulin receptor was accomplished by binding the receptors to an
insoluble matrix of insulin agarose.

The receptors were fully activated

by an initial autophosphorylation in the presence of 750

~M

ATP and,

after washing, the exogenous kinase activity was assessed.
The assessment of in situ autophosphorylation of denervated
skeletal muscle insulin receptors gave inconclusive results.

The amount

of autophosphorylation of the insulin receptor f3-subunit that occurred
in the presence of insulin was lower than that observed in controls.
However, the decrease in autophosphorylation was paralleled by a
decrease in the specific activity of the ATP pools attained just prior
to insulin addition.

It was of interest that there was no difference in

the amount of radioactivity associated with the

~-subunit

in the absence

of insulin despite the consistent finding of a decrease in ATP specific
activity.

This result suggests there may be an increase in the basal

autophosphorylation of the receptor.
With the in situ phosphorylation results somewhat murky in their
interpretation, we developed an alternate method for assessing the
activation of the insulin receptor in the denervated versus the control
muscle.

An intravenous injection of saline or insulin and subsequent

homogenization of the hind limb muscles in buffer containing phosphatase
inhibitors allowed the demonstration of an increase in the kinase
activity of the insulin receptors isolated from insulin treated rats.
Two different methods were used to clear the solutions of phosphatase
and kinase inhibitors with identical results obtained in each.
Furthermore, the increase in the exogenous substrate kinase activity
witnessed after insulin treatment was due to an increase in tyrosine
phosphorylation, most likely due to insulin receptor associated tyrosine
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kinase activity..

In these experiments no difference was seen in the

ability of the kinase activity from denervated skeletal muscle to be
activated even though the ipsilateral soleus muScles from the same legs
demonstrated resistance to both in vivo and in vitro insulin stimulation
of glycogen synthesis .

The finding that the insulin receptors in denervated skeletal
muscle can bind insulin and the intrinsic tyrosine kinase activity of
the insulin receptors can be activated as well as controls demonstrates
that the insulin resistance of denervated skeletal muscle is a true
'post receptor' defect.

As such, the denervated skeletal muscle can

serve as a model for insulin resistance.

The exact cause of the insulin

resistance of denervated skeletal muscle remains unsolved.

It may be

due to a change in the activity of the tsecond messenger' of insulin or
perhaps to a decrease in the sought substrate for the insulin receptor
kinase, or may be related to the change in the membrane potential seen
after denervation.

Whatever the reason, finding the cau.se will likely

give insight into the mechanism of insulin action.
In contrast to denervated skeletal muscle, there was a pronounced
change in the insulin receptor derived from diabetic skeletal muscle.
The binding domain of the insulin receptor did not appear to be altered
after 7 days of insulinopenic diabetes induced in the rat by treatment
with streptozotocin except that the nwnber of insulin receptors increased

nearly two fold when normalized to the protein in the wheat

germ agglutinin eluate without a change in binding affinity.

Cross-

linking of the a-subunit showed no changes in the migration in the
diabetic derived muscle receptor as compared to the control.

When the
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kinase activity of the diabetic derived insulin receptor was investigated a significant decrease in the ability to autophosphorylate was
observed as well as a concommitant decrease in the exogenous substrate
kinase activity when assessed by two different methods with two different phosphoacceptors.

The kinetic changes that occurred could be

reversed by treatment of the animals with insulin to normalize blood
glucose levels.
In addition to the change in kinase'activity of the f)-subunit of
the insulin receptor, we also discovered that 7 days insulinopenic
diabetes also resulted in the appearance of a subpopulation of

~-sub

units that had a retarded migratory behavior on electrophoresis gels.
This subpopulation could be eliminated by insulin treatment of the
diabetic rat.

Digestion of the immunoprecipitated insulin receptor with

glycosidases increased the migration of the phosphorylated f3-subunit.
Treatment with endoglycosidase H enhanced the separation of the phosphorylated fj-subunit that co-migrated with control and the one that
appeared in the diabetic derived insulin receptor preparation.

Neuramini-

dase, on the other hand, appeared to reduce or eliminate the differences
in migration of the control and diabetic derived insulin receptor populations, suggesting that the differences in migration were due to an
excessive sialidation of the f3-subunit of the insulin receptor in diabetes.

We were however unable to completely eliminate the second,

slower migrating band of the diabeticf3-subunit by sequential digestion
with neuraminidase and endoglycosidase H, which suggests that other
carbohydrate components contribute to the alteration in insulin receptor
migratory behavior on electrophoresis gels.
structural properties is the cause of the

Whether this alteration in

chang~

in kinase activity
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observed in the insulin receptor or is coincidental is unknown.

It is

interesting that both the structural change and the alteration in kinase
activity are reversed by insulin treatment and when one is observed, so
is the other.
In conclusion, the work presented in this dissertation does point
out that some, but not all, insulin resistant states may show a concordant change in the properties of the insulin receptor.

The exact role

of the alteration in the kinase activity and structural changes play in
the insulin resistance associated with insulinopenic diabetes

~waits

the

direct demonstration of the role the kinase activity plays ip initiating
insulin's action in the cell.

In the case of skeletal muscle, one must

look past the receptor to discover the reason for the insulin resistance
seen so soon after denervation.
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experiments we established that 2-deoxyglucose uptake of muscles incubated with or without insulin was linear with time under these conditions.
The correlation coefficients (r) of 2-deoxyglucose uptake (0.1 mM)
VS.

time (10,15,20 and 30 min.) were 0.996 in the absence and in the

presence of 1 mU/ml of insulin; with 5 roM 2-deoxyglucose the respective
r values were 0.972 without and 0.989 with insulin, (n
point).

=4

muscles/time

With 5 roM 2-deoxyglucose in the presence of insulin initial

rates of 2-deoxyglucose uptake decreased after 15 min., and only the
first two time points were used in the calculation of the r value.

In

subsequent experiments, all incubations with 5 mM 2-deoxyglucose were
limited to 15 min.
The degree of phosphorylation of intracellular 2-deoxyglucose was
determined after separating 2-deoxyglucose from 2-deoxyglucose-6-P0
chromatography on Dowex l-X8 columns (11).
[

14

4

by

It was assumed that

CJsucrose and extracellular free 2-deoxyglucose were distributed

identically, and that 2-deoxyglucose-6-P0

4

was only found intra-

cellularly.
Glucose-6-phosphate (G-6-P) content.

Muscles were preincubated and

incubated as described for the glycogen synthesis experiments except
that [14C]glucose was omitted.

Immediately after incubation the muscles

were frozen between two blocks of dry ice, placed into 1 ml of ice cold

6% perchloric acid and homogenized for 1 min. with an ice-cooled
Polytron tissue homogenizer (Brinkman, Ill.).

The precipitated protein

was pelleted by centrifugation at 5000 x gfor 15 min.
was neutralized with KHC0

3

The supernate

and G-6-P assayed by the method of Lowry and

Passoneau (12) in an Aminco-Bowman spectrofluorometer.

